0001437749-17-003944.txt : 20170307 0001437749-17-003944.hdr.sgml : 20170307 20170307163242 ACCESSION NUMBER: 0001437749-17-003944 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20170131 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ocean Power Technologies, Inc. CENTRAL INDEX KEY: 0001378140 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRIC SERVICES [4911] IRS NUMBER: 222535818 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33417 FILM NUMBER: 17672387 BUSINESS ADDRESS: STREET 1: 1590 REED ROAD CITY: PENNINGTON STATE: NJ ZIP: 08534 BUSINESS PHONE: 609-730-0400 MAIL ADDRESS: STREET 1: 1590 REED ROAD CITY: PENNINGTON STATE: NJ ZIP: 08534 FORMER COMPANY: FORMER CONFORMED NAME: Ocean Power Technologies, INc. DATE OF NAME CHANGE: 20061012 10-Q 1 optt20170131_10q.htm FORM 10-Q optt20170131_10q.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q     

 

(Mark One)

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended January 31, 2017

 

Or

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period From                     to                    

 

Commission file number: 001-33417

 

OCEAN POWER TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

22-2535818

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

1590 REED ROAD, PENNINGTON, NJ 08534

(Address of Principal Executive Offices, Including Zip Code)

 

(609) 730-0400

(Registrant's Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

  

Large accelerated filer ☐

 

Accelerated filer ☐

 

Non-accelerated filer ☐

 

Smaller reporting company ☑

             

 

 

 

 

(Do not check if a smaller reporting company)

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

 

As of February 28, 2017 the number of outstanding shares of common stock of the registrant was 6,313,996.

 

 

 
 

 

   

OCEAN POWER TECHNOLOGIES, INC.

INDEX TO FORM 10-Q

   

 

Page

 

Number

PART I — FINANCIAL INFORMATION

 

Item 1. Financial Statements:

4

Consolidated Balance Sheets as of January 31, 2017 (unaudited) and April 30, 2016

4

Unaudited Consolidated Statements of Operations for the three and nine months ended January 31, 2017 and 2016

5

Unaudited Consolidated Statements of Comprehensive Loss for the three and nine months ended January 31, 2017 and 2016

6

Unaudited Consolidated Statements of Stockholders' Equity for the nine months ended January 31, 2017

7

Unaudited Consolidated Statements of Cash Flows for the nine months ended January 31, 2017 and 2016

8

Unaudited Notes to Consolidated Financial Statements

9

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3. Quantitative and Qualitative Disclosures About Market Risk

33

Item 4. Controls and Procedures

33

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

35

Item 1A. Risk Factors

37

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

38

Item 3. Defaults Upon Senior Securities

38

Item 4. Mine Safety Disclosures

38

Item 5. Other Information

38

Item 6. Exhibits

39

 

PowerBuoy® is a registered trademark of Ocean Power Technologies, Inc. and the Ocean Power Technologies logo is a trademark of Ocean Power Technologies, Inc. All other trademarks appearing in this report are the property of their respective holders.

 

 

 
 

 

  

Special Note Regarding Forward-Looking Statements

 

We have made statements in this Quarterly Report on Form 10-Q that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements convey our current expectations or forecasts of future events. Forward-looking statements include statements regarding our future financial position, business strategy, pending, threatened, and current litigation, liquidity, budgets, projected costs, plans and objectives of management for future operations. The words "may," "continue," "estimate," "intend," "plan," "will," "believe," "project," "expect," "anticipate", “goal” and similar expressions may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking.

 

The forward-looking statements contained in or incorporated by reference are largely based on our expectations, which reflect estimates and assumptions made by our management. These estimates and assumptions reflect our best judgment based on currently known market conditions and other factors. Although we believe such estimates and assumptions to be reasonable, they are inherently uncertain and involve a number of risks and uncertainties that are beyond our control, including:

 

 

our ability to commercialize our PowerBuoys, and achieve and sustain profitability;

 

 

our continued development of our proprietary technologies, and expected continued use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services;

 

 

our ability to obtain additional funding, as and if needed which will be subject to a number of factors, including market conditions, and our operating performance;

 

 

our estimates regarding expenses, future revenues and capital requirements;

 

 

the adequacy of our cash balances and our need for additional financings;

 

 

our ability to develop and manufacture a commercially viable PowerBuoy product;

 

 

that we will be successful in our efforts to commercialize our PowerBuoy or the timetable upon which commercialization can be achieved, if at all;

 

 

our ability to identify and penetrate markets for our PowerBuoys and our wave energy technology;

 

 

our ability to implement our commercialization strategy as planned, or at all;

 

 

our ability to maintain the listing of our common stock on the NASDAQ Capital Market;

 

 

the reliability of our technology and our PowerBuoys;

 

 

our ability to improve the power output, survivability and reliability of our PowerBuoys;

 

 

the impact of pending and threatened litigation on our business, financial condition and liquidity;

 

 

changes in current legislation, regulations and economic conditions that affect the demand for renewable energy;

 

 

our ability to compete effectively in our target markets;

 

 

our limited operating history and history of operating losses;

 

 

our sales and marketing capabilities and strategy in the United States and internationally; and

 

 

our ability to protect our intellectual property portfolio.

 

Any or all of our forward-looking statements in this report may turn out to be inaccurate. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. They may be affected by inaccurate assumptions we might make or unknown risks and uncertainties, including the risks, uncertainties and assumptions described in Item 1A "Risk Factors" of our Annual Report on Form 10-K for the year ended April 30, 2016, in our Quarterly Reports on Form 10-Q for the quarters ended July 31, 2016 and October 31, 2016, and elsewhere in this report. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur as contemplated and actual results could differ materially from those anticipated or implied by the forward-looking statements.

 

Many of these factors are beyond our ability to control or predict. These factors are not intended to represent a complete list of the general or specific factors that may affect us. You should not unduly rely on these forward-looking statements, which speak only as of the date of this filing. Unless required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise.

 

 

 
3

 

 

PART I — FINANCIAL INFORMATION

 

Item 1.      Financial Statements

 

Ocean Power Technologies, Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share data)

 

   

January 31, 2017

   

April 30, 2016

 
   

(Unaudited)

         
ASSETS                
Current assets:                

Cash and cash equivalents

  $ 11,110     $ 6,730  

Marketable securities

    25       75  

Restricted cash

    299       300  

Unbilled receivables

    324       37  

Litigation receivable

    -       2,500  

Other current assets

    337       117  
Total current assets     12,095       9,759  
Property and equipment, net     195       273  
Other noncurrent assets     131       319  
Total assets   $ 12,421     $ 10,351  
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current liabilities:                

Accounts payable

  $ 189     $ 373  

Accrued expenses

    3,121       2,675  

Litigation payable

    -       3,000  

Unearned revenue

    -       39  

Warrant liabilities

    653       -  

Current portion of long-term debt and capital lease obligations

    34       81  

Deferred credits payable current

    600       -  
Total current liabilities     4,597       6,168  
Long-term debt and capital lease obligations     32       55  
Deferred credits payable non-current     -       600  
Total liabilities     4,629       6,823  
Commitments and contingencies (note 11)                
Ocean Power Technologies, Inc. stockholders’ equity:                

Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding

    -       -  

Common stock, $0.001 par value; authorized 50,000,000 shares, issued 6,313,996 and 2,352,100 shares, respectively

    6       2  

Treasury stock, at cost; 46,776 and 6,894 shares, respectively

    (260 )     (138 )

Additional paid-in capital

    193,000       181,670  

Accumulated deficit

    (184,794 )     (177,884 )

Accumulated other comprehensive loss

    (160 )     (122 )
Total stockholders' equity     7,792       3,528  
Total liabilities and stockholders’ equity   $ 12,421     $ 10,351  

 

See accompanying notes to unaudited consolidated financial statements.

 

 

 
4

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Operations

(in thousands, except per share data)

  

   

Three months ended January 31,

   

Nine months ended January 31,

 
   

2017

   

2016

   

2017

   

2016

 
                                 

Revenues

  $ 221     $ 5     $ 593     $ 605  

Cost of revenues

    363       5       615       605  
Gross profit (loss)     (142 )     -       (22 )     -  

Operating expenses:

                               
Product development costs     950       1,752       3,894       5,412  
Selling, general and administrative costs     1,617       1,690       4,859       5,419  
Total operating expenses     2,567       3,442       8,753       10,831  

Operating loss

    (2,709 )     (3,442 )     (8,775 )     (10,831 )

(Loss) gain on fair value of warrant liabilities

    (104 )     -       1,161       -  

Interest income, net

    24       1       26       10  

Other (expense) income, net

    -       (3 )     -       240  

Foreign exchange loss

    (26 )     (188 )     (20 )     (194 )

Loss before income taxes

    (2,815 )     (3,632 )     (7,608 )     (10,775 )
Income tax benefit     698       1,674       698       1,674  

Net loss

    (2,117 )     (1,958 )     (6,910 )     (9,101 )
Less: Net profit attributable to the non-controlling interest in Ocean Power                                
Technologies (Australasia) Pty Ltd.     -       -       -       (45 )

Net loss attributable to Ocean Power Technologies, Inc.

  $ (2,117 )   $ (1,958 )   $ (6,910 )   $ (9,146 )

Basic and diluted net loss per share

  $ (0.37 )   $ (1.05 )   $ (1.84 )   $ (5.07 )
Weighted average shares used to compute basic and diluted net loss per share     5,783,494       1,865,464       3,763,564       1,803,559  

 

 See accompanying notes to unaudited consolidated financial statements.

 

 

 
5

 

 

 Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Comprehensive Loss

(in thousands)

   

   

Three months ended January 31,

   

Nine months ended January 31,

 
   

2017

   

2016

   

2017

   

2016

 
                                 

Net loss

  $ (2,117 )   $ (1,958 )   $ (6,910 )   $ (9,101 )

Foreign currency translation adjustment

    3       151       (38 )     106  

Total comprehensive loss

    (2,114 )     (1,807 )     (6,948 )     (8,995 )

Comprehensive income attributable to the non-controlling interest in Ocean Power Technologies (Australasia) Pty Ltd.

    -       -       -       (73 )

Comprehensive loss attributable to Ocean  Power Technologies, Inc.

  $ (2,114 )   $ (1,807 )   $ (6,948 )   $ (9,068 )

 

See accompanying notes to unaudited consolidated financial statements.

 

 

 
6

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Stockholders' Equity

(in thousands, except share data) 

  

                                                   

Accumulated

         
                                   

Additional

           

Other

         
   

Common Shares

   

Treasury Shares

   

Paid-In

   

Accumulated

   

Comprehensive

         
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Total Equity

 
                                                                 

Balances, April 30, 2016

    2,352,100     $ 2       (6,894 )   $ (138 )   $ 181,670     $ (177,884 )   $ (122 )   $ 3,528  

Net loss

    -       -       -       -       -       (6,910 )     -       (6,910 )

Stock based compensation

    -       -       -       -       224       -       -       224  

Issuance of restricted stock, net

    189,896       -       -       -       774       -       -       774  

Sale of stock

    3,772,000       4       -       -       10,332       -       -       10,336  

Acquisition of treasury stock

    -       -       (39,882 )     (122 )     -       -       -       (122 )

Other comprehensive loss

    -       -       -       -       -       -       (38 )     (38 )

Balances, January 31, 2017

    6,313,996     $ 6       (46,776 )   $ (260 )   $ 193,000     $ (184,794 )   $ (160 )   $ 7,792  

 

 See accompanying notes to unaudited consolidated financial statements.

 

 

 
7

 

  

 Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Cash Flows

(in thousands)

  

   

Nine months ended January 31,

 
   

2017

   

2016

 
                 

Cash flows from operating activities:

               
Net loss   $ (6,910 )   $ (9,101 )
Adjustments to reconcile net loss to net cash used in operating activities                
Foreign exchange gain     20       194  
Depreciation and amortization     104       84  
Compensation expense related to stock option grants & restricted stock     998       298  
Gain on fair value of warrant liabilities     (1,161 )     -  
Payment for litigation settlements     (500 )     -  
Changes in operating assets and liabilities:                
Decrease in accounts receivable     -       89  
(Increase) decrease in unbilled receivables     (286 )     44  
Increase in other current assets     (222 )     (30 )
Decrease in other noncurrent assets     169       27  
(Decrease) increase in accounts payable     (186 )     98  
Increase in accrued expenses     461       221  
Decrease in unearned revenues     (39 )     -  
Net cash used in operating activities     (7,552 )     (8,076 )

Cash flows from investing activities:

               
Purchases of marketable securities     (25 )     -  
Maturities of marketable securities     75       25  
Restricted cash     1       111  
Purchases of equipment     (22 )     (24 )
Net cash provided by investing activities     29       112  

Cash flows from financing activities:

               
Proceeds from sale of common stock, net of issuance costs     -       205  
Proceeds from issuance of common stock and related warrants, net of costs     12,150       -  
Repayment of debt     (70 )     (75 )
Acquisition of treasury stock     (122 )     (4 )
Net cash provided by financing activities     11,958       126  

Effect of exchange rate changes on cash and cash equivalents

    (55 )     (85 )
Net increase (decrease) in cash and cash equivalents     4,380       (7,923 )

Cash and cash equivalents, beginning of period

    6,730       17,336  

Cash and cash equivalents, end of period

  $ 11,110     $ 9,413  

 

See accompanying notes to unaudited consolidated financial statements.

 

 
8

 

  

Ocean Power Technologies, Inc. and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

 

(1) Background, Basis of Presentation and Liquidity

 

a)

Background

 

Ocean Power Technologies, Inc. (the “Company”) was incorporated in 1984 in New Jersey, commenced business operations in 1994 and re-incorporated in Delaware in 2007. The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since 1997. The Company markets its PowerBuoys in the United States and internationally. Since fiscal 2002, government agencies have accounted for a significant portion of the Company’s revenues.  These revenues were largely for the support of product development efforts. The Company’s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.

 

b)

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form 10-K for the year ended April 30, 2016 filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form 10-Q.

 

c)

Liquidity/Going Concern

 

The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $184.8 million as of January 31, 2017. As of January 31, 2017, the Company had approximately $11.1 million in cash on hand. The Company generated revenues of $0.6 million during each of the nine months ended January 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities as of January 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending January 31, 2018. The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.

 

Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies may include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.

 

In fiscal 2017 and 2016, the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed three equity financing arrangements during the nine months ended January 31, 2017.  The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company may be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and may cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.

 

 

 
9

 

 

On June 2, 2016, the Company entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the June Purchase Agreement, the Company sold an aggregate of 417,000 shares of Common Stock together with warrants to purchase up to an aggregate of 145,952 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.35 of a share of Common Stock at a combined purchase price of $4.60. The net proceeds to the Company from the offering were approximately $1.7 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of $6.08 per share, became exercisable on December 3, 2016 (“Initial Exercise Date”), and will expire five years following the Initial Exercise Date. 

 

On July 22, 2016, the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The net proceeds to the Company from the offering were approximately $3.6 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

 

On October 19, 2016, the Company sold 2,760,000 shares of common stock at a price of $2.75 per share, which includes the sale of 360,000 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $6.9 million, after deducting placement agent fees and offering expenses payable by the Company.

 

The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing may not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it may be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it may be forced to cease operations.

 

(2) Summary of Significant Accounting Policies

 

(a) Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Participation of stockholders other than the Company in the net assets and in the earnings or losses of a consolidated subsidiary is reflected as a non-controlling interest in the Company's Consolidated Balance Sheets and Statements of Operations, which adjusts the Company's consolidated results of operations to reflect only the Company's share of the earnings or losses of the consolidated subsidiary. As of January 31, 2017, there were no non-controlling interests.

 

In September 2015, the Company re-purchased the non-controlling interest (consisting of 11.8%) of OPTA for nominal consideration and now has 100% ownership of OPTA. The Company also periodically evaluates its relationships with other entities to identify whether they are variable interest entities, and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is included in the consolidated financial statements. As of January 31, 2017, there were no such entities.

 

(b) Use of Estimates

 

The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.

 

 

 
10

 

 

(c) Revenue Recognition

 

The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.

 

The Company has two types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.

 

Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria may be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.

 

In addition, recognition of revenue (and the related costs) may be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management may make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects may have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.

 

Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within one year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.

 

A portion of the Company’s projects have been under cost-sharing contracts.

 

(d) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least 100% of the bank’s total obligations under the agreement.

 

   

January 31, 2017

   

April 30, 2016

 
   

(in thousands)

 

Checking and savings accounts

  $ 8,587     $ 4,535  

Overnight repurchase account

    2,523       2,195  
    $ 11,110     $ 6,730  

 

(e) Marketable Securities

 

Marketable securities with original maturities longer than three months but that mature in less than one year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of January 31, 2017 and April 30, 2016, all of the Company’s investments were classified as held-to-maturity.

 

 

 
11

 

 

(f) Restricted Cash and Credit Facility

 

A portion of the Company’s cash is restricted under the terms of two security agreements.

 

One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, one of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility carries a fee of 1% per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of January 31, 2017, there was €0.3 million ($0.3 million) in letters of credit outstanding under this agreement.

 

The second agreement was between the Company and the New Jersey Board of Public Utilities (“NJBPU”). The Company received a $0.5 million recoverable grant award from the NJBPU, repayable over a five-year period beginning in November 2011. The agreement also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of January 31, 2017, the grant was fully repaid and therefore there was no certificate of deposit. See Note (6) “Debt” for additional information. Restricted cash includes the following:

 

   

January 31, 2017

   

April 30, 2016

 
   

(in thousands)

 

NJBPU agreement

  $ -     $ 50  

Barclay's Bank Agreement

    299       250  
    $ 299     $ 300  

 

(g) Foreign Exchange Gains and Losses

 

The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions may result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in foreign exchange gain in the accompanying consolidated statements of operations.

 

(h) Property and Equipment

 

Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (three to seven years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

(i) Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.

 

 

 
12

 

 

The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least 10% of the Company's consolidated revenues for at least one of the periods indicated:

 

   

Three months ended January 31,

   

Nine months ended January 31,

 
   

2017

   

2016

   

2017

   

2016

 

Mitsui Engineering & Shipbuilding

    56 %     -       83 %     -  

U.S. Department of Defense Office of

                               

Naval Research

    44 %     -       17 %     -  

US Department of Energy

    -       100 %     -       33 %

European Union (WavePort project)

    -       -       -       67 %
      100 %     100 %     100 %     100 %

 

The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.

 

(j) Warrant Liabilities

 

The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “(loss) gain on fair value of warrant liabilities”. The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “additional paid-in capital”, a component of “stockholders' equity” on the consolidated balance sheets.

 

(k) Net Loss per Common Share

 

Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.

 

In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling 680,429 for the three and nine months ended January 31, 2017 and 154,537 for the three and nine months ended January 31, 2016, were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.  

 

(l) Recently Issued Accounting Standards

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers”. This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Qualitative and quantitative information is required about:

 

 

Contracts with customers—including revenue and impairments recognized, disaggregation of revenue and information about contract balances and performance obligations (including the transaction price allocated to the remaining performance obligations).

 

Significant judgments and changes in judgments—determining the timing of satisfaction of performance obligations (over time or at a point in time), and determining the transaction price and amounts allocated to performance obligations.

 

Certain assets—assets recognized from the costs to obtain or fulfill a contract.

 

In August 2015, the FASB issued updated guidance deferring the effective date of the revenue recognition standard. In March and April 2016, the FASB issued additional updated guidance, which clarifies certain aspects of the ASU and the related implementation guidance issued by the FASB-IASB Joint Transition Resource Group for Revenue Recognition. This guidance is effective for the Company for annual reporting periods beginning after December 15, 2017. The Company is currently evaluating the impact that this guidance will have on its results of operations, financial position and cash flows.

 

In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the first annual period ending after December 15, 2016, and interim periods thereafter. Early application is permitted. The Company is evaluating the effect ASU 2014-15 will have on its consolidated financial statements and disclosures and have not yet determined the effect of the standard on its ongoing financial reporting at this time. See Note (1) “Background, Basis of Presentation and Liquidity” for discussion on the Company’s ability to continue as a going concern.

 

 

 
13

 

 

In January 2016, the FASB issued ASU No. 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities”, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company will evaluate the effect of ASU 2016-01 for future periods as applicable. 

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU 2016-02 will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.

 

In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718)”, or ASU No. 2016-09. The amendments of ASU No. 2016-09 were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity may be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No. 2016-09 is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The Company will evaluate the effect of ASU 2016-09 for future periods as applicable.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”. The standard provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets held. The ASU is effective for public companies for annual periods, and interim periods within those annual periods, beginning after December 15, 2019. The Company is evaluating the effect ASU 2016-13 will have on its consolidated financial statements and disclosures and believes the standard will have no impact on its ongoing financial reporting at this time.

 

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”, providing additional guidance on eight specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU 2016-13 will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.

 

In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”, providing additional guidance on specific restricted cash flow classification on the cash flow statement. Cash flow should include restricted cash in total cash, and an entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU 2016-18 will have on its consolidated financial statements and disclosures and believes the effect of the standard on its ongoing financial reporting will not have a material impact.

 

(3) Marketable Securities

 

Marketable securities with initial maturities greater than three months but that mature within one year from the balance sheet date are classified as current assets and are summarized as follows:

  

   

January 31, 2017

   

April 30, 2016

 
   

(in thousands)

 

Certificate of Deposit

  $ 25     $ 75  

 

 

 
14

 

 

(4) Balance Sheet Detail

 

Accrued expenses

 

January 31, 2017

   

April 30, 2016

 
   

(in thousands)

 

Project costs (a)

  $ 1,239     $ 818  

Contract loss reserve

    199       199  

Employee incentive payments

    463       688  

Accrued salary and benefits

    593       456  

Legal and accounting fees

    329       240  

Other

    298       274  
    $ 3,121     $ 2,675  

 

 

(a)

Project costs at January 31, 2017 include accruals of $0.8 million and $0.5 million for the disposition of the legacy Reedsport project anchors and site remediation for the legacy PB40 projects, respectively. The Reedsport project is anticipated to be completed by the end of the first quarter of fiscal 2018. The PB40 project is weather dependant and therefore it is not possible to predict a specific end date.

 

(5) Related Party Transactions

 

In April 2014, the Company entered into an Executive Transition Agreement with George W. Taylor, who was formerly employed by the Company as Executive Vice Chairman and served on the Company’s Board of Directors prior to that date. Under this agreement, Dr. Taylor received fifteen months of consulting fees at a monthly rate of $20 thousand (this period terminated on July 18, 2015). During the nine months ended January 31, 2016 the Company recorded $53 thousand in expense relating to this agreement, which was recorded in selling, general and administrative expense in the unaudited consolidated statements of operations.  There were no such amounts recorded during the three and nine months ended January 31, 2017.

 

(6) Debt

 

The Company was awarded a recoverable grant totaling $0.5 million between April 2009 and June 2010 from the NJBPU under the Renewable Energy Business Venture Assistance Program. Under the terms of this agreement, the amount to be repaid is a fixed monthly amount of principal only, repayable over a five-year period beginning in November 2011. The terms also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of April 30, 2016 the Company had $50 thousand outstanding and the respective $50 thousand certificate of deposit was recorded within “Other current assets” on the balance sheet. As of January 31, 2017, the grant was fully repaid, and therefore, there is no balance outstanding and no respective certificate of deposit assigned to restricted cash. See Note 2(f). “Summary of Significant Accounting Policies - Restricted Cash and Credit Facility” for more information regarding the certificate of deposit.

 

(7) Deferred Credits Payable

 

During the year ended April 30, 2001, in connection with the sale of common stock to an investor, the Company received $0.6 million from the investor in exchange for an option to purchase up to 500,000 metric tons of carbon emissions credits generated by the Company during the years 2008 through 2012, at a 30% discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to 30% of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).  Under the terms of the agreement, if the Company did not become entitled under applicable laws to the full amount of emission credits covered by the option by December 31, 2012, the Company was obligated to return the option fee of $0.6 million, less the aggregate discount on any emission credits sold to the investor prior to such date. In December 2012, the Company and the investor agreed to extend the period for the sale of emission credits until December 31, 2017. As of January 31, 2017, the Company has not generated any emissions credits eligible for purchase under the agreement. The $0.6 million is reflected on the balance sheet within “Deferred credits payable current” and “Deferred credits payable non-current” as of January 31, 2017 and April 30, 2016, respectively.

 

 

 
15

 

  

(8) Warrants

 

On June 2, 2016, the Company entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “June Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the June Purchase Agreement, the Company sold an aggregate of 417,000 shares of Common Stock together with warrants to purchase up to an aggregate of 145,952 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.35 of a share of Common Stock at a combined purchase price of $4.60. The warrants have an exercise price of $6.08 per share, became exercisable on December 3, 2016 (“Initial Exercise Date”), and will expire five years following the Initial Exercise Date. 

 

On July 22, 2016, the Company entered into a Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain institutional purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The Warrants were exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

  

The warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC 480. As such, the warrants with a value of $0.7 million at January 31, 2017 are reflected within “warrant liabilities” in the unaudited consolidated balance sheets. There were no such amounts at April 30, 2016.

 

An unrealized loss and unrealized gain of $0.1 million and $1.2 million, respectively, were included within “(Loss) gain on fair value of warrant liabilities” in the consolidated statements of operations for the three and nine months ended January 31, 2017, respectively. There were no unrealized gains or losses during the three and nine months ended January 31, 2016. The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:

 

   

January 31, 2017

 
Dividend rate     0.0%    
Risk-free rate     1.9%    

Expected life (years)

  4.5 - 4.9  

Expected volatility

  129.0% - 138.2%  

 

(9) Stock-Based Compensation

 

The aggregate stock-based compensation expense related to all stock-based transactions recorded in the consolidated statements of operations was approximately $1.0 million and $0.3 million during the nine months ended January 31, 2017 and 2016, respectively.

 

(a) Stock Options

 

Valuation Assumptions for Options Granted during the nine months ended January 31, 2017 and 2016

 

The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the nine months ended January 31, 2017, was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the "simplified" method as permitted by the SEC's Staff Accounting Bulletin No. 110, Share-Based Payment. Expected volatility was based on the Company’s historical volatility during the nine months ended January 31, 2017. The below assumptions were used to determine the weighted average per share fair value of $1.89 and $4.05 for stock options granted during the nine months ended January 31, 2017 and 2016, respectively.

 

   

Nine months ended January 31,

 
   

2017

   

2016

 

Risk-free interest rate

    1.3 %     1.6 %

Expected dividend yield

    0.0 %     0.0 %

Expected life (in years)

    5.50       5.5  

Expected volatility

    96.2 %     85.7 %

 

 

 
16

 

  

A summary of stock options under our stock incentive plans is detailed in the following table. 

 

                   

Weighted

 
                   

Average

 
           

Weighted

   

Remaining

 
   

Shares

   

Average

   

Contractual

 
   

Underlying

   

Exercise

   

Term

 
   

Options

   

Price

   

(In Years)

 

Outstanding as of April 30, 2016

    89,303     $ 42.90       3.6  

Forfeited

    (987 )   $ 46.45          

Exercised

    -     $ -          

Granted

    171,749     $ 2.12          

Outstanding as of January 31, 2017

    260,065     $ 15.96       7.2  

Exercisable as of January 31, 2017

    157,066     $ 24.44       5.6  

 

As of January 31, 2017, the total intrinsic value of outstanding and exercisable options was approximately $107 thousand and $95 thousand, respectively. As of January 31, 2017, approximately 101,392 additional options are expected to vest in the future with an intrinsic value of approximately $10 thousand and a weighted average remaining contractual term of 9.6 years. There was approximately $0.2 million and $0.1 million of total recognized compensation cost related to stock options during the nine months ended January 31, 2017 and 2016, respectively. As of January 31, 2017, there was approximately $0.2 million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of 0.8 years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.

 

(b) Restricted Stock

 

Compensation expense for non-restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the nine months ended January 31, 2017, the Company granted 223,662 shares subject to service-based vesting requirements and no shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company’s total shareholder return (“TSR”) relative to the total shareholder return of three alternative energy Exchange Traded Funds as measured over a specific performance period. No vesting of the relevant shares will occur in instances where the Company’s TSR for the relevant period is below 80% of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period may occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.

 

In January 2016, the Board of Directors authorized a modification to certain outstanding restricted stock grants, which converted certain grants with performance-based grants to service-based grants. The modification of the restricted stock grants did not have a material impact on the Company’s statement of operations during the nine months ended January 31, 2017. Restricted stock issued and unvested as of January 31, 2017 included 4,000 shares of unvested restricted stock subjected to performance-based vesting requirements.

 

A summary of non-vested restricted stock under our stock incentive plans is as follows:

 

           

Weighted

 
   

Number

   

Average Price per

 
   

of Shares

   

Share

 
                 

Issued and unvested at April 30, 2016

    40,008     $ 6.70  

Granted

    223,662     $ 3.94  

Forfeited

    (28,266 )   $ 3.98  

Vested

    (139,492 )   $ 4.70  

Issued and unvested at January 31, 2017

    95,912     $ 3.99  

 

There was approximately $0.8 million and $0.2 million of total recognized compensation cost related to restricted stock for the nine months ended January 31, 2017 and 2016, respectively. As of January 31, 2017, there was approximately $0.2 million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of 0.4 years.

 

 

 
17

 

 

(c)Treasury Stock

 

During the nine months ended January 31, 2017 and 2016, 39,882 and 1,839 shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.

 

(10) Fair Value Measurements

 

The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a three-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument’s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the three hierarchy levels.

 

Level 1

Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

 

 

Level 2

Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.

 

 

Level 3   

Unobservable inputs are not corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.

 

Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were no transfers between any levels during the three and nine months ended January 31, 2017 and 2016.

 

The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.

 

Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.

 

Warrant Liabilities

 

The fair value of the Company's warrant liabilities (refer to Note 8) recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level 3 measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.  

 

The following table presents financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2017.

 

   

Total Carrying Value in Consolidated Balance Sheet

   

Quoted prices in active markets for identical assts or liabilities

(Level 1)

   

Significant other observable inputs

(Level 2)

   

Significant unobservable inputs

(Level 3)

 

As of January 31, 2017:

 

(in thousands)

 

Warrant liabilities

  $ 653     $ -     $ -     $ 653  

 

 

 
18

 

  

The changes in the value of the warrant liabilities during the nine months ended January 31, 2017 were as follows.

 

Fair value – April 30, 2016

  $ -  

Issuance

    1,814  

Transfers

    -  

Change in fair value

    (1,161 )

Fair value – January 31, 2017

  $ 653  

 

There were no re-measured assets or liabilities at fair value on a non-recurring basis during the nine months ended January 31, 2017 and 2016, respectively.

 

 (11) Commitments and Contingencies

 

(a) Litigation

 

Shareholder Litigation and Demands 

 

The Company and its former Chief Executive Officer Charles Dunleavy were named as defendants in consolidated securities class action lawsuits that were pending in the United States District Court for the District of New Jersey captioned In Re: Ocean Power Technologies, Inc. Securities Litigation, Civil Action No. 14-3799 (FLW) (LHG).

 

On May 5, 2016, the parties entered into a Stipulation and Agreement of Class Settlement (“Stipulation”) in which they agreed to a settlement of the consolidated securities class action lawsuits, subject to Court approval. The Stipulation provides, among other things, for a settlement payment by or on behalf of the Company of $3.0 million in cash, of which the Company would pay $0.5 million and the Company’s insurer would pay $2.5 million, and the issuance by the Company of 380,000 shares (valued at $0.6 million on the date the Stipulation was signed by the parties) of its Common Stock to the class members. In connection with the settlement, the parties have agreed to execute mutually agreeable releases. The amounts agreed in the Stipulation, including the amount to be contributed by our insurance carrier, were reflected in the Company’s Consolidated Financial Statements as of April 30, 2016. In July 2016, the Company paid the $0.5 million portion of the settlement and the remaining balance of $2.5 million was paid by the Company’s insurer in August 2016. On November 14, 2016, the Court held its previously scheduled Settlement Hearing to consider whether to grant final approval of the settlement, and on November 15, 2016, the Court issued its Final Judgment approving the settlement and dismissing the proceeding with prejudice. The 380,000 shares of common stock were issued on November 22, 2016. The time to file an appeal from the Final Judgment has expired without any appeal being filed.  

 

The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on March 18, 2015 in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No. 3:15-cv-01980-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.

 

On July 10, 2015, a second derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No. 3:15-cv-05469, was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief.

 

On April 21, 2016, a third derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No. 3:16-cv-02249, was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief.

 

On June 9, 2016, a fourth derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief.

 

On October 25, 2016, the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the four derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for November 14, 2016 in the securities class action and further order of the Court. Defendants have not responded to the consolidated derivative actions because the actions remain stayed pending further order from the Court.

 

 

 
19

 

 

The Company and certain of its current directors are defendants in a lawsuit filed by an alleged shareholder in the Superior Court of New Jersey, Mercer County Chancery Division on January 25, 2016, captioned Stern v. Ocean Power Technologies, Inc., et al., Civil Action No. C-5-16. The complaint alleges that certain provisions of the Company’s Certificate of Incorporation and By-laws providing that the Company’s directors may be removed only for cause and only by an affirmative vote of at least 75% of the votes which all the stockholders would be entitled to cast in any annual election of directors are invalid under Section 141(k) of the Delaware General Corporation Law. The Complaint asserts a breach of fiduciary claim against the director defendants and a declaratory judgment claim against all defendants seeking, among other things, to invalidate the current provisions and declare that the Company’s directors may be removed and replaced without cause and by a simple majority vote. The Complaint seeks declaratory and injunctive relief as well as unspecified costs and attorneys’ fees. By Unanimous Written Consent dated June 17, 2016, the Company’s Board of Directors amended the Company’s By-laws to delete the “only for cause” requirement, thereby allowing for removal of directors with or without cause by the Company’s stockholders. In addition, the Board proposed, subject to approval by the Company’s stockholders at the next annual general meeting of stockholders, a similar amendment to the director removal provision in the Company’s Certificate of Incorporation. On June 22, 2016, the parties to the lawsuit submitted a Stipulation and Proposed Order Staying Proceedings that (1) stays the case pending the stockholder vote on the proposed amendment to the Company’s Certificate of Incorporation; (2) provides for dismissal of the action with prejudice if the stockholders approve the amendment, subject to plaintiff’s right to make a fee application to the court and defendants’ right to oppose any such application; and (3) provides for the stay to be lifted and the action to resume, without waiver of any parties’ rights, if the stockholders do not approve the amendment. The Court approved the Stipulation on June 30, 2016. On September 2, 2016, the Company filed a definitive proxy statement with the SEC which includes this proposal. At the annual shareholder meeting on October 21, 2016, the proposal was not approved because an insufficient number of votes were cast to satisfy the requirement that the proposal be approved by the holders of at least 75% of the outstanding shares of common stock entitled to vote at the meeting.  However, stockholders approved an amendment to the Company’s Certificate of Incorporation to add a provision which requires that any provision of the Certificate of Incorporation that is contrary to a requirement of the Delaware General Corporate Law shall be read in conformity with the applicable requirement of the Delaware General Corporate Law. The parties have agreed that the case shall remain stayed until further steps, if any, can be agreed to and taken as needed.

 

Employment Litigation 

 

On June 10, 2014, the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective June 9, 2014, and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On June 17, 2014, Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On July 28, 2014, Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.

 

Except for the Stipulation noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.

 

(b) Regulatory Matters

 

SEC Investigation

 

On February 4, 2015, the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on July 12, 2016, the SEC issued a second subpoena requesting information related to the Company’s April 4, 2014 public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.

 

Spain IVA (sales tax)

 

In June 2012, the Company received notice that the Spanish tax authorities are inquiring into its 2010 IVA (value-added tax) filing for which the Company benefitted from the offset of approximately $0.3 million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued two letters of credit totaling €0.3 million ($0.3 million) at the request of the Spanish tax authorities. Separately, as of January 31, 2017 the Company has received $0.2 million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during February 2017, the Spanish tax authorities approved of the release of the two outstanding letters of credit.

 

 

 
20

 

 

Spain Income Tax Audit

 

We are currently undergoing an income tax audit in Spain for the period from 2008 to 2014, when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. We have not established any provision for losses related to this matter.

 

(12) Income Taxes

 

During the three and nine months ended January 31, 2017, the Company recorded an income tax benefit of $0.7 million, representing the proceeds from the sale of $7.8 million of New Jersey net operating loss carryforwards and research and development tax credits. During the three and nine months ended January 31, 2016, the Company recorded an income tax benefit of $1.7 million representing the proceeds from the sale of $19.7 million of New Jersey net operating loss carryforwards and research and development tax credits.

 

Other than as a result of the sale of New Jersey net operating loss carryforwards, the Company did not recognize any consolidated income tax benefit (expense) during the three and nine month periods ended January 31, 2017 and 2016.

 

During the three and nine months ended January 31, 2017, the Company had no material changes in uncertain tax positions.

 

(13) Operating Segments and Geographic Information

 

The Company's business consists of one segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with one operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the three and nine months ended January 31, 2017 and 2016, the Company’s primary business operations were in North America.

 

 

 
21

 

    

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with the accompanying unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q. Some of the information contained in this management’s discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business, pending and threatened litigation and our liquidity includes forward-looking statements that involve risks and uncertainties. You should review the "Risk Factors" section of our Annual Report on Form 10-K for the year ended April 30, 2016, in our Quarterly Reports on Form 10-Q for the quarters ended July 31, 2016 and October 31, 2016, and elsewhere in this report, for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. References to a fiscal year in this Form 10-Q refer to the year ended April 30 of that year (e.g., fiscal 2016 refers to the year ended April 30, 2016).

 

Overview

 

Nearly 70% of the earth’s surface is covered by water, with over 40% of the world’s population living within approximately 150 miles of a coast. Thousands of information gathering and/or power systems are deployed in the oceans today to increase understanding of weather, climate change, biological processes, and marine mammal patterns and to support exploration and operations for industries such as oil and gas. Most of these systems are powered by battery, solar, wind, fuel cell, or fossil fuel generators that are unreliable and expensive to operate while also limited in their electric power delivery. These incumbent systems often require significant tradeoffs in sensor accuracy, data processing and communications bandwidth and frequency in order to operate with limited available power. More persistent power systems requiring less maintenance, like our systems, may have the ability to save costs over current operating systems. Just as importantly, increases in available power may allow for better sensors and faster data sampling and higher frequency communication intervals up to real-time which could as a result improve scientific and economic returns.

 

Incorporated in 1984 and headquartered in Pennington, New Jersey, we believe we are the leader in ocean wave power conversion technology. We are developing and commercializing our proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. Our PowerBuoys use proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. We currently have designed and continue to develop our PowerBuoy product line which is based on modular, ocean-going buoys, which we have been periodically ocean testing since 1997.

 

We have designed our autonomous PowerBuoy to generate power for use in remote locations, independent of an existing conventional power grid. Our current PowerBuoy product, the PB3, incorporates a unique power take-off (“PTO”) and onboard system for energy storage and management, and is significantly smaller than our previous iteration utility-scale PowerBuoy. We are continuing to develop and test our PowerBuoys, which we believe could be utilized in a variety of applications.

 

Our PB3 PowerBuoy design leverages portions of earlier features that we do not believe require further validation prior to implementation in our current products. Currently, our product development and engineering efforts are focusing primarily on developing technologies that will increase the energy output and reliability of our product through design scalability to maintain quality and speed time to our targeted markets. Our marketing and development efforts are targeting applications that require reliable, persistent, and sustainable power sources operating independently of the utility grid, either by supplying electric power to payloads that are integrated directly in our PowerBuoy or located in its vicinity including on the seabed and in the water column.

 

Based on our market research and available public data, management believes that there is the potential for us to pursue business opportunities in multiple markets that would have a direct need for our PowerBuoys including oil and gas, ocean observing, defense and security, communications, and offshore wind. Depending on power needs, sensor types and other considerations, we believe our PowerBuoy could have the ability to satisfy several application requirements within these markets. We believe that the PB3 generates sufficient persistent power to meet the application needs of many of the potential customers within our target markets. We are continuing our development efforts to increase the energy output of the PowerBuoy to generate more power required for other applications within these markets.

 

Since fiscal 2002, government agencies have accounted for a significant portion of our revenues. These revenues were largely for the support of our development efforts relating to our technology and development of our PowerBuoys. Our goal is that an increased portion of our revenues be from the sale or lease of our products and sales of services, as compared to revenue from grants to support our business operations. As we continue to develop and commercialize our products, we expect to have a net loss of cash from operating activities unless and until we achieve positive cash flow from the commercialization of our products and services. During fiscal 2016 and 2017, we continued work on projects with the U.S. Department of Defense (“DOD”), and Mitsui Engineering and Shipbuilding Co., Ltd. (“MES”), with whom we signed our first commercial leasing agreement in May 2016, and we continued our efforts to increase the reliability and power output of our PowerBuoys.

 

 

 
22

 

 

Product Development

 

The development of our technology has been funded by capital raised and by development engineering contracts received starting in fiscal 1995, including projects with the U.S. Department of Energy (“DOE”), the U.S. Navy, the Department of Homeland Security and MES. Through these historic projects, the Company also continued development of our current and our next generation PowerBuoy technology.

 

During fiscal 2017, we continue to focus on the commercialization of our PowerBuoy technology in autonomous application markets. We completed our work under our DOE contract that focused on further optimization of our modular PTO technology and delivered the project final report to the DOE in February 2016. In January 2016, we successfully completed the final stage and associated review with the DOE of the contract deliverables during which the DOE reviewed advancements related to PTO design aspects such as reliability, cost take out, manufacturability and scalability. As we continued to focus on the development and validation of our PB3 PowerBuoy commercial product, our activities concentrated mainly on implementing all of our lessons learned during our efforts in the prior fiscal year from our ocean deployments and accelerated life testing (“ALT”). The resulting improved PB3 PowerBuoy was deployed off the coast of New Jersey in July of 2016 and was retrieved early December 2016 upon completing all intended testing and validation. Inspection and refurbishment of the PB3 PowerBuoy were completed and this PB3 was shipped for delivery to MES in Japan to fulfill the requirements of our lease with MES, including a deployment off of Kozu-Island in the Pacific Ocean. ALT of the PB3 commercial PTO is ongoing with no failures to date. In addition to the deployment of the PB3 PowerBuoy, the prior generation pre-commercial PB3 (“PB3-A1”), was fitted with a sensor that collects tagged marine mammal migration information as well as with a Self-Contained Ocean Observing Payload (“SCOOP”). The marine mammal migration detection sensor was attached to the PB3-A1 PowerBuoy as part of an agreed scope of work with the Wildlife Conservation Society (“WCS”) through a memorandum of agreement between WCS and OPT. The SCOOP payload was integrated into PB3-A1 to complete the Phase 1 work scope of a Cooperative Research and Development Agreement (“CRADA”) between the National Data Buoy Center (“NDBC”) and OPT. The PB3-A1, deployed off the coast of New Jersey in May 2016, was retrieved in October 2016. From July 2016 through October 2016, both PB3-A1 and PB3 were concurrently deployed generating valuable performance validation data. Both the NDBC SCOOP as well as the WCS tagged mammal migration detection sensor met all of their performance requirements. This pre-commercial PowerBuoy is now undergoing a full upgrade to achieve full commercial status by retrofitting it with the final commercial PTO including our modular energy storage system, and to make it available to support our on-going commercialization efforts. In addition to the PB3 commercial product validation activities, a concerted effort has been underway which focuses on proactively implementing additional features driven by extensive and direct discussions with potential users and customers in our target markets. Such features include:

 

 

The design, development and implementation of a versatile mooring interface that allows the PB3 to accommodate various types of mooring configurations depending on the specifics and the needs of the customer, eliminating the need for a redesign to the device.

 

The design, development and implementation of a flexible power transmission system intended to support delivery of power and communication capabilities to customer payloads which are external to the PowerBuoy, and which may reside in the water column or on the seabed.

 

Additionally, and building upon our initial success in implementing an auto-ballast system in our commercial PB3, we are further enhancing this feature in order to achieve faster and more cost effective PB3 deployments and retrievals.

 

Further, the development of our PB15, the next scale-up of our autonomous PowerBuoy which is in accordance with our product roadmap, is underway. Our intent is to complete the preliminary design of our PB15 in fiscal 2017. We believe the PB15 PowerBuoy would have a peak rating of 15kW and an average continuous power output that depends on the deployment site’s metocean conditions. While this scale-up leverages every aspect of the product development and validation of the PB3, it also strategically positions the product to allow OPT to respond to higher power needs as expressed by potential end-users and customers in our target markets.

 

As previously stated, the PB3 has achieved commercial status through a series of design iterations which focused on improving its reliability and survivability in the ocean environment. Though the PB3 will continue to undergo further enhancements through customary product life cycle management, we believe the PB3 has achieved a maturity level for immediate commercial use. We believe that the PB3 will generate and store sufficient power to address various application requirements in our target markets. Our product development and engineering efforts are focused, in part, on increasing the energy output and efficiency of our PowerBuoys and, if we are able to do so, we believe the PowerBuoy would be useful for additional applications where cost savings and additional power are required by our potential customers. We continue to explore opportunities in these target markets, and we have not yet finalized any product offerings in these potential markets. We believe that by increasing the energy output of our PowerBuoys we may be able to address larger segments of our target markets. By improving our design and manufacturing, we also seek to reduce the cost of our PowerBuoys through further design iterations and manufacturing ramp-up. In so doing, we seek to improve customer value, displace additional incumbent solutions, and become a viable power source for new applications in our target markets.

 

 

 
23

 

 

Commercial Activities

 

We are seeking to build strategic alliances with other companies that have developed or are developing in-ocean applications requiring a persistent source of power that is also capable of real time data collection, processing and communication, to address potential customer needs. As announced in October 2015, we signed a memorandum of understanding (“MOU”) with Gardline Environmental, Ltd. to jointly investigate innovative metocean monitoring and maritime security systems for prospective customers using both companies’ technologies. The MOU can be terminated by either party, and each party will bear its own respective work scope costs associated with the MOU.

 

In May 2016, we entered into a contract with MES totaling $1.0 million, a portion of which was performed in fiscal 2016 as agreed under a letter of intent signed in March 2016. The contract with MES included certain engineering and other services, and a six-month lease of our PB3 PowerBuoy, commencing in February 2017, and extending through July 2017.

 

In September 2016, we entered into a contract with the Department of Defense Office of Naval Research (“ONR”) totaling approximately $0.2 million to carry out the first phase of a project which focuses on the initial concept design and development of a mass-on-spring PTO-based PowerBuoy leveraging a number of OPT patents covering such a technology. If successful, this device is expected to be able to respond to the unique set of requirements expected in various military marine applications.

 

In November 2016, we entered into a joint marketing agreement with Sonalysts, Inc. The purpose of this agreement is for OPT and Sonalysts to collaboratively identify and pursue opportunities leveraging our individual products and capabilities. Sonalysts has primary capabilities in operations and analysis; modeling and simulation; systems engineering and integration; program support; and undersea wireless communications technologies.

 

In February 2017, we entered into a joint application engineering and marketing agreement with HAI Technologies (“HAI”). The purpose is for OPT and HAI to jointly and collaboratively identify, pursue and develop opportunities and applications in the oil and gas industry while leveraging our respective products and capabilities. HAI Technologies has unique capabilities in a variety of subsea applications, including new and advanced chemical injection solutions for subsea oil production fields for which OPT’s PowerBuoy technology in general and the PB3 PowerBuoy in particular may enable the implementation of such solutions in a cost effective manner.

 

During the nine months ended January 31, 2017, we deployed the PB3-A1 PowerBuoy and deployed the commercial PB3 PowerBuoy. The PB3-A1 included a payload from the NDBC, under a CRADA to conduct ocean demonstrations of its innovative SCOOP monitoring system as well as a WCS tagged marine mammal migration pattern monitoring sensor. The WCS sensor was used in a first step to assess whether the PB3 could ultimately provide power to WCS’ sensors, transmit data, and provide real-time data communication for acoustic monitoring of the movements of marine wildlife in certain waters. In June 2016, we deployed the PB3-A1 off the coast of New Jersey. The SCOOP was powered by the PB3-A1, where it provided metocean data to OPT and to NDBC without issue throughout the duration of the deployment. The data collected by the WCS sensor was processed by WCS and indicated no issues in terms of compatibility of the sensor with the PowerBuoy, which prompted discussions between OPT and WCS regarding potentially integrating such sensors into the PB3 to provide power and real time communications to it, which may result in a future commercial solution. The PB3-A1was retrieved in October 2016 and is undergoing a full system update by incorporating the full commercial PTO to be brought up to full commercial status similar to the PB3.

 

During the nine months ended January 31, 2017, we progressed discussions with our Technical Advisory Panel members, made up of company representatives from the oil and gas industry as well as experts from academia, and conducted extensive business development meetings and other activities with potential customers and business partners. We also continued our accelerated life testing to further validate the reliability and durability of our PowerBuoys. 

  

Capital Raises

 

On June 2, 2016, we entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the June Purchase Agreement, we sold an aggregate of 417,000 shares of Common Stock together with warrants to purchase up to an aggregate of 145,952 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.35 of a share of Common Stock at a combined purchase price of $4.60. The net proceeds to the Company from the offering were approximately $1.7 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of $6.08 per share, became exercisable on December 3, 2016 (“Initial Exercise Date”), and will expire five years following the Initial Exercise Date. 

 

On July 22, 2016, we entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, we sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The net proceeds to the Company from the offering were approximately $3.6 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants will be exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

 

 

 
24

 

  

On October 19, 2016, we sold 2,760,000 shares of common stock at a price of $2.75 per share, which includes the sale of 360,000 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $6.9 million, after deducting placement agent fees and offering expenses payable by the Company.

 

The sale of additional equity or convertible securities could result in dilution to our stockholders. If additional funds are raised through the issuance of debt securities or preferred stock, these securities could have rights senior to those associated with our common stock and could contain covenants that would restrict our operations. We do not have any committed sources of debt or equity financing and we cannot assure you that financing will be available in amounts or on terms acceptable to us when needed, or at all. If we are unable to obtain required financing when needed, we may be required to reduce the scope of our operations, including our planned product development and marketing efforts, which could materially and adversely affect our financial condition and operating results. If we are unable to secure additional financing, we may be forced to cease our operations.

 

Backlog

 

As of January 31, 2017 our backlog was approximately $0.5 million and on April 30, 2016, our backlog was negligible.

 

Our backlog can include both funded amounts, which are unfilled firm orders for our products and services for which funding has been both authorized and appropriated by the customer (U.S. Congress, in the case of U.S. Government agencies), and unfunded amounts, which are unfilled firm orders for which funding has not been appropriated. If any of our contracts were to be terminated, our backlog would be reduced by the expected value of the remaining terms of such contract. Our backlog was fully funded at January 31, 2017.

 

The amount of contract backlog is not necessarily indicative of future revenue because modifications to, or terminations of present contracts and production delays can provide additional revenue or reduce anticipated revenue. A substantial portion of our revenue has been for the support of our product development efforts. These revenues are recognized using the percentage-of-completion method, and changes in estimates from time to time may have a significant effect on revenue and backlog. Our backlog is also typically subject to large variations from time to time due to the timing of new awards.

 

Business Strategy

 

As part of our strategic pivot in operations initiated in fiscal 2015, we are currently focused on developing and commercializing our PowerBuoy products and services for use in autonomous power applications. Generally, these applications are independent of the power grid and are located in remote offshore locations. We have incorporated our prior knowledge and best practices into our product design and validation processes, some of which were gained during the development of utility scale buoys. Based on market research and available public data, we believe considerable business opportunities may exist in markets which require autonomous offshore power. Based on our market research and available public data, management believes that there is the potential for us to pursue business opportunities in multiple markets that would have a direct need for our PowerBuoys including oil and gas, ocean observing, defense and security, communications, and offshore wind.

 

Our business strategy is to commercialize our autonomous PowerBuoy products. In order to achieve this goal, we are pursuing the following business objectives:

 

 

Sell and/or Lease PowerBuoys. We believe our autonomous PowerBuoy is well suited for many remote offshore applications. Within our selected markets we intend to sell or lease PowerBuoys, and provide services associated with product sales or leases such as maintenance, application engineering, planning, training, and logistics support required for the PowerBuoy life-cycle.

 

 

Concentrate sales and marketing efforts in specific geographic markets. We are currently focusing our sales and marketing efforts in North America, Europe, Australia, and parts of Asia, including Japan. We believe that each of these areas has appropriate wave conditions, political and economic stability, sizeable end market opportunities, and high levels of industrialization and economic development.

 

 

 
25

 

 

 

Expand our relationships in key market areas. We believe that an important element of our business strategy is to collaborate with other organizations to leverage our combined expertise, market presence and access, and core competences across key markets. We have formed such a relationship with several well-known organizations, including MES in Japan, the NDBC, the WCS, Gardline Environmental (an international and multi-disciplinary marine service company at the forefront of marine management with offices on five continents), Sonalysts, Inc. (Sonalysts has primary capabilities in operations and analysis; modeling and simulation; systems engineering and integration; program support; and undersea wireless communications technologies) and HAI. We continue to seek other opportunities to collaborate with application experts from within our selected markets.

 

 

Outsource most of the equipment fabrication and deployment. We outsource all fabrication, anchoring, mooring, cabling supply, and in most cases deployment of our PowerBuoy in order to minimize our capital requirements as we scale our business. However, our PTO is a proprietary subsystem and is assembled and tested at our facility. We believe this distributed manufacturing and assembly approach enables us to focus on our value-adding core competencies while also enabling the cost effectiveness of our PowerBuoy through leveraging a larger more qualified supply base.

 

 

Continue to increase PowerBuoy output. Our product development and engineering efforts are focused on increasing the energy output, reliability, and expected operating life of our PowerBuoys, as well as optimizing manufacturability of our designs with a focus on cost competitiveness. We believe that by increasing the energy output we will be able to address larger segments of our target markets.

 

Going Concern

 

The consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared assuming the Company will continue as a going concern. The Company experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $184.8 million as of January 31, 2017. As of January 31, 2017, the Company had approximately $11.1 million in cash on hand. The Company generated revenues of $0.6 million for each of the nine months ended January 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities balances as of January 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending January 31, 2018.

 

The report of our independent registered public accounting firm on our consolidated financial statements filed with our Annual Report on Form 10-K for fiscal 2016, contains an explanatory paragraph regarding our ability to continue as a going concern, based on, among other factors, that our ability to continue as a going concern is dependent upon our ability to raise additional external capital and increase revenues. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company cannot provide assurances that it will be successful in its efforts to generate revenues, become profitable, raise additional outside capital or to continue as a going concern. If the Company is not successful in efforts to raise additional capital sufficient to support operations, the Company would be forced to cease operations, in which event investors would lose their entire investment in the Company.

 

Financial Operations Overview

 

The following describes certain line items in our statement of operations and some of the factors that affect our operating results.

 

Revenues

 

The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.

 

The Company has two types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.

 

Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria may be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.

 

 

 
26

 

 

In addition, recognition of revenue (and the related costs) may be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management may make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects may have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.

 

A portion of the revenue during the three and nine months ended January 31, 2016 was from cost-sharing contracts.

 

The following table provides information regarding the breakdown of our revenues by customer for the three and nine months ended January 31, 2017 and 2016. 

 

   

Three months ended January 31,

   

Nine months ended January 31,

 
   

2017

   

2016

   

2017

   

2016

 
   

($ millions)

 

Mitsui Engineering & Shipbuilding

  $ 0.1     $ -     $ 0.5     $ -  

U.S. Department of Defense Office of Naval Research

    0.1       -       0.1       -  

US Department of Energy

    -       -       -       0.2  

European Union (WavePort project)

    -       -       -       0.4  
    $ 0.2     $ -     $ 0.6     $ 0.6  

 

We currently focus our sales and marketing efforts on North America, Europe, Australia and Japan. The following table shows the percentage of our revenues by geographical location of our customers for the nine months ended January 31, 2017 and 2016.

 

   

Nine months ended January 31,

 

Customer Location

 

2017

   

2016

 
                 

Asia and Australia

    83 %     -  

United States

    17 %     33 %

Europe

    -       67 %
      100 %     100 %

 

Cost of revenues

 

Our cost of revenues consists primarily of incurred material, labor and manufacturing overhead expenses, such as engineering expense, equipment depreciation and maintenance and facility related expenses, and includes the cost of PowerBuoy parts and services supplied by third-party suppliers. Cost of revenues also includes PowerBuoy system delivery and deployment expenses and may include anticipated losses at completion on certain contracts. 

 

Our ability to generate a gross profit will depend on the nature of future contracts, our success at generating revenues through sales or leases of our PowerBuoy systems, the nature of our contracts generating revenues to fund our product development efforts, and our ability to manage costs incurred on fixed price commercial contracts.

 

Product development costs

 

Our product development costs consist of salaries and other personnel-related costs and the costs of products, materials and outside services used in our product development and unfunded research activities. Our product development costs relate primarily to our efforts to increase the power output and reliability of our PowerBuoy system, and to the development of new products, product applications and complementary technologies. We expense all of our product development costs as incurred. Over the next several years, it is our goal to fund the majority of our product development efforts with sources from commercial relationships, including cost-sharing agreements. If we are unable to obtain commercial relationships or cost-sharing arrangements, we may be forced to curtail our development expenses and scope to reduce our overall expenses. We recently narrowed our development focus to the PB3 to drive toward commercialization of that product and to reduce our overall expenses. In the future, we also may continue to develop the PB15 (formerly known as PB10) if we determine that future relationships warrant incurring the costs associated with such product development.

 

 

 
27

 

 

Selling, general and administrative costs

 

Our selling, general and administrative costs consist primarily of professional fees, salaries and other personnel-related costs for employees and consultants engaged in sales and marketing and support of our PowerBuoy systems and costs for executive, accounting and administrative personnel, professional fees and other general corporate expenses.

 

Fair Value of Financial Instruments

 

The fair value of our financial instruments reflects the amounts that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value of our warrant liabilities are subject to remeasurement each financial statement reporting period, as such, changes in this fair value are reflected in the Statement of Operations.

 

Our financial instruments not required to be adjusted to fair value on a recurring basis consist principally of cash and restricted cash, accounts receivable, accounts payable, and accrued expenses. We believe the carrying amount of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to their relatively short maturities.

 

Interest income, net

 

Interest income, net consists of interest received on cash and cash equivalents, investments in commercial bank-issued certificates of deposit and US Treasury bills and notes and interest expense paid on certain obligations to third parties. Total cash, cash equivalents, restricted cash, and marketable securities were $11.4 million as of January 31, 2017, compared to $9.8 million as of January 31, 2016.

  

Foreign exchange gain (loss)

 

We transact business in various countries and have exposure to fluctuations in foreign currency exchange rates. Foreign exchange gains and losses arise in the translation of foreign-denominated assets and liabilities, which may result in realized and unrealized gains or losses from exchange rate fluctuations. Since we conduct our business in US dollars and our functional currency is the US dollar, our main foreign exchange exposure, if any, results from changes in the exchange rate between the US dollar and the British pound sterling, the Euro and the Australian dollar. Due to the macroeconomic pressures in certain European countries, foreign exchange rates may become more volatile in the future.

 

We may invest our foreign cash reserves in certificates of deposit and we maintain cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These foreign-denominated certificates of deposit and cash accounts had a balance of $1.3 million as of January 31, 2017, compared to our total cash, cash equivalents, restricted cash, and marketable securities balances of $11.4 million as of January 31, 2017. These foreign currency balances are translated at each month end to our functional currency, the US dollar, and any resulting gain or loss is recognized in our results of operations.

 

In addition, a portion of our operations is conducted through our subsidiaries in countries other than the United States, specifically Ocean Power Technologies Ltd. in the United Kingdom, the functional currency of which is the British pound sterling, and Ocean Power Technologies (Australasia) Pty Ltd. in Australia, the functional currency of which is the Australian dollar. Both of these subsidiaries have foreign exchange exposure that results from changes in the exchange rate between their functional currency and other foreign currencies in which they conduct business.

 

We currently do not hedge our exchange rate exposure. However, we assess the anticipated foreign currency working capital requirements and capital asset acquisitions of our foreign operations and attempt to maintain a portion of our cash, cash equivalents and marketable securities denominated in foreign currencies sufficient to satisfy these anticipated requirements. We also assess the need and cost to utilize financial instruments to hedge currency exposures on an ongoing basis and may hedge against exchange rate exposure in the future.

 

 

 
28

 

  

Results of Operations

 

Three months ended January 31, 2017 compared to the three months ended January 31, 2016

 

The following table contains selected statement of operations information, which serves as the basis of the discussion of our results of operations for the three months ended January 31, 2017 and 2016.

 

                   

% change

 
   

Three months ended January 31,

   

2017 period to

 
   

2017

   

2016

   

2016 period

 
                         

Revenues

  $ 221     $ 5       4320 %

Cost of revenues

    363       5       7160 %
Gross profit (loss)     (142 )     -          

Operating expenses:

                       
Product development costs     950       1,752       -46 %
Selling, general and administrative costs     1,617       1,690       -4 %
Total operating expenses     2,567       3,442          

Operating loss

    (2,709 )     (3,442 )        

Loss on fair value of warrant liabilities

    (104 )     -       100 %

Interest income, net

    24       1       2300 %

Other expense

    -       (3 )     -100 %

Foreign exchange loss

    (26 )     (188 )     -86 %

Loss before income taxes

    (2,815 )     (3,632 )        
Income tax benefit     698       1,674       -58 %

Net loss

  $ (2,117 )   $ (1,958 )     8 %

 

Revenues

 

Revenues during the three months ended January 31, 2017 were 0.2 million, an increase of $0.2 million, as compared to the three months ended January 31, 2016. The increase in revenue is attributable to the MES and ONR agreements.

 

Cost of revenues

 

Cost of revenues during the three months ended January 31, 2017 were 0.4 million, an increase of $0.4 million, as compared to the three months ended January 31, 2016. The cost of revenues incurred during the three months ended January 31, 2017, were related to the MES and ONR projects. During the three months ended January 31, 2017, we incurred increased costs in connection with the MES project, which resulted in a gross loss for the three and nine months ended January 31, 2017.

 

Product development costs

 

Product development costs during the three months ended January 31, 2017 were 1.0 million, a decrease of $0.8 million, or 46%, as compared to the three months ended January 31, 2016. During the three months ended January 31, 2017, product development costs primarily related to the deployment of the commercial design PB3 PowerBuoy. During the three months ended January 31, 2016, product development costs reflected costs related to deployment of the legacy PB40 utility scale PowerBuoy.

 

Selling, general and administrative costs

 

Selling, general and administrative costs during the three months ended January 31, 2017 were 1.6 million, a decrease of $0.1 million, or 4%, as compared to the three months ended January 31, 2016. The decrease is primarily attributable to decreased legal costs, partially offset by an increase in equity compensation.

 

Loss on fair value of warrant liabilities

 

The loss on fair value of warrant liabilities during the three months ended January 31, 2017 was 0.1 million, attributable to the net fair market value at January 31, 2017. There were no such amounts during the three months ended January 31, 2016 as there were no warrant liabilities.

 

 

 
29

 

 

Interest income, net

 

Interest income, net during the three months ended January 31, 2017 was $24 thousand an increase of $23 thousand as compared to the three months ended January 31, 2016.

 

Foreign exchange loss

 

Foreign exchange loss during the three months ended January 31, 2017 was $26 thousand, a decrease of $0.2 million, or 86%, as compared to a loss of $0.2 million during the three months ended January 31, 2016. The difference was attributable primarily to the relative change in value of the British pound sterling, Euro and Australian dollar compared to the US dollar during the two periods.

 

Income tax benefit

 

During the three months ended January 31, 2017 and 2016, the Company sold New Jersey net operating loss carryforwards and research and development credits resulting in income tax benefits of $0.7 million and $1.7 million, respectively.

 

Nine months ended January 31, 2017 compared to the nine months ended January 31, 2016

 

The following table contains selected statement of operations information, which serves as the basis of the discussion of our results of operations for the nine months ended January 31, 2017 and 2016.

 

                   

% change

 
   

Nine months ended January 31,

   

2017 period to

 
   

2017

   

2016

   

2016 period

 
                         

Revenues

  $ 593     $ 605       -2 %

Cost of revenues

    615       605       2 %
Gross profit (loss)     (22 )     -          

Operating expenses:

                       
Product development costs     3,894       5,412       -28 %
Selling, general and administrative costs     4,859       5,419       -10 %
Total operating expenses     8,753       10,831          

Operating loss

    (8,775 )     (10,831 )        

Gain on fair value of warrant liabilities

    1,161       -       100 %

Interest income, net

    26       10       160 %

Other income

    -       240       -100 %

Foreign exchange loss

    (20 )     (194 )     -90 %

Loss before income taxes

    (7,608 )     (10,775 )        
Income tax benefit     698       1,674       -58 %

Net loss

    (6,910 )     (9,101 )     -24 %
Less: Net profit attributable to the non-controlling interest in Ocean Power Technologies (Australasia) Pty Ltd     -       (45 )     -100 %

Net loss attributable to Ocean Power Technologies, Inc

  $ (6,910 )   $ (9,146 )     -24 %

 

Revenues

 

Revenues during each of the nine months ended January 31, 2017 and 2016 were 0.6 million. During the nine months ended January 31, 2017, $0.5 million of revenue was attributable to the MES agreement, announced in June 2016, coupled with the $0.1 million attributable to the ONR contract, compared to revenue from our WavePort contract with the EU for our project in Spain and the billable work under our prior contracts with the DOE during the nine months ended January 31, 2016.

 

Cost of revenues

 

Cost of revenues during each of the nine months ended January 31, 2017 and 2016 were $0.6 million. During the three months ended January 31, 2017 we incurred increased costs in connection with the MES project, which resulted in a gross loss for the three and nine months ended January 31, 2017.

 

 

 
30

 

 

Product development costs

 

Product development costs during the nine months ended January 31, 2017 were 3.9 million, a decrease of $1.5 million, or 28%, as compared to the nine months ended January 31, 2016. During the nine months ended January 31, 2017 product development costs were primarily attributable to the redeployment of the pre-commercial PB3, the deployment of the commercial design PB3 PowerBuoy and estimated costs related to the retrieval of the PB40 mooring system. During the nine months ended January 31, 2016 product development costs related to the deployment of the legacy PB40 utility scale PowerBuoy as well as costs related to the redesigned commercial PB3.

 

Selling, general and administrative costs

 

Selling, general and administrative costs during the nine months ended January 31, 2017 were $4.9 million, a decrease of $0.6 million, or 10%, as compared to the nine months ended January 31, 2016. The decrease is primarily attributable to increased overhead costs absorbed into revenue producing projects and product development, and lower legal expense, partially offset by increased equity compensation expense.

 

Gain on fair value of warrant liabilities

 

The gain on fair value of warrant liabilities during the nine months ended January 31, 2017 was $1.2 million attributable to the net fair market value at January 31, 2017. There were no such amounts during the nine months ended January 31, 2016 as there were no warrant liabilities.

 

Interest income, net

 

Interest income, net during the nine months ended January 31, 2017 was $26 thousand, an increase of $16 thousand as compared to the nine months ended January 31, 2016.

 

Other income

 

During the nine months ended January 31, 2016, the Company received a refund of $0.2 million related to research and development expenditures in Australia. There were no such amounts during the nine months ended January 31, 2017.

 

Foreign exchange loss

 

Foreign exchange loss during the nine months ended January 31, 2017 was $20 thousand, a decrease of $0.2 million compared to the nine months ended January 31, 2016. The difference was primarily attributable to the relative change in value of the British pound sterling, Euro and Australian dollar compared to the US dollar during the two periods.

 

Income tax benefit

 

During the nine months ended January 31, 2017 and 2016, the Company sold New Jersey net operating loss carryforwards and research and development credits resulting in income tax benefits of $0.7 million and $1.7 million, respectively.

 

Liquidity and Capital Resources

 

Since our inception, the cash flows from customer revenues have not been sufficient to fund our operations and provide the capital resources for the planned growth of our business. For the two years ended April 30, 2016, our aggregate revenues were $4.8 million, our aggregate net losses were $26.3 million and our aggregate net cash used in operating activities was $28.1 million. Refer to “Liquidity Outlook” below for additional information. 

 

Net cash used in operating activities

 

Net cash flows used in operating activities during the nine months ended January 31, 2017 were $7.6 million, a decrease of $0.5 million compared to $8.1 million during the nine months ended January 31, 2016. The decrease was primarily related to decreased cash out flows for product development costs of $1.7 million, selling, general and administrative costs of $0.4 million, and stock compensation expense of $0.2 million coupled with the proceeds received from the Spanish Tax authorities as a result of the conclusion of the tax inquiry of $0.2 million. These items were partially offset by $1.0 million of decreased proceeds related to the NOL sales, decreased revenue receipts of $0.5 million, litigation settlement payment totaling $0.5 million and a refund received related to research and development expenditures in Australia of $0.2 million during the nine months ended January 31, 2016.

 

 

 
31

 

 

Net cash provided by investing activities

 

Net cash provided by investing activities during the nine months ended January 31, 2017 of $29 thousand, primarily related to maturities of marketable securities of $75 thousand, partially offset by purchase of marketable securities of $25 thousand and purchases of fixed asset equipment of $22 thousand.

 

Net cash provided by investing activities during the nine months ended January 31, 2016 of $0.1 million, primarily related to an increase in restricted cash balances of $0.1 million and maturities of marketable securities of $25 thousand, partially offset by purchases of fixed asset equipment of $24 thousand.

 

Net cash provided by financing activities

 

Net cash provided by financing activities during the nine months ended January 31, 2017 of $12.0 million, primarily related to proceeds from the sale of common stock, net of issuance costs, totaling $12.2 million, partially offset by the acquisition of treasury stock related to the payment of employee taxes of $0.1 million and debt payments of $0.1 million.

 

Net cash provided by financing activities during the nine months ended January 31, 2016 of $0.1 million, primarily related to proceeds from the sale of common stock, net of issuance costs, totaling $0.2 million, partially offset by debt payments of $0.1 million.

 

Effect of exchange rates on cash and cash equivalents

 

The effect of exchange rates on cash and cash equivalents was a decrease of $55 thousand and $85 thousand in the nine months ended January 31, 2017 and 2016, respectively. The effect of exchange rates on cash and cash equivalents results primarily from gains or losses on consolidation of foreign subsidiaries and foreign denominated cash and cash equivalents.

 

Liquidity Outlook

 

Our financial statements have been prepared assuming we will continue as a going concern. We have experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $184.8 million at January 31, 2017. As of January 31, 2017, we had approximately $11.1 million in cash on hand. In addition, as of January 31, 2017, our restricted cash balance was approximately $0.3 million. The Company generated revenues of $0.6 million during each of the nine months ended January 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities balances as of January 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending January 31, 2018. These conditions raise substantial doubt about our ability to continue as a going concern.

 

We expect to devote substantial resources to continue our development efforts for our PowerBuoys and to expand our sales, marketing and manufacturing programs associated with the planned commercialization of the PowerBuoys. Our future capital requirements will depend on a number of factors, including but not limited to:

 

 

our ability to commercialize our PowerBuoys, and achieve and sustain profitability;

 

 

our continued development of our proprietary technologies, and expected continued use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services;

 

 

our ability to obtain additional funding, as and if needed which will be subject to a number of factors, including market conditions, and our operating performance;

 

 

our estimates regarding expenses, future revenues and capital requirements;

 

 

the adequacy of our cash balances and our need for additional financings;

 

 

our ability to develop and manufacture a commercially viable PowerBuoy product;

 

 

that we will be successful in our efforts to commercialize our PowerBuoy or the timetable upon which commercialization can be achieved, if at all;

 

 

our ability to identify and penetrate markets for our PowerBuoys and our wave energy technology;

 

 

 
32

 

 

 

our ability to implement our commercialization strategy as planned, or at all;

 

 

our ability to maintain the listing of our common stock on the NASDAQ Capital Market;

 

 

the reliability of our technology and our PowerBuoys;

 

 

our ability to improve the power output, survivability and reliability of our PowerBuoys;

 

 

the impact of pending and threatened litigation on our business, financial condition and liquidity;

 

 

changes in current legislation, regulations and economic conditions that affect the demand for renewable energy;

 

 

our ability to compete effectively in our target markets;

 

 

our limited operating history and history of operating losses;

 

 

our sales and marketing capabilities and strategy in the United States and internationally; and

 

 

our ability to protect our intellectual property portfolio.

 

Our business is capital intensive and, to date, we have been funding our business principally through sales of our securities, and we expect to continue to fund our business with sales of our securities and, to a limited extent, with our revenues until, if ever, we generate sufficient cash flow to internally fund our business. This is largely a result of the high product development costs associated with our product development. We may choose to reduce our operating expenses through personnel reductions, and reductions in our research and development and other operating costs during the remainder of fiscal year 2017, if we are not successful in our efforts to raise additional capital. We cannot assure you that we will be able to increase our revenues and cash flow to a level which would support our operations and provide sufficient funds to pay our obligations for the foreseeable future. Further, we cannot assure you that we will be able to secure additional financing or raise additional capital or, if we are successful in our efforts to raise additional capital, of the terms and conditions upon which any such financing would be extended. If we are unable to raise additional capital when needed or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 Off-Balance Sheet Arrangements

 

Since inception, we have not engaged in any off-balance sheet financing activities.

 

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

Item 4.

CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2017 pursuant to Rules 13a-15(b) or 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (“SEC”) rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, as appropriate, to allow timely decisions regarding required disclosure. Based on such evaluation, management concluded that our disclosure controls and procedures were effective as of January 31, 2017 to ensure that non-financial statement and related disclosure information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

 

 

 
33

 

  

Changes in Internal Control over Financial Reporting

 

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended January 31, 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 
34

 

 

PART II — OTHER INFORMATION

 

Item 1.

LEGAL PROCEEDINGS

 

Shareholder Litigation and Demands 

 

The Company and its former Chief Executive Officer Charles Dunleavy were named as defendants in consolidated securities class action lawsuits that were pending in the United States District Court for the District of New Jersey captioned In Re: Ocean Power Technologies, Inc. Securities Litigation, Civil Action No. 14-3799 (FLW) (LHG).

 

On May 5, 2016, the parties entered into a Stipulation and Agreement of Class Settlement (“Stipulation”) in which they agreed to a settlement of the consolidated securities class action lawsuits, subject to Court approval. The Stipulation provides, among other things, for a settlement payment by or on behalf of the Company of $3.0 million in cash, of which the Company would pay $0.5 million and the Company’s insurer will pay $2.5 million, and the issuance by the Company of 380,000 shares (valued at $0.6 million on the date the Stipulation was signed by the parties) of its Common Stock to the class members. In connection with the settlement, the parties have agreed to execute mutually agreeable releases. The amounts agreed in the Stipulation, including the amount to be contributed by our insurance carrier, were reflected in the Company’s Consolidated Financial Statements as of April 30, 2016. In July 2016, the Company paid the $0.5 million portion of the settlement and the remaining balance of $2.5 million was paid by the Company’s insurer in August 2016. On November 14, 2016, the Court held its previously scheduled Settlement Hearing to consider whether to grant final approval of the settlement, and on November 15, 2016, the Court issued its Final Judgment approving the settlement and dismissing the proceeding with prejudice. The 380,000 shares of common stock were issued on November 22, 2016. The time to file an appeal from the Final Judgment has expired without any appeal being filed.  

 

The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on March 18, 2015 in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No. 3:15-cv-01980-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.

 

On July 10, 2015, a second derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No. 3:15-cv-05469, was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief.

 

On April 21, 2016, a third derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No. 3:16-cv-02249, was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief.

 

On June 9, 2016, a fourth derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief.

 

On October 25, 2016, the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the four derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for November 14, 2016 in the securities class action and further order of the Court. Defendants have not responded to the consolidated derivative actions because the actions remain stayed pending further order from the Court.

 

The Company and certain of its current directors are defendants in a lawsuit filed by an alleged shareholder in the Superior Court of New Jersey, Mercer County Chancery Division on January 25, 2016, captioned Stern v. Ocean Power Technologies, Inc., et al., Civil Action No. C-5-16. The complaint alleges that certain provisions of the Company’s Certificate of Incorporation and By-laws providing that the Company’s directors may be removed only for cause and only by an affirmative vote of at least 75% of the votes which all the stockholders would be entitled to cast in any annual election of directors are invalid under Section 141(k) of the Delaware General Corporation Law. The Complaint asserts a breach of fiduciary claim against the director defendants and a declaratory judgment claim against all defendants seeking, among other things, to invalidate the current provisions and declare that the Company’s directors may be removed and replaced without cause and by a simple majority vote. The Complaint seeks declaratory and injunctive relief as well as unspecified costs and attorneys’ fees. By Unanimous Written Consent dated June 17, 2016, the Company’s Board of Directors amended the Company’s By-laws to delete the “only for cause” requirement, thereby allowing for removal of directors with or without cause by the Company’s stockholders. In addition, the Board proposed, subject to approval by the Company’s stockholders at the next annual general meeting of stockholders, a similar amendment to the director removal provision in the Company’s Certificate of Incorporation. On June 22, 2016, the parties to the lawsuit submitted a Stipulation and Proposed Order Staying Proceedings that (1) stays the case pending the stockholder vote on the proposed amendment to the Company’s Certificate of Incorporation; (2) provides for dismissal of the action with prejudice if the stockholders approve the amendment, subject to plaintiff’s right to make a fee application to the court and defendants’ right to oppose any such application; and (3) provides for the stay to be lifted and the action to resume, without waiver of any parties’ rights, if the stockholders do not approve the amendment. The Court approved the Stipulation on June 30, 2016. On September 2, 2016, the Company filed a definitive proxy statement with the SEC which includes this proposal. At the annual shareholder meeting on October 21, 2016, the proposal was not approved because an insufficient number of votes were cast to satisfy the requirement that the proposal be approved by the holders of at least 75% of the outstanding shares of common stock entitled to vote at the meeting.  However, stockholders approved an amendment to the Company’s Certificate of Incorporation to add a provision which requires that any provision of the Certificate of Incorporation that is contrary to a requirement of the Delaware General Corporate Law shall be read in conformity with the applicable requirement of the Delaware General Corporate Law. The parties have agreed that the case shall remain stayed until further steps, if any, can be agreed to and taken as needed.

 

 

 
35

 

 

Employment Litigation

 

On June 10, 2014, the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective June 9, 2014, and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On June 17, 2014, Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On July 28, 2014, Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue the suspension pending resolution of the derivatives litigation.

 

Except for the Stipulation noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.

 

(b) Regulatory Matters

 

SEC Investigation

 

On February 4, 2015, the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on July 12, 2016, the SEC issued a second subpoena requesting information related to the Company’s April 4, 2014 public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.

 

Spain IVA (sales tax)

 

In June 2012, the Company received notice that the Spanish tax authorities are inquiring into its 2010 IVA (value-added tax) filing for which the Company benefitted from the offset of approximately $0.3 million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued two letters of credit in the amount of €0.3 million ($0.3 million) at the request of the Spanish tax authorities. As of January 31, 2017 the Company has received $0.2 million from the Spanish Tax authorities as a result of the conclusion of the inquiry.

 

Spain Income Tax Audit

 

We are currently undergoing an income tax audit in Spain for the period from 2008 to 2014, when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. We have not established any provision for losses related to this matter.

 

 

 
36

 

  

Item 1A.

RISK FACTORS

 

The discussion of our business and operations should be read together with the risk factors contained in Item 1A of our Annual Report on Form 10-K for the year ended April 30, 2016 and set forth below in this Quarterly Report on Form 10-Q. These risk factors describe various risks and uncertainties to which we are or may become subject. These risks and uncertainties have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner. There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K filed with the SEC on July 15, 2016 and our Form 10-Q for the quarter ended October 31, 2016, except as discussed below.

 

Our auditors have raised substantial doubts as to our ability to continue as a going concern.

 

Our financial statements have been prepared assuming we will continue as a going concern. Due to the significant product development costs associated with our business and operations, we have experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $184.8 million as of January 31, 2017. As of January 31, 2017, the Company had approximately $11.1 million in cash on hand. The Company generated revenues of $0.6 million during each of the nine months ended January 31, 2017 and 2016. We generated revenues of only $0.7 million in fiscal 2016, and $4.1 million in fiscal 2015. Based on the Company’s cash and cash equivalents and marketable securities balances as of January 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending January 31, 2018. We continue to experience operating losses and currently have only two revenue producing contracts.

 

During the nine months ended January 31, 2017, our net burn rate (cash used in operations less cash generated by operations) including product development spending was approximately $0.9 million per month, excluding $0.5 million cash paid in relation to the litigation settlement and $0.7 million cash received from the sale of the New Jersey net operating loss carryforwards.

 

Our business is capital intensive and, to date, we have been funding our business principally through sales of our securities, and we expect to continue to fund our business with sales of our securities and, to a limited extent, with our revenues until, if ever, we generate sufficient cash flow to internally fund our business. This is a largely a result of the high product development costs associated with our product development. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. We anticipate that our operating expenses will be approximately $12.0 million in fiscal 2017. Through the nine months ended January 31, 2017, the Company has already incurred approximately $8.8 million in such operating costs. We may choose to reduce our operating expenses through personnel reductions, and reductions in our research and development and other operating costs during fiscal year 2017, if we are not successful in our efforts to raise additional capital. We cannot assure you that we will be able to increase our revenues and cash flow to a level which would support our operations and provide sufficient funds to pay our obligations for the foreseeable future. Further, we cannot assure you that we will be able to secure additional financing or raise additional capital or, if we are successful in our efforts to raise additional capital, of the terms and conditions upon which any such financing would be extended. If we are unable to meet our obligations, we would be forced to cease operations, in which event investors would lose their entire investment in our company.

 

We have a history of operating losses and may not achieve or maintain profitability and positive cash flow. 

 

We have incurred net losses since we began operations in 1994, including net losses attributable to Ocean Power Technologies, Inc. of $6.9 million during the nine months ended January 31, 2017 and $13.1 million in fiscal 2016. As of January 31, 2017, we had an accumulated deficit of $184.8 million. To date, our activities have consisted primarily of activities related to the development and testing of our technologies and our PowerBuoy. Thus, our losses to date have resulted primarily from costs incurred in our research and development programs and from our selling, general and administrative costs. As we continue to develop our proprietary technologies, we expect to continue to have a net use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services. 

 

We do not know whether we will be able to successfully commercialize our PowerBuoys, or whether we can achieve profitability. There is significant uncertainty about our ability to successfully commercialize our PowerBuoys in our targeted markets. Even if we do achieve commercialization of our PowerBuoy and become profitable, we may not be able to achieve or, if achieved, sustain profitability on a quarterly or annual basis.

 

We may not be able to raise sufficient capital to continue to operate our business.

 

Historically, we have funded our business operations through sales of equity securities. We do not know whether we will be able to secure additional equity funding or, if secured, whether the terms will be favorable to us or our investors. Our ability to obtain additional funding will be subject to a number of factors, including market conditions, our operating performance, pending litigation and investor sentiment. These factors may make additional funding unavailable, or the timing, amount, terms and conditions of additional funding unattractive. If we issue additional equity securities to raise capital, our existing stockholders would experience dilution or may be subordinated to any rights, preferences or privileges granted to the new equity holders.

 

 

 
37

 

 

We have filed a shelf registration statement on Form S-3 with the SEC registering the sale of up to $15,000,000 of debt, equity and other securities (the “Shelf Registration Statement”), which was declared effective on April 26, 2016. In June 2016, we completed an offering off of the Shelf Registration Statement of an aggregate of 417,000 shares of common stock together with warrants to purchase up to an aggregate of 145,952 shares of common stock. In July 2016, we completed a best efforts public offering off of the Shelf Registration Statement of 595,000 units, with each unit consisting of one share of common stock and 0.3 of a warrant to purchase one share of our common stock, for a total of 178,500 warrants.

 

On October 19, 2016, we sold 2,760,000 shares of common stock at a price of $2.75 per share, which includes the sale of 360,000 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $6.9 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. We are using the net proceeds from this offering for general corporate purposes, which may include additional development, testing and demonstrations of our PowerBuoy system with the goal of furthering and accelerating its commercialization efforts and expanding its sales and marketing functions.

 

Future sales under the Shelf Registration Statement or other sales of equity or convertible securities could be dilutive to our stockholders. We cannot assure you that we will be able to issue any such securities or, if issued, what the terms of those securities would be. In particular, any new securities issued could have rights senior to those associated with our common stock and could contain covenants that would restrict our operations. Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, our business, operating results, financial condition and prospects could be materially and adversely affected and we may be unable to continue our operations.

 

Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The following table details the Company’s share repurchases during the quarter:  

 

Period

 

Total Number of Shares

Purchased (1)

    Average Price Paid per Share     Total Number of Shares Purchased as Part of Publicly Announced Plans     Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan  
                                 

November 1-30, 2016

    24,113     $ 2.32       -     $ -  

December 1-31, 2016

    -     $ -       -     $ -  

January 1-31, 2017

    9,409     $ 3.05       -     $ -  

 

(1) Represents shares delivered back to the Company by employees to pay taxes related to the vesting of restricted shares.

 

Item 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

Item 4.

MINE SAFETY DISCLOSURES

 

Not applicable.

 

Item 5.

OTHER INFORMATION

 

None.

 

 

 
38

 

    

Item 6.   EXHIBITS
     
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2

*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

     

101

 

The following materials formatted in eXtensible Business Reporting Language (XBRL) from Ocean Power Technologies, Inc Quarterly Report on Form 10-Q for the quarter ended January 31, 2017, filed March 7, 2017: (i) Consolidated Balance Sheets – January 31, 2017 (unaudited) and April 30, 2016, (ii) Consolidated Statements of Operations (unaudited) – Three and Nine months ended January 31, 2017 and 2016, (iii) Consolidated Statements of Comprehensive Loss (unaudited) – Three and Nine months ended January 31, 2017 and 2016, (iv) Consolidated Statements of Cash Flows (unaudited) –Nine months ended January 31, 2017 and 2016, (v) Consolidated Statements of Stockholders’ Equity (unaudited) – Nine months ended January 31, 2017 and 2016 (vi) Notes to Consolidated Financial Statements.**

     

 

 

* As provided in Item 601(b)(32)(ii) of Regulation S-K, this exhibit shall not be deemed to be “filed” or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability under those sections. 

     

 

 

** As provided in Rule 406T of Regulation S-T, this exhibit shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability under those sections.

 

 

 
39

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Ocean Power Technologies, Inc.

 

 

(Registrant)

 

 

 

 

 

 

 

 

 

Date: March 7, 2017

 

/s/ George H. Kirby III

 

 

By: 

George H. Kirby III

 

 

 

Chief Executive Officer

 

 

 

Date: March 7, 2017

 

/s/ Matthew T. Shafer

 

 

By:

Matthew T. Shafer

 

 

 

Chief Financial Officer

 

 

 

40 

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm

Exhibit 31.1 

 

CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT

 

I, George H. Kirby, certify that:

 

1.

 

I have reviewed this Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc.;

 

 

 

2.

 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

 

4.

 

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

(b)

 

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

(c)

 

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

(d)

 

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

     

5.

 

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or other persons performing the equivalent functions):

 

(a)

 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

 

(b)

 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date: March 7, 2017

 

 

 

 

 

 

 

 

/s/ George H. Kirby III

 

 

 

George H. Kirby III

 

 

 

Chief Executive Officer

 

 

EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm

Exhibit 31.2

  

CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT

 

I, Matthew T. Shafer, certify that:

 

1.

 

I have reviewed this Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc.;

 

 

 

2.

 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

 

3.

 

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

 

4.

 

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     

(b)

 

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

(c)

 

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

(d)

 

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

     

5.

 

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or other persons performing the equivalent functions):

 

(a)

 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

 

(b)

 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date: March 7, 2017

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Matthew T. Shafer

 

 

 

Matthew T. Shafer

 

 

 

Chief Financial Officer

 

 

EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm

Exhibit 32.1

  

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc. (the "Company") for the period ended January 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, George H. Kirby III, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)

 

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

(2)

 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: March 7, 2017

 

 

 

 

 

 

 

 

/s/ George H. Kirby III

 

 

 

George H. Kirby III

 

 

 

Chief Executive Officer

 

  

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.2 5 ex32-2.htm EXHIBIT 32.2 ex32-2.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc. (the "Company") for the period ended January 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Matthew T. Shafer, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)

 

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

(2)

 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: March 7, 2017

 

 

 

 

 

 

 

 

/s/ Matthew T. Shafer

 

 

 

Matthew T. Shafer

 

 

 

Chief Financial Officer

 

 

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.INS 6 optt-20170131.xml EXHIBIT 101.INS false --04-30 Q3 2017 2017-01-31 10-Q 0001378140 6313996 Yes Smaller Reporting Company Ocean Power Technologies, Inc. No No optt 0.75 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,814 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,161</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> P5Y 1814000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7)</div>&nbsp;Deferred Credits Payable</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2001,</div> in connection with the sale of common stock to an investor, the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million from the investor in exchange for an option to purchase up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> metric tons of carbon emissions credits generated by the Company during the years <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> at a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).&nbsp;&nbsp;Under the terms of the agreement, if the Company did not become entitled under applicable laws to the full amount of emission credits covered by the option by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company was obligated to return the option fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million, less the aggregate discount on any emission credits sold to the investor prior to such date. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company and the investor agreed to extend the period for the sale of emission credits until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company has not generated any emissions credits eligible for purchase under the agreement. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div></div> million is reflected on the balance sheet within &#x201c;Deferred credits payable current&#x201d; and &#x201c;Deferred credits payable non-current&#x201d; as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. </div></div></div> 0.3 0.3 500000 -200000 300000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"><tr><td style="WIDTH: 5%; VERTICAL-ALIGN: top"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">c)</div></div></div></div></td> <td style="WIDTH: 95%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Liquidity/Going Concern</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$184.8</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.1</div> million in cash on hand. The Company generated revenues of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div></div> million during each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Based on the Company&#x2019;s cash and cash equivalents and marketable securities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company believes that it will be able to finance its capital requirements and operations into the quarter ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company&#x2019;s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company&#x2019;s future results of operations involve significant risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> equity financing arrangements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> &nbsp;The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (as amended, the &#x201c;Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June</div> Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into the Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July</div> Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.6</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5th)</div> anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company sold </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,760,000</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.75</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360,000</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.9</div> million, after deducting placement agent fees and offering expenses payable by the Company. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 19.8pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company&#x2019;s Common Stock and could contain covenants that would restrict its operations. Financing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be forced to cease operations.</div></div></div></div></div></div></div> 2500000 2500000 P5Y 3 1 4.60 6.75 7800000 19700000 7800000 19700000 20000 P1Y90D 380000 600000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8)</div> Warrants</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (as amended, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June</div> Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June</div> Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July</div> Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5th)</div> anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480.</div> As such, the warrants with a value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.7</div> million at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> are reflected within &#x201c;warrant liabilities&#x201d; in the unaudited consolidated balance sheets. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div>such amounts at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">An unrealized loss and unrealized gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.2</div> million, respectively, were included within &#x201c;(Loss) gain on fair value of warrant liabilities&#x201d; in the consolidated statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div></div>unrealized gains or losses during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%" width="1213"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%" width="12"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" width="250" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px" width="12"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="1213">Dividend rate</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="1213">Risk-free rate</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="1213"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.9</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="1213"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">129.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">138.2%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="12" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 653000 653000 653000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(j) Warrant Liabilities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within &#x201c;(loss) gain on fair value of warrant liabilities&#x201d;. The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to &#x201c;additional paid-in capital&#x201d;, a component of &#x201c;stockholders' equity&#x201d; on the consolidated balance sheets.</div></div></div></div></div></div></div> 189000 373000 3121000 2675000 329000 240000 593000 456000 -160000 -122000 193000000 181670000 224000 224000 1000000 300000 200000 100000 800000 200000 680429 154537 680429 154537 12421000 10351000 12095000 9759000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"><tr><td style="WIDTH: 5%; VERTICAL-ALIGN: top"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">b)</div></div></div></div></td> <td style="WIDTH: 95%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Basis of Presentation</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> of Regulation&nbsp;S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and elsewhere in this Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q.</div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1)</div>&nbsp;Background, Basis of Presentation and Liquidity</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">a)</div></div></div></div></td> <td style="WIDTH: 95%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Background</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Ocean Power Technologies, Inc. (the &#x201c;Company&#x201d;) was incorporated in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1984</div> in New Jersey, commenced business operations in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1994</div> and re-incorporated in Delaware in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2007.</div> The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1997.</div> The Company markets its PowerBuoys in the United States and internationally. Since fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2002,</div> government agencies have accounted for a significant portion of the Company&#x2019;s revenues.&nbsp;&nbsp;These revenues were largely for the support of product development efforts. The Company&#x2019;s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div></td> </tr> </table> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">b)</div></div></div></div></td> <td style="WIDTH: 95%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Basis of Presentation</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> of Regulation&nbsp;S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and elsewhere in this Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div></td> </tr> </table> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">c)</div></div></div></div></td> <td style="WIDTH: 95%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Liquidity/Going Concern</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$184.8</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.1</div> million in cash on hand. The Company generated revenues of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div></div> million during each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Based on the Company&#x2019;s cash and cash equivalents and marketable securities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company believes that it will be able to finance its capital requirements and operations into the quarter ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company&#x2019;s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company&#x2019;s future results of operations involve significant risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> equity financing arrangements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> &nbsp;The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (as amended, the &#x201c;Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June</div> Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into the Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July</div> Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.6</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5th)</div> anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company sold </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,760,000</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.75</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360,000</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.9</div> million, after deducting placement agent fees and offering expenses payable by the Company. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 19.8pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company&#x2019;s Common Stock and could contain covenants that would restrict its operations. Financing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be forced to cease operations.</div></div></div></div> 11110000 6730000 8587000 4535000 2523000 2195000 17336000 9413000 4380000 -7923000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(d)&nbsp;Cash and Cash Equivalents</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company considers all highly liquid investments with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the bank&#x2019;s total obligations under the agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,587 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,535 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,523 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,195 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,110 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,730 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(f)&nbsp;Restricted Cash and Credit Facility</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s cash is restricted under the terms of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> security agreements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 24.2pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility carries a fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%</div> per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">($0.3</div> million) in letters of credit outstanding under this agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> agreement was between the Company and the New Jersey Board of Public Utilities (&#x201c;NJBPU&#x201d;). The Company received a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million recoverable grant award from the NJBPU, repayable over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year period beginning in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011.</div> The agreement also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the grant was fully repaid and therefore there was no certificate of deposit. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6)</div> &#x201c;Debt&#x201d; for additional information. Restricted cash includes the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NJBPU agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div> 6.08 9.36 0.35 0.3 145952 178500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11)</div>&nbsp;Commitments and Contingencies</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a) Litigation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shareholder Litigation and Demands&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company and its former Chief Executive Officer Charles Dunleavy were named as defendants in consolidated securities class action lawsuits that were pending in the United States District Court for the District of New Jersey captioned In Re: Ocean Power Technologies, Inc. Securities Litigation, Civil Action No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3799</div> (FLW) (LHG). </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the parties entered into a Stipulation and Agreement of Class Settlement (&#x201c;Stipulation&#x201d;) in which they agreed to a settlement of the consolidated securities class action lawsuits, subject to Court approval. The Stipulation provides, among other things, for a settlement payment by or on behalf of the Company of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.0</div> million in cash, of which the Company would pay <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million and the Company&#x2019;s insurer would pay <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million, and the issuance by the Company of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380,000</div> shares (valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million on the date the Stipulation was signed by the parties) of its Common Stock to the class members. In connection with the settlement, the parties have agreed to execute mutually agreeable releases. The amounts agreed in the Stipulation, including the amount to be contributed by our insurance carrier, were reflected in the Company&#x2019;s Consolidated Financial Statements as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company paid the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million portion of the settlement&nbsp;and the remaining balance&nbsp;of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million was paid by the Company&#x2019;s insurer in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Court held its previously scheduled Settlement Hearing to consider whether to grant final approval of the settlement, and on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Court issued its Final Judgment approving the settlement and dismissing the proceeding with prejudice. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380,000</div> shares of common stock were issued on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The time to file an appeal from the Final Judgment has expired without any appeal being filed. &nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:15</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01980</div>-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:15</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">05469,</div> was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:16</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02249,</div> was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> in the securities class action and further order of the Court. Defendants have not responded to the consolidated derivative actions because the actions remain stayed pending further order from the Court.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company and certain of its current directors are defendants in a lawsuit filed by an alleged shareholder in the Superior Court of New Jersey, Mercer County Chancery Division on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> captioned Stern v. Ocean Power Technologies, Inc., et al., Civil Action No. C-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.</div> The complaint alleges that certain provisions of the Company&#x2019;s Certificate of Incorporation and By-laws providing that the Company&#x2019;s directors <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be removed only for cause and only by an affirmative vote of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%</div> of the votes which all the stockholders would be entitled to cast in any annual election of directors are invalid under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141(k)</div> of the Delaware General Corporation Law. The Complaint asserts a breach of fiduciary claim against the director defendants and a declaratory judgment claim against all defendants seeking, among other things, to invalidate the current provisions and declare that the Company&#x2019;s directors <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be removed and replaced without cause and by a simple majority vote. The Complaint seeks declaratory and injunctive relief as well as unspecified costs and attorneys&#x2019; fees. By Unanimous Written Consent dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company&#x2019;s Board of Directors amended the Company&#x2019;s By-laws to delete the &#x201c;only for cause&#x201d; requirement, thereby allowing for removal of directors with or without cause by the Company&#x2019;s stockholders. In addition, the Board proposed, subject to approval by the Company&#x2019;s stockholders at the next annual general meeting of stockholders, a similar amendment to the director removal provision in the Company&#x2019;s Certificate of Incorporation. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the parties to the lawsuit submitted a Stipulation and Proposed Order Staying Proceedings that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1)</div> stays the case pending the stockholder vote on the proposed amendment to the Company&#x2019;s Certificate of Incorporation; <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2)</div> provides for dismissal of the action with prejudice if the stockholders approve the amendment, subject to plaintiff&#x2019;s right to make a fee application to the court and defendants&#x2019; right to oppose any such application; and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3)</div> provides for the stay to be lifted and the action to resume, without waiver of any parties&#x2019; rights, if the stockholders do not approve the amendment. The Court approved the Stipulation on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company filed a definitive proxy statement with the SEC which includes this proposal. At the annual shareholder meeting on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the proposal was not approved because an insufficient number of votes were cast to satisfy the requirement that the proposal be approved by the holders of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%</div> of the outstanding shares of common stock entitled to vote at the meeting.&nbsp; However, stockholders approved an amendment to the Company&#x2019;s Certificate of Incorporation to add a provision which requires that any provision of the Certificate of Incorporation that is contrary to a requirement of the Delaware General Corporate Law shall be read in conformity with the applicable requirement of the Delaware General Corporate Law</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">. The parties have agreed that the case shall remain stayed until further steps, if any, can be agreed to and taken as needed.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Employment Litigation&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except for the Stipulation noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Regulatory Matters</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">SEC Investigation</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the SEC issued a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> subpoena requesting information related to the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> public offering. The Company has provided information to the SEC in response&nbsp;to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC&#x2019;s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Spain IVA (sales tax)</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company received notice that the Spanish tax authorities are inquiring into its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> IVA (value-added tax) filing for which the Company benefitted from the offset of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> letters of credit totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">($0.3</div> million) at the request of the Spanish tax authorities. Separately, as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> the Company has received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Spanish tax authorities approved of the release of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> outstanding letters of credit.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Spain Income Tax Audit</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We are currently undergoing an income tax audit in Spain for the period from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. We have not established any provision for losses related to this matter.</div></div></div> 0.001 0.001 50000000 50000000 6313996 2352100 6000 2000 -2114000 -1807000 -6948000 -9068000 73000 -2114000 -1807000 -6948000 -8995000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(i)&nbsp;Concentration of Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company's consolidated revenues for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the periods indicated:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Nine months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">US Department of Energy</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">European Union (WavePort project)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.</div></div></div></div></div></div></div> 0.56 0.83 0.44 0.17 1 0.33 0.67 1 1 1 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Consolidation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Participation of stockholders other than the Company in the net assets and in the earnings or losses of a consolidated subsidiary is reflected as a non-controlling interest in the Company's Consolidated Balance Sheets and Statements of Operations, which adjusts the Company's consolidated results of operations to reflect only the Company's share of the earnings or losses of the consolidated subsidiary. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there were no non-controlling interests. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company re-purchased the non-controlling interest (consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.8%)</div> of OPTA for nominal consideration and now has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> ownership of OPTA. The Company also periodically evaluates its relationships with other entities to identify whether they are variable interest entities, and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is included in the consolidated financial statements. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there were no such entities.</div></div></div></div></div></div></div> 1239000 818000 363000 5000 615000 605000 600000 600000 600000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6)</div>&nbsp;Debt</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company was awarded a recoverable grant totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> from the NJBPU under the Renewable Energy Business Venture Assistance Program. Under the terms of this agreement, the amount to be repaid is a fixed monthly amount of principal only, repayable over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year period beginning in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011.</div> The terms also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50</div> thousand outstanding and the respective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50</div> thousand certificate of deposit was recorded within &#x201c;Other current assets&#x201d; on the balance sheet. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the grant was fully repaid, and therefore, there is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div>balance outstanding and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div>respective certificate of deposit assigned to restricted cash. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2(f).</div> &#x201c;Summary of Significant Accounting Policies - Restricted Cash and Credit Facility&#x201d; for more information regarding the certificate of deposit.</div></div></div> 39000 104000 84000 -104000 1161000 700000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9)</div>&nbsp;Stock-Based Compensation</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The aggregate stock-based compensation expense related to all stock-based transactions recorded in the consolidated statements of operations was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Stock Options</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Assumptions for Options Granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the &quot;simplified&quot; method as permitted by the SEC's Staff Accounting Bulletin No.&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110,</div><div style="display: inline; font-style: italic;"> Share-Based Payment.</div> Expected volatility was based on the Company&#x2019;s historical volatility during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The below assumptions were used to determine the weighted average per share fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.89</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.05</div> for stock options granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Nine months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.6</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.50 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">96.2</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85.7</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of stock options under our stock incentive plans is detailed in the following table.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Underlying</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Term</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Options</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Years)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 49%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89,303 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42.90 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(987</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46.45 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171,749 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.12 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260,065 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15.96 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.2 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable as of January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157,066 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24.44 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the total intrinsic value of outstanding and exercisable options was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$107</div> thousand and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$95</div> thousand, respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101,392</div> additional options are expected to vest in the future with an intrinsic value of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10</div> thousand and a weighted average remaining contractual term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.6</div> years. There was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million of total recognized compensation cost related to stock options during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.8</div> years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b)&nbsp;Restricted Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Compensation expense for non-restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">223,662</div> shares subject to service-based vesting requirements and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company&#x2019;s total shareholder return (&#x201c;TSR&#x201d;) relative to the total shareholder return of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> alternative energy Exchange Traded Funds as measured over a specific performance period. No vesting of the relevant shares will occur in instances where the Company&#x2019;s TSR for the relevant period is below <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80%</div> of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Board of Directors authorized a modification to certain outstanding restricted stock grants, which converted certain grants with performance-based grants to service-based grants. The modification of the restricted stock grants did not have a material impact on the Company&#x2019;s statement of operations during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Restricted stock issued and unvested as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> included <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,000</div> shares of unvested restricted stock subjected to performance-based vesting requirements.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of non-vested restricted stock under our stock incentive plans is as follows:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Number</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average Price per</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Share</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,008 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.70 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">223,662 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.94 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,266</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.98 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(139,492</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.70 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">95,912 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.99 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.8</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million of total recognized compensation cost related to restricted stock for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.4</div>&nbsp;years.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c)Treasury Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,882</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,839</div> shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.</div></div></div> -0.37 -1.05 -1.84 -5.07 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(k)&nbsp;Net Loss per Common Share</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,429</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154,537</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.<div style="display: inline; font-weight: bold;"> &nbsp;</div></div></div></div></div></div></div></div> -55000 -85000 P292D P146D 200000 200000 800000 500000 100000 -1161000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%" width="1213"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%" width="12"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" width="250" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px" width="12"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="1213">Dividend rate</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="1213">Risk-free rate</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="1213"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.9</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" width="12" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 86%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="1213"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" width="12">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" width="57"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">129.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff" width="103"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" width="90"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">138.2%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" width="12" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 0 P4Y182D P4Y328D 1.29 1.382 0.019 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10)</div> Fair Value Measurements</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument&#x2019;s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> hierarchy levels.</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>&nbsp;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unobservable inputs are not corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were no transfers between any levels during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Warrant Liabilities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of the Company's warrant liabilities (refer to Note&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8)</div> recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table presents financial assets and liabilities measured at fair value on a recurring basis as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">As of January 31, 2017:</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The changes in the value of the warrant liabilities during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> were as follows.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,814 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,161</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div></div></div>re-measured assets or liabilities at fair value on a non-recurring basis during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div></div> -20000 -194000 -26000 -188000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(g)&nbsp;Foreign Exchange Gains and Losses</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in foreign exchange gain&nbsp;in the accompanying consolidated statements of operations.</div></div></div></div></div></div></div> -142000 -22000 -2815000 -3632000 -7608000 -10775000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12)</div>&nbsp;Income Taxes</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company recorded an income tax benefit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.7</div></div> million, representing the proceeds from the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.8</div></div> million of New Jersey net operating loss carryforwards and research and development tax credits. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded an income tax benefit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div></div> million representing the proceeds from the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19.7</div></div> million of New Jersey net operating loss carryforwards and research and development tax credits.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Other than as a result of the sale of New Jersey net operating loss carryforwards, the Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not </div></div></div></div>recognize any consolidated income tax benefit (expense) during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div></div>material changes in uncertain tax positions.</div></div></div> 0 0 0 0 -698000 -1674000 -698000 -1674000 -186000 98000 -89000 461000 221000 -39000 222000 30000 -169000 -27000 -1000 -111000 286000 -44000 24000 1000 26000 10000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3)</div>&nbsp;Marketable Securities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with initial maturities greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets and are summarized as follows:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificate of Deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 300000 4629000 6823000 12421000 10351000 4597000 6168000 0 0 300000 300000 0.01 3000000 3000000 500000 50000 0 32000 55000 34000 81000 199000 199000 25000 75000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(e) Marketable Securities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with original maturities longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature in less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> all of the Company&#x2019;s investments were classified as held-to-maturity.</div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificate of Deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 0 0.118 11958000 126000 29000 112000 -7552000 -8076000 -2117000 -1958000 -6910000 -9146000 45000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(l) Recently Issued Accounting Standards</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Revenue from Contracts with Customers&#x201d;. This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Qualitative and quantitative information is required about:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contracts with customers&#x2014;including revenue and impairments recognized, disaggregation of revenue and information about contract balances and performance obligations (including the transaction price allocated to the remaining performance obligations).</div></div></td> </tr> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Significant judgments and changes in judgments&#x2014;determining the timing of satisfaction of performance obligations (over time or at a point in time), and determining the transaction price and amounts allocated to performance obligations.</div></div></td> </tr> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain assets&#x2014;assets recognized from the costs to obtain or fulfill a contract.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued updated guidance deferring the effective date of the revenue recognition standard. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued additional updated guidance, which clarifies certain aspects of the ASU and the related implementation guidance issued by the FASB-IASB Joint Transition Resource Group for Revenue Recognition. This guidance is effective for the Company for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The Company is currently evaluating the impact that this guidance will have on its results of operations, financial position and cash flows.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;Disclosure of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern&#x201d;, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> annual period ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods thereafter. Early application is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> will have on its consolidated financial statements and disclosures and have not yet determined the effect of the standard on its ongoing financial reporting at this time. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1)</div>&nbsp;&#x201c;Background, Basis of Presentation and Liquidity&#x201d; for discussion on the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;Recognition and Measurement of Financial Assets and Financial Liabilities&#x201d;, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> for future periods as applicable.&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842)&#x201d;.</div> The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Compensation - Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718)&#x201d;,</div> or ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The amendments of ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods within those annual periods. Early adoption is permitted. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> for future periods as applicable.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> &#x201c;Financial Instruments - Credit Losses (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326):</div> Measurement of Credit Losses on Financial Instruments&#x201d;. The standard provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets held. The ASU is effective for public companies for annual periods, and interim periods within those annual periods, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and believes the standard will have no impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Classification of Certain Cash Receipts and Cash Payments&#x201d;, providing additional guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Restricted Cash&#x201d;, providing additional guidance on specific restricted cash flow classification on the cash flow statement. Cash flow should include restricted cash in total cash, and an entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> will have on its consolidated financial statements and disclosures and believes the effect of the standard on its ongoing financial reporting will not have a material impact.</div></div></div></div></div></div></div> 1 2567000 3442000 8753000 10831000 -2709000 -3442000 -8775000 -10831000 298000 274000 50000 0 337000 117000 131000 319000 3000 151000 -38000 106000 -38000 -38000 463000 688000 -3000 240000 500000 500000 122000 4000 22000 24000 25000 0.001 0.001 5000000 5000000 0 0 0 0 205000 1700000 3600000 6900000 12150000 75000 25000 -6910000 -9101000 -2117000 -1958000 -6910000 195000 273000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(h)&nbsp;Property and Equipment</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.</div></div></div></div></div></div></div> P3Y P7Y 53000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5)</div>&nbsp;Related Party Transactions</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company entered into an Executive Transition Agreement with George W. Taylor, who was formerly employed by the Company as Executive Vice Chairman and served on the Company&#x2019;s Board of Directors prior to that date. Under this agreement, Dr. Taylor received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifteen</div> months of consulting fees at a monthly rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20</div> thousand (this period terminated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015).</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$53</div> thousand in expense relating to this agreement, which was recorded in selling, general and administrative expense in the unaudited consolidated statements of operations. &nbsp;There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div></div>such amounts recorded during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> </div></div></div> 70000 75000 950000 1752000 3894000 5412000 500000 299000 300000 50000 299000 250000 -184794000 -177884000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c) Revenue Recognition</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero.</div> The Company&#x2019;s share of the costs is recorded as product development expense.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, recognition of revenue (and the related costs) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s projects have been under cost-sharing contracts.</div></div></div></div></div></div></div> 593000 605000 221000 5000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,587 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,535 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,523 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,195 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,110 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,730 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">As of January 31, 2017:</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">653 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Accrued expenses</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Project costs (a)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,239 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">818 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contract loss reserve</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">199 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">199 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee incentive payments</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">463 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">688 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued salary and benefits</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">593 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">456 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal and accounting fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">329 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">298 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,121 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,675 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NJBPU agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Nine months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">US Department of Energy</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">European Union (WavePort project)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Underlying</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Term</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Options</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Years)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 49%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89,303 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42.90 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(987</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46.45 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171,749 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.12 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260,065 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15.96 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.2 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable as of January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157,066 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24.44 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Number</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average Price per</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Share</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,008 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.70 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">223,662 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.94 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,266</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.98 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(139,492</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.70 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at January 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">95,912 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.99 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Nine months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.6</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.50 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">96.2</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85.7</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13)</div>&nbsp;Operating Segments and Geographic Information</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's business consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company&#x2019;s primary business operations were in North America.</div></div></div> 1617000 1690000 4859000 5419000 998000 298000 28266 3.98 223662 0 223662 3.94 4000 40008 95912 6.70 3.99 139492 4.70 0 0 0.962 0.857 0.013 0.016 157066 24.44 987 171749 1.89 4.05 107000 89303 260065 42.90 15.96 10000 101392 46.45 2.12 2.75 P5Y182D P5Y182D 95000 P5Y219D P3Y219D P7Y73D P9Y219D 2352100 -6894 6313996 -46776 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2)</div>&nbsp;Summary of Significant Accounting Policies</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Consolidation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Participation of stockholders other than the Company in the net assets and in the earnings or losses of a consolidated subsidiary is reflected as a non-controlling interest in the Company's Consolidated Balance Sheets and Statements of Operations, which adjusts the Company's consolidated results of operations to reflect only the Company's share of the earnings or losses of the consolidated subsidiary. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there were no non-controlling interests. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company re-purchased the non-controlling interest (consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.8%)</div> of OPTA for nominal consideration and now has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> ownership of OPTA. The Company also periodically evaluates its relationships with other entities to identify whether they are variable interest entities, and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is included in the consolidated financial statements. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no </div>such entities.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c) Revenue Recognition</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero.</div> The Company&#x2019;s share of the costs is recorded as product development expense.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, recognition of revenue (and the related costs) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s projects have been under cost-sharing contracts.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(d)&nbsp;Cash and Cash Equivalents</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company considers all highly liquid investments with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the bank&#x2019;s total obligations under the agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,587 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,535 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,523 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,195 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,110 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,730 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(e) Marketable Securities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with original maturities longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature in less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> all of the Company&#x2019;s investments were classified as held-to-maturity.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(f)&nbsp;Restricted Cash and Credit Facility</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s cash is restricted under the terms of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> security agreements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 24.2pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility carries a fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%</div> per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">($0.3</div> million) in letters of credit outstanding under this agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> agreement was between the Company and the New Jersey Board of Public Utilities (&#x201c;NJBPU&#x201d;). The Company received a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million recoverable grant award from the NJBPU, repayable over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year period beginning in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011.</div> The agreement also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the grant was fully repaid and therefore there was no certificate of deposit. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6)</div> &#x201c;Debt&#x201d; for additional information. Restricted cash includes the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;<div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">NJBPU agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">299 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div>&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(g)&nbsp;Foreign Exchange Gains and Losses</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in foreign exchange gain&nbsp;in the accompanying consolidated statements of operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(h)&nbsp;Property and Equipment</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(i)&nbsp;Concentration of Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company's consolidated revenues for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the periods indicated:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Nine months ended January 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">US Department of Energy</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">European Union (WavePort project)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(j) Warrant Liabilities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within &#x201c;(loss) gain on fair value of warrant liabilities&#x201d;. The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to &#x201c;additional paid-in capital&#x201d;, a component of &#x201c;stockholders' equity&#x201d; on the consolidated balance sheets.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(k)&nbsp;Net Loss per Common Share</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,429</div></div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154,537</div> </div>for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.<div style="display: inline; font-weight: bold;"> &nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"></div></div></div></div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(l) Recently Issued Accounting Standards</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Revenue from Contracts with Customers&#x201d;. This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Qualitative and quantitative information is required about:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contracts with customers&#x2014;including revenue and impairments recognized, disaggregation of revenue and information about contract balances and performance obligations (including the transaction price allocated to the remaining performance obligations).</div></div></td> </tr> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Significant judgments and changes in judgments&#x2014;determining the timing of satisfaction of performance obligations (over time or at a point in time), and determining the transaction price and amounts allocated to performance obligations.</div></div></td> </tr> <tr> <td style="WIDTH: 5%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 90%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain assets&#x2014;assets recognized from the costs to obtain or fulfill a contract.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued updated guidance deferring the effective date of the revenue recognition standard. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued additional updated guidance, which clarifies certain aspects of the ASU and the related implementation guidance issued by the FASB-IASB Joint Transition Resource Group for Revenue Recognition. This guidance is effective for the Company for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The Company is currently evaluating the impact that this guidance will have on its results of operations, financial position and cash flows.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;Disclosure of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern&#x201d;, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> annual period ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods thereafter. Early application is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> will have on its consolidated financial statements and disclosures and have not yet determined the effect of the standard on its ongoing financial reporting at this time. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1)</div>&nbsp;&#x201c;Background, Basis of Presentation and Liquidity&#x201d; for discussion on the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;Recognition and Measurement of Financial Assets and Financial Liabilities&#x201d;, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> for future periods as applicable.&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842)&#x201d;.</div> The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Compensation - Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718)&#x201d;,</div> or ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The amendments of ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods within those annual periods. Early adoption is permitted. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> for future periods as applicable.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> &#x201c;Financial Instruments - Credit Losses (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326):</div> Measurement of Credit Losses on Financial Instruments&#x201d;. The standard provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets held. The ASU is effective for public companies for annual periods, and interim periods within those annual periods, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and believes the standard will have no impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Classification of Certain Cash Receipts and Cash Payments&#x201d;, providing additional guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Restricted Cash&#x201d;, providing additional guidance on specific restricted cash flow classification on the cash flow statement. Cash flow should include restricted cash in total cash, and an entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> will have on its consolidated financial statements and disclosures and believes the effect of the standard on its ongoing financial reporting will not have a material impact.</div></div></div></div> 417000 595000 2760000 360000 189896 4000 10332000 10336000 774000 774000 7792000 3528000 2000 -138000 181670000 -177884000 -122000 6000 -260000 193000000 -184794000 -160000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4)</div>&nbsp;Balance Sheet Detail</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Accrued expenses</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">January 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Project costs (a)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,239 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">818 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contract loss reserve</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">199 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">199 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee incentive payments</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">463 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">688 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued salary and benefits</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">593 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">456 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal and accounting fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">329 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">298 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">274 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,121 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,675 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"></div></div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 18pt; VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(a)</div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=""><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Project costs at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> include accruals of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.8</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million for the disposition of the legacy Reedsport project anchors and site remediation for the legacy <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">PB40</div> projects, respectively. The Reedsport project is anticipated to be completed by the end of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">PB40</div> project is weather dependant and therefore it is not possible to predict a specific end date.</div></div></div></td> </tr> </table></div> 46776 6894 39882 1839 39882 260000 138000 122000 122000 324000 37000 700000 1700000 700000 1700000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.</div></div></div></div></div></div></div> 5783494 1865464 Project costs at January 31, 2017 include accruals of $0.8 milliion and $0.5 million for the disposition of the legacy Reedsport project anchors and site remediation for the legacy PB40 projects, respectively. Both efforts are anticipated to be completed in the first quarter of fiscal 2018. Common Stock and share data at October 31, 2015 has been adjusted retroactively to reflect a 1-for-10 reverse stock split effective October 27, 2015. xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares iso4217:EUR utr:T utr:Rate 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member 2011-11-01 2011-11-30 0001378140 us-gaap:TaxAuthoritySpainMember 2012-06-01 2012-06-30 0001378140 2014-04-01 2014-04-30 0001378140 2015-05-01 2016-01-31 0001378140 us-gaap:EmployeeStockOptionMember 2015-05-01 2016-01-31 0001378140 us-gaap:RestrictedStockMember 2015-05-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2015-05-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:EuropeanUnionWaverPortProjectMember 2015-05-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2015-05-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfEnergyMember 2015-05-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:UsDepartmentOfDefenseOfficeOfNavalResearchMember 2015-05-01 2016-01-31 0001378140 us-gaap:FairValueMeasurementsNonrecurringMember 2015-05-01 2016-01-31 0001378140 us-gaap:NewJerseyDivisionOfTaxationMember 2015-05-01 2016-01-31 0001378140 2015-05-01 2016-04-30 0001378140 2015-11-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2015-11-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:EuropeanUnionWaverPortProjectMember 2015-11-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2015-11-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfEnergyMember 2015-11-01 2016-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:UsDepartmentOfDefenseOfficeOfNavalResearchMember 2015-11-01 2016-01-31 0001378140 us-gaap:NewJerseyDivisionOfTaxationMember 2015-11-01 2016-01-31 0001378140 optt:BarclaysBankMember 2016-05-01 2016-10-31 0001378140 2016-05-01 2017-01-31 0001378140 us-gaap:EmployeeStockOptionMember 2016-05-01 2017-01-31 0001378140 optt:NonVestedRestrictedStockMember 2016-05-01 2017-01-31 0001378140 us-gaap:RestrictedStockMember 2016-05-01 2017-01-31 0001378140 us-gaap:RestrictedStockMember optt:PerformanceBasedVestingMember 2016-05-01 2017-01-31 0001378140 us-gaap:RestrictedStockMember optt:ServiceBasedVestingMember 2016-05-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-05-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:EuropeanUnionWaverPortProjectMember 2016-05-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2016-05-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfEnergyMember 2016-05-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:UsDepartmentOfDefenseOfficeOfNavalResearchMember 2016-05-01 2017-01-31 0001378140 us-gaap:FairValueMeasurementsNonrecurringMember 2016-05-01 2017-01-31 0001378140 us-gaap:WarrantMember 2016-05-01 2017-01-31 0001378140 us-gaap:WarrantMember us-gaap:MaximumMember 2016-05-01 2017-01-31 0001378140 us-gaap:WarrantMember us-gaap:MinimumMember 2016-05-01 2017-01-31 0001378140 us-gaap:NewJerseyDivisionOfTaxationMember 2016-05-01 2017-01-31 0001378140 optt:CurrentMember 2016-05-01 2017-01-31 0001378140 us-gaap:MaximumMember 2016-05-01 2017-01-31 0001378140 us-gaap:MinimumMember 2016-05-01 2017-01-31 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-05-01 2017-01-31 0001378140 us-gaap:AdditionalPaidInCapitalMember 2016-05-01 2017-01-31 0001378140 us-gaap:CommonStockMember 2016-05-01 2017-01-31 0001378140 us-gaap:RetainedEarningsMember 2016-05-01 2017-01-31 0001378140 us-gaap:TreasuryStockMember 2016-05-01 2017-01-31 0001378140 optt:PurchaseAgreementMember 2016-06-02 2016-06-02 0001378140 optt:StipulationMember 2016-07-01 2016-07-31 0001378140 optt:PurchaseAgreementMember 2016-07-22 2016-07-22 0001378140 optt:StipulationMember 2016-08-01 2016-08-31 0001378140 2016-10-19 2016-10-19 0001378140 us-gaap:OverAllotmentOptionMember 2016-10-19 2016-10-19 0001378140 2016-11-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-11-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:EuropeanUnionWaverPortProjectMember 2016-11-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2016-11-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfEnergyMember 2016-11-01 2017-01-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:UsDepartmentOfDefenseOfficeOfNavalResearchMember 2016-11-01 2017-01-31 0001378140 us-gaap:NewJerseyDivisionOfTaxationMember 2016-11-01 2017-01-31 0001378140 optt:StipulationMember 2016-11-14 2016-11-14 0001378140 optt:StipulationMember 2016-11-16 2016-12-15 0001378140 2001-04-30 0001378140 us-gaap:CorporationMember 2010-06-30 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member 2011-11-30 0001378140 us-gaap:TaxAuthoritySpainMember 2012-06-30 0001378140 2015-04-30 0001378140 optt:OptaMember 2015-09-30 0001378140 optt:SternLawsuitMember 2016-01-25 0001378140 2016-01-31 0001378140 2016-04-30 0001378140 optt:NonVestedRestrictedStockMember 2016-04-30 0001378140 optt:CheckingAndSavingsAccountsMember 2016-04-30 0001378140 optt:OvernightRepurchaseAccountMember 2016-04-30 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member 2016-04-30 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member us-gaap:CertificatesOfDepositMember 2016-04-30 0001378140 us-gaap:WarrantMember 2016-04-30 0001378140 optt:BarclaysBankAgreementMember 2016-04-30 0001378140 optt:NJBPUAgreementMember 2016-04-30 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-04-30 0001378140 us-gaap:AdditionalPaidInCapitalMember 2016-04-30 0001378140 us-gaap:CommonStockMember 2016-04-30 0001378140 us-gaap:RetainedEarningsMember 2016-04-30 0001378140 us-gaap:TreasuryStockMember 2016-04-30 0001378140 optt:PurchaseAgreementMember 2016-06-02 0001378140 optt:PurchaseAgreementMember 2016-07-22 0001378140 2016-10-19 0001378140 2017-01-31 0001378140 optt:BarclaysBankMember 2017-01-31 0001378140 us-gaap:EmployeeStockOptionMember 2017-01-31 0001378140 us-gaap:RestrictedStockMember 2017-01-31 0001378140 us-gaap:RestrictedStockMember optt:PerformanceBasedVestingMember 2017-01-31 0001378140 optt:CheckingAndSavingsAccountsMember 2017-01-31 0001378140 optt:OvernightRepurchaseAccountMember 2017-01-31 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member 2017-01-31 0001378140 optt:NewJerseyBoardOfPublicUtilities1Member us-gaap:CertificatesOfDepositMember 2017-01-31 0001378140 optt:PB40ProjectsMember 2017-01-31 0001378140 optt:ReedsportProjectMember 2017-01-31 0001378140 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-01-31 0001378140 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-01-31 0001378140 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-01-31 0001378140 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-01-31 0001378140 us-gaap:WarrantMember 2017-01-31 0001378140 us-gaap:TaxAuthoritySpainMember 2017-01-31 0001378140 optt:BarclaysBankAgreementMember 2017-01-31 0001378140 optt:NJBPUAgreementMember 2017-01-31 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-31 0001378140 us-gaap:AdditionalPaidInCapitalMember 2017-01-31 0001378140 us-gaap:CommonStockMember 2017-01-31 0001378140 us-gaap:RetainedEarningsMember 2017-01-31 0001378140 us-gaap:TreasuryStockMember 2017-01-31 0001378140 2017-02-28 EX-101.SCH 7 optt-20170131.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Document - Note 3 - Marketable Securities link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Balance Sheet Detail link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Debt link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Deferred Credits Payable link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 8 - Warrants link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 11 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 12 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 13 - Operating Segments and Geographic Information link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 3 - Marketable Securities (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 4 - Balance Sheet Detail (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 8 - Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 9 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 10 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 4 - Balance Sheet Detail (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Balance Sheet Detail - Balance Sheet Details (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 5 - Related Party Transactions (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 6 - Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 7 - Deferred Credits Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 8 - Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 8 - Warrants - Fair Value Assumptions for Warrants (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 9 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 9 - Share-based Compensation - Fair Value Assumptions for Options (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 9 - Share-based Compensation - Stock Options Under the Plans (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 9 - Stock-based Compensation - Non-vested Restricted Stock Under the Plans (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 10 - Fair Value Measurements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 10 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 10 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 12 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 13 - Operating Segments and Geographic Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 optt-20170131_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 optt-20170131_def.xml EXHIBIT 101.DEF EX-101.LAB 10 optt-20170131_lab.xml EXHIBIT 101.LAB Document And Entity Information Note To Financial Statement Details Textual us-gaap_LitigationSettlementAmount Litigation Settlement, Amount statementsignificantaccountingpoliciespolicies us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Risk-free interest rate us-gaap_LongTermDebt Long-term Debt statementnote2summaryofsignificantaccountingpoliciestables statementnote3marketablesecuritiestables statementnote4balancesheetdetailtables statementnote8warrantstables us-gaap_LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment statementnote9sharebasedcompensationtables Segment Reporting Disclosure [Text Block] statementnote10fairvaluemeasurementstables us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Expected volatility Consolidation, Policy [Policy Text Block] statementnote2summaryofsignificantaccountingpoliciescashandcashequivalentsdetails statementnote2summaryofsignificantaccountingpoliciescashrestrictedundersecurityagreementsdetails Litigation receivable Amount due from a litigation. statementnote2summaryofsignificantaccountingpoliciesrevenuesbymajorcustomersdetails statementnote3marketablesecuritiesmarketablesecuritiesthatmaturewithinoneyeardetails statementnote4balancesheetdetailbalancesheetdetailsdetails us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Expected life (in years) (Year) us-gaap_IncreaseDecreaseInDeferredRevenue Decrease in unearned revenues statementnote8warrantsfairvalueassumptionsforwarrantsdetails statementnote9sharebasedcompensationfairvalueassumptionsforoptionsdetails Foreign currency translation adjustment statementnote9sharebasedcompensationstockoptionsundertheplansdetails statementnote9stockbasedcompensationnonvestedrestrictedstockundertheplansdetails statementnote10fairvaluemeasurementsfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisdetails statementnote10fairvaluemeasurementschangesonvalueofwarrantliabilitydetails us-gaap_IncreaseDecreaseInAccruedLiabilities Increase in accrued expenses Notes To Financial Statements Notes To Financial Statements [Abstract] Purchase Agreement [Member] Represents the purchase agreement. us-gaap_MarketableSecuritiesCurrent Marketable securities optt_ClassOfWarrantOrRightExpirationPeriod Class of Warrant or Right, Expiration Period Period from date of issuance that the warrant or right expires. us-gaap_LineOfCredit Long-term Line of Credit Other comprehensive loss Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Forfeited (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Beginning Balance, issued and unvested (in dollars per share) Ending Balance, issued and unvested (in dollars per share) Cash and Cash Equivalents, Policy [Policy Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Granted (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Vested (in dollars per share) Significant Accounting Policies [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Beginning Balance, issued and unvested (in shares) Ending Balance, issued and unvested (in shares) us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Total stockholders' equity Balance Balance Basis of Accounting, Policy [Policy Text Block] us-gaap_PolicyTextBlockAbstract Accounting Policies optt_LitigationSettlementAmountPaidByInsurer Litigation Settlement, Amount Paid by Insurer Amount of judgment or settlement paid by the entity's insurer in respect of litigation. Income Tax Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeited (in shares) Stipulation [Member] Represents the Stipulation and Agreement of Class Settlement. Accounting Policies [Abstract] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period us-gaap_IncreaseDecreaseInAccountsPayable (Decrease) increase in accounts payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Revenues, percentage us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value us-gaap_ComprehensiveIncomeNetOfTax Comprehensive loss attributable to Ocean Power Technologies, Inc. Exercisable, weighted average exercise price (in dollars per share) Exercisable, weighted average remaining contractual term (Year) Exercisable, shares underlying options (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Operating expenses: Sales Revenue, Net [Member] Revenues Revenues us-gaap_TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired Acquisition of treasury stock (in shares) Balance, weighted average remaining contractual term (Year) Preferred stock, shares outstanding (in shares) optt_StockIssuedDuringPeriodSharesLitigationSettlement Stock Issued During Period, Shares, Litigation Settlement Number of new stock issued for litigation settlement during the period. Estimate of Fair Value Measurement [Member] us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Portion at Fair Value Measurement [Member] optt_StockIssuedDuringPeriodValueLitigationSettlement Stock Issued During Period, Value, Litigation Settlement Equity impact of the value of new stock issued during the period for litigation settlement. Concentration Risk Benchmark [Domain] Measurement Basis [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Beginning Balance, weighted average exercise price (in dollars per share) Ending Balance, weighted average exercise price (in dollars per share) optt_PricePerCommonStockAndWarrant Price Per Common Stock and Warrant Per unit amount of common stock and warrant issued. Long-term debt and capital lease obligations Concentration Risk Benchmark [Axis] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Forfeited. (in dollars per share) Corporation [Member] Granted. (in dollars per share) Exercised. (in dollars per share) Legal Entity Type of Counterparty [Domain] Legal Entity of Counterparty, Type [Axis] Maximum [Member] Minimum [Member] Range [Axis] Range [Domain] us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Customer [Axis] Customer [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Beginning Balance, shares underlying options (in shares) Ending Balance, shares underlying options (in shares) optt_OwnershipPercentage Ownership Percentage The percentage of ownership of common stock or equity participation in the investee. Contract loss reserve Checking and Savings Accounts [Member] Checking and savings accounts [member] Barclays Bank Agreement [Member] Barclays bank agreement [member] NJBPU Agreement [Member] NJBPU agreement [member] U.S. Department of Defense Office of Naval Research [Member] Related to the customer U.S. Department of Defense Office of Naval Research. Supplemental Balance Sheet Disclosures [Text Block] US Department of Energy [Member] US department of energy [member] Mitsui Engineering and Ship Building [Member] Mitsui engineering and ship building [member] Customer Concentration Risk [Member] European Union Waver Port Project [Member] European union waver port project [member] Stock based compensation Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] us-gaap_LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount Current [Member] Current [member] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Deferred credits payable current Customer Advances and Deposits, Current New Jersey Board of Public Utilities 1 [Member] The entity of New jersey board of public utilities 1 Customer Advances and Deposits Disclosure [Text Block] Customer Advances And Deposits Disclosure optt_DeferredCreditsPayableOptionDetails Deferred Credits Payable Option Details Deferred credits payable option details us-gaap_TreasuryStockValueAcquiredCostMethod Acquisition of treasury stock optt_DeferredCreditsPayableMarketDiscountRate Deferred Credits Payable Market Discount Rate Deferred Credits Payable Market Discount Rate optt_DeferredCreditsPayableMarketLiquidatedDamagesRate Deferred Credits Payable Market Liquidated Damages Rate Deferred Credits Payable Market Liquidated Damages Rate us-gaap_TreasuryStockValue Treasury stock, at cost; 46,776 and 6,894 shares, respectively Vesting [Axis] Performance based vesting [Member] Performance based vesting [member] Vesting [Domain] Weighted average shares used to compute basic and diluted net loss per share (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party us-gaap_SharePrice Share Price us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Basic and diluted net loss per share (in dollars per share) Award Type [Axis] Equity Award [Domain] us-gaap_IncreaseDecreaseInUnbilledReceivables (Increase) decrease in unbilled receivables us-gaap_IncreaseDecreaseInAccountsReceivable Decrease in accounts receivable us-gaap_RepaymentsOfDebt Repayment of debt optt_InputTax Input Tax Input tax. Scenario, Unspecified [Domain] optt_AffirmativeVotePercentageByStockholders Affirmative Vote Percentage By Stockholders Percentage of affirmative votes from the entity's stockholders. Scenario [Axis] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stern Lawsuit [Member] Lawsuit filed by alleged shareholder. Related Party Transactions Disclosure [Text Block] Exercised (in shares) Issuance of restricted stock, net (in shares) Issuance of restricted stock, net Fair Value Disclosures [Text Block] Statement [Table] Litigation Case [Domain] Foreign Currency Transactions and Translations Policy [Policy Text Block] us-gaap_IncreaseDecreaseInOtherNoncurrentAssets Decrease in other noncurrent assets Litigation Case [Axis] us-gaap_IncreaseDecreaseInOtherCurrentAssets Increase in other current assets Commitments and Contingencies Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Forfeited (in shares) Earnings Per Share, Policy [Policy Text Block] us-gaap_NetIncomeLossAttributableToNoncontrollingInterest Technologies (Australasia) Pty Ltd. Over-Allotment Option [Member] Granted (in shares) Income Statement [Abstract] Sale of Stock [Axis] Less: Net profit attributable to the non-controlling interest in Ocean Power Sale of Stock [Domain] us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by investing activities Cash flows from financing activities: us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues us-gaap_IncreaseDecreaseInRestrictedCash Restricted cash Sale of stock us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders’ equity us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive income attributable to the non-controlling interest in Ocean Power Technologies (Australasia) Pty Ltd. us-gaap_RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) optt_ProceedFromSaleOfLossCarryforwardsAndTaxCredits Proceed from Sale of Loss Carryforwards and Tax Credits Amount received from sale of net operating loss carryforwards and other tax credits. Accumulated other comprehensive loss Deferred credits payable non-current Customer Advances or Deposits, Noncurrent Reedsport Project [Member] Costs related to the dispostion of the legacy Reedsport project anchors PB40 Projects [Member] Costs related to the environmental remediation of the legacy PB40 Projects. Investment Type [Axis] Investments [Domain] us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Total comprehensive loss Net loss Net loss us-gaap_EnvironmentalExitCostsCostsAccruedToDate Environmental Exit Costs, Costs Accrued to Date Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Environmental Exit Costs, Name of Property [Domain] Environmental Exit Cost by Property [Axis] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights Changes in operating assets and liabilities: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right us-gaap_IncomeTaxExpenseBenefit Income Tax Expense (Benefit) Income tax benefit us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss before income taxes us-gaap_AssetsFairValueAdjustment Assets, Fair Value Adjustment Statement of Comprehensive Income [Abstract] us-gaap_LiabilitiesCurrent Total current liabilities (Loss) gain on fair value of warrant liabilities Litigation payable Foreign exchange loss Foreign exchange gain Class of Stock [Axis] Maturities of marketable securities Gain on fair value of warrant liabilities Fair Value Adjustment of Warrants us-gaap_DerivativeLiabilitiesCurrent Derivative Liability, Current Compensation expense related to stock option grants & restricted stock Unearned revenue Other noncurrent assets Interest income, net Current portion of long-term debt and capital lease obligations Treasury stock (in shares) Revenue Recognition, Policy [Policy Text Block] Counterparty Name [Domain] Common stock, $0.001 par value; authorized 50,000,000 shares, issued 6,313,996 and 2,352,100 shares, respectively us-gaap_TableTextBlock Notes Tables Counterparty Name [Axis] Tax Authority, Spain [Member] Common stock, shares issued (in shares) Certificates of Deposit [Member] New Jersey Division of Taxation [Member] Common stock, shares authorized (in shares) Schedule of Other Assets and Other Liabilities [Table Text Block] Amendment Flag Warrant Liability, Policy [Policy Text Block] Disclosure of accounting policy for warrant liability. Depreciation and amortization Common stock, par value (in dollars per share) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Warrant Disclosure [Text Block] The entire disclosure for warrants. Schedule of Share-based Compensation, Activity [Table Text Block] us-gaap_PaymentsToAcquireMarketableSecurities Purchases of marketable securities us-gaap_AssetsCurrent Total current assets Changes on Value of Warrant Liability [Table Text Block] Tabular disclosure of pertinent information about the changes on the value of the warrant liability. Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Other (expense) income, net Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Expected volatility us-gaap_OperatingExpenses Total operating expenses Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding Current Fiscal Year End Date Adjustments to reconcile net loss to net cash used in operating activities Preferred stock, shares issued (in shares) Statement of Financial Position [Abstract] Preferred stock, shares authorized (in shares) Document Fiscal Period Focus Issuance The value of warrants issued during the period. Document Fiscal Year Focus Warrant liabilities Fair value – April 30, 2016 Fair value – January 31, 2017 The current portion of warrant liability. Accounts payable Preferred stock par value (in dollars per share) Transfers The amount of warrant liability transferred in or out during the period. us-gaap_AccruedLiabilitiesCurrent Accrued expenses Accrued expenses total Document Period End Date Overnight Repurchase Account [Member] Represents overnight repurchase account. Document Type Employee incentive payments us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) Statement of Cash Flows [Abstract] us-gaap_OperatingIncomeLoss Operating loss us-gaap_PaymentsForLegalSettlements Payments for Legal Settlements Payment for litigation settlements us-gaap_GrossProfit Gross profit (loss) Statement of Stockholders' Equity [Abstract] Document Information [Line Items] Cost of revenues Document Information [Table] Accrued salary and benefits Entity Filer Category us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Other Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Other current assets Other Assets, Current Legal and accounting fees optt_NumberOfFinancingAgreementsClosed Number of Financing Agreements Closed Refers to the number of financing agreements closed by the company. Business Description and Basis of Presentation [Text Block] us-gaap_MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest Unbilled receivables us-gaap_PaymentsToAcquireMachineryAndEquipment Purchases of equipment Entity Central Index Key Entity Registrant Name Project costs (a) Entity [Domain] Legal Entity [Axis] LIABILITIES AND STOCKHOLDERS' EQUITY us-gaap_Assets Total assets Property, Plant and Equipment, Policy [Policy Text Block] OPTA [Member] OPTA [member] Barclays Bank [Member] The entity of Barclays bank. Additional paid-in capital Ocean Power Technologies, Inc. stockholders’ equity: Entity Common Stock, Shares Outstanding (in shares) Cash flows from operating activities: Statement [Line Items] optt_ForeignTaxExaminationRefund Foreign Tax Examination Refund The amount of tax refund due to the result of a foreign tax examination. optt_RelatedPartyTransactionTermOfAgreement Related Party Transaction Term of Agreement Period of the Executive Transition Agreement under which the executive will receive a monthly consulting fee. optt_RelatedPartyTransactionMonthlyConsultingFee Related Party Transaction Monthly Consulting Fee The amount of the consulting fee that is paid on a reoccurring basis. Financial Instrument [Axis] Financial Instruments [Domain] Trading Symbol AOCI Attributable to Parent [Member] us-gaap_LineOfCreditFacilityCommitmentFeePercentage Line of Credit Facility, Commitment Fee Percentage Reported Value Measurement [Member] Non-vested Restricted Stock [Member] us-gaap_Liabilities Total liabilities Commitments and contingencies (note 11) Liquidity, Policy [Policy Text Block] Disclosure of liquidity accounting policy. us-gaap_RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Restricted cash Restricted cash, current Fair Value, Hierarchy [Axis] Service-based Vesting [Member] Shares which will vest based on service. Cash and Cash Equivalents [Domain] ASSETS us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents [Axis] Effect of exchange rate changes on cash and cash equivalents Marketable Securities, Policy [Policy Text Block] Restricted Cash and Cash Equivalents [Axis] us-gaap_NetIncomeLoss Net loss attributable to Ocean Power Technologies, Inc. Concentration Risk, Credit Risk, Policy [Policy Text Block] Schedule of Restricted Cash and Cash Equivalents [Table Text Block] Schedule of Cash and Cash Equivalents [Table Text Block] us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Warrant [Member] Restricted Stock [Member] Property and equipment, net Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Employee Stock Option [Member] Marketable Securities [Table Text Block] optt_LongTermDebtPaymentTerms1 Long-term Debt Payment Terms Long-erm debt payment terms Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Debt Disclosure [Text Block] Selling, general and administrative costs Risk-free rate us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Dividend rate us-gaap_PaymentsForRepurchaseOfCommonStock Acquisition of treasury stock Proceeds from issuance of common stock and related warrants, net of costs Proceeds from Issuance or Sale of Equity Expected life (years) (Year) Retained Earnings [Member] Treasury Stock [Member] Fair Value, Measurements, Recurring [Member] Fair Value, Measurements, Nonrecurring [Member] Additional Paid-in Capital [Member] Measurement Frequency [Axis] Proceeds from sale of common stock, net of issuance costs Fair Value, Measurement Frequency [Domain] Use of Estimates, Policy [Policy Text Block] Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] New Accounting Pronouncements, Policy [Policy Text Block] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Cash flows from investing activities: Common Stock [Member] Equity Components [Axis] us-gaap_NumberOfOperatingSegments Number of Operating Segments Equity Component [Domain] Product development costs us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Expected dividend yield EX-101.PRE 11 optt-20170131_pre.xml EXHIBIT 101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - shares
9 Months Ended
Jan. 31, 2017
Feb. 28, 2017
Document Information [Line Items]    
Entity Registrant Name Ocean Power Technologies, Inc.  
Entity Central Index Key 0001378140  
Trading Symbol optt  
Current Fiscal Year End Date --04-30  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   6,313,996
Document Type 10-Q  
Document Period End Date Jan. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
ASSETS    
Cash and cash equivalents $ 11,110 $ 6,730
Marketable securities 25 75
Restricted cash 299 300
Unbilled receivables 324 37
Litigation receivable 2,500
Other current assets 337 117
Total current assets 12,095 9,759
Property and equipment, net 195 273
Other noncurrent assets 131 319
Total assets 12,421 10,351
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable 189 373
Accrued expenses 3,121 2,675
Litigation payable 3,000
Unearned revenue 39
Warrant liabilities 653
Current portion of long-term debt and capital lease obligations 34 81
Deferred credits payable current 600
Total current liabilities 4,597 6,168
Long-term debt and capital lease obligations 32 55
Deferred credits payable non-current 600
Total liabilities 4,629 6,823
Commitments and contingencies (note 11)
Ocean Power Technologies, Inc. stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding
Common stock, $0.001 par value; authorized 50,000,000 shares, issued 6,313,996 and 2,352,100 shares, respectively 6 2
Treasury stock, at cost; 46,776 and 6,894 shares, respectively (260) (138)
Additional paid-in capital 193,000 181,670
Retained Earnings (Accumulated Deficit) (184,794) (177,884)
Accumulated other comprehensive loss (160) (122)
Total stockholders' equity 7,792 3,528
Total liabilities and stockholders’ equity $ 12,421 $ 10,351
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Jan. 31, 2017
Apr. 30, 2016
Preferred stock par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 6,313,996 2,352,100
Treasury stock (in shares) 46,776 6,894
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Revenues $ 221 $ 5 $ 593 $ 605
Cost of revenues 363 5 615 605
Gross profit (loss) (142) (22)
Operating expenses:        
Product development costs 950 1,752 3,894 5,412
Selling, general and administrative costs 1,617 1,690 4,859 5,419
Total operating expenses 2,567 3,442 8,753 10,831
Operating loss (2,709) (3,442) (8,775) (10,831)
(Loss) gain on fair value of warrant liabilities (104) 1,161
Interest income, net 24 1 26 10
Other (expense) income, net (3) 240
Foreign exchange loss (26) (188) (20) (194)
Loss before income taxes (2,815) (3,632) (7,608) (10,775)
Income tax benefit 698 1,674 698 1,674
Net loss (2,117) (1,958) (6,910) (9,101)
Less: Net profit attributable to the non-controlling interest in Ocean Power        
Technologies (Australasia) Pty Ltd. (45)
Net loss attributable to Ocean Power Technologies, Inc. $ (2,117) $ (1,958) $ (6,910) $ (9,146)
Basic and diluted net loss per share (in dollars per share) $ (0.37) $ (1.05) $ (1.84) $ (5.07)
Weighted average shares used to compute basic and diluted net loss per share (in shares) [1] 5,783,494 1,865,464    
[1] Common Stock and share data at October 31, 2015 has been adjusted retroactively to reflect a 1-for-10 reverse stock split effective October 27, 2015.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Net loss $ (2,117) $ (1,958) $ (6,910) $ (9,101)
Foreign currency translation adjustment 3 151 (38) 106
Total comprehensive loss (2,114) (1,807) (6,948) (8,995)
Comprehensive income attributable to the non-controlling interest in Ocean Power Technologies (Australasia) Pty Ltd. (73)
Comprehensive loss attributable to Ocean Power Technologies, Inc. $ (2,114) $ (1,807) $ (6,948) $ (9,068)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Stockholders' Equity (Unaudited) - 9 months ended Jan. 31, 2017 - USD ($)
$ in Thousands
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Apr. 30, 2016 2,352,100 (6,894)        
Balance at Apr. 30, 2016 $ 2 $ (138) $ 181,670 $ (177,884) $ (122) $ 3,528
Net loss (6,910) (6,910)
Stock based compensation 224 224
Issuance of restricted stock, net (in shares) 189,896        
Issuance of restricted stock, net 774 774
Sale of stock $ 4 10,332 $ 10,336
Acquisition of treasury stock (in shares) (39,882)       (39,882)
Acquisition of treasury stock $ (122) $ (122)
Other comprehensive loss (38) (38)
Balance (in shares) at Jan. 31, 2017 6,313,996 (46,776)        
Balance at Jan. 31, 2017 $ 6 $ (260) $ 193,000 $ (184,794) $ (160) $ 7,792
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Cash flows from operating activities:    
Net loss $ (6,910) $ (9,101)
Adjustments to reconcile net loss to net cash used in operating activities    
Foreign exchange gain 20 194
Depreciation and amortization 104 84
Compensation expense related to stock option grants & restricted stock 998 298
Gain on fair value of warrant liabilities (1,161) 0
Payment for litigation settlements (500)
Changes in operating assets and liabilities:    
Decrease in accounts receivable 89
(Increase) decrease in unbilled receivables (286) 44
Increase in other current assets (222) (30)
Decrease in other noncurrent assets 169 27
(Decrease) increase in accounts payable (186) 98
Increase in accrued expenses 461 221
Decrease in unearned revenues (39)
Net cash used in operating activities (7,552) (8,076)
Cash flows from investing activities:    
Purchases of marketable securities (25)
Maturities of marketable securities 75 25
Restricted cash 1 111
Purchases of equipment (22) (24)
Net cash provided by investing activities 29 112
Cash flows from financing activities:    
Proceeds from sale of common stock, net of issuance costs 205
Proceeds from issuance of common stock and related warrants, net of costs 12,150
Repayment of debt (70) (75)
Acquisition of treasury stock (122) (4)
Net cash provided by financing activities 11,958 126
Effect of exchange rate changes on cash and cash equivalents (55) (85)
Net increase (decrease) in cash and cash equivalents 4,380 (7,923)
Cash and cash equivalents, beginning of period 6,730 17,336
Cash and cash equivalents, end of period $ 11,110 $ 9,413
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Background, Basis of Presentation and Liquidity
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]
(1)
 Background, Basis of Presentation and Liquidity
 
a)
Background
 
Ocean Power Technologies, Inc. (the “Company”) was incorporated in
1984
in New Jersey, commenced business operations in
1994
and re-incorporated in Delaware in
2007.
The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since
1997.
The Company markets its PowerBuoys in the United States and internationally. Since fiscal
2002,
government agencies have accounted for a significant portion of the Company’s revenues.  These revenues were largely for the support of product development efforts. The Company’s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.
 
b)
Basis of Presentation
 
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form
10
-Q and Article 
10
of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form
10
-K for the year ended
April
30,
2016
filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form
10
-Q.
 
c)
Liquidity/Going Concern
 
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of
$184.8
million as of
January
31,
2017.
As of
January
31,
2017,
the Company had approximately
$11.1
million in cash on hand. The Company generated revenues of
$0.6
million during each of the
nine
months ended
January
31,
2017
and
2016.
Based on the Company’s cash and cash equivalents and marketable securities as of
January
31,
2017,
the Company believes that it will be able to finance its capital requirements and operations into the quarter ending
January
31,
2018.
The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
 
Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies
may
include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.
 
In fiscal
2017
and
2016,
the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed
three
equity financing arrangements during the
nine
months ended
January
31,
2017.
 The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company
may
be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and
may
cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.
 
On
June
2,
2016,
the Company entered into a securities purchase agreement, which was amended on
June
7,
2016
(as amended, the “Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The net proceeds to the Company from the offering were approximately
$1.7
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of
$6.08
per share, became exercisable on
December
3,
2016
(“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
 
On
July
22,
2016,
the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The net proceeds to the Company from the offering were approximately
$3.6
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(5th)
anniversary of the initial date of issuance.
 
On
October
19,
2016,
the Company sold
2,760,000
shares of common stock at a price of
$2.75
per share, which includes the sale of
360,000
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$6.9
million, after deducting placement agent fees and offering expenses payable by the Company.
 
The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing
may
not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it
may
be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it
may
be forced to cease operations.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
(2)
 Summary of Significant Accounting Policies
 
(a) Consolidation
 
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Participation of stockholders other than the Company in the net assets and in the earnings or losses of a consolidated subsidiary is reflected as a non-controlling interest in the Company's Consolidated Balance Sheets and Statements of Operations, which adjusts the Company's consolidated results of operations to reflect only the Company's share of the earnings or losses of the consolidated subsidiary. As of
January
31,
2017,
there were no non-controlling interests.
 
In
September
2015,
the Company re-purchased the non-controlling interest (consisting of
11.8%)
of OPTA for nominal consideration and now has
100%
ownership of OPTA. The Company also periodically evaluates its relationships with other entities to identify whether they are variable interest entities, and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is included in the consolidated financial statements. As of
January
31,
2017,
there were
no
such entities.
 
(b) Use of Estimates
 
The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.
 
(c) Revenue Recognition
 
The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.
 
The Company has
two
types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of
zero.
The Company’s share of the costs is recorded as product development expense.
 
Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria
may
be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.
 
In addition, recognition of revenue (and the related costs)
may
be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management
may
make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects
may
have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.
 
Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within
one
year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.
 
A portion of the Company’s projects have been under cost-sharing contracts.
 
(d) Cash and Cash Equivalents
 
The Company considers all highly liquid investments with a maturity of
three
months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least
100%
of the bank’s total obligations under the agreement.
 
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Checking and savings accounts
  $
8,587
    $
4,535
 
Overnight repurchase account
   
2,523
     
2,195
 
    $
11,110
    $
6,730
 
 
(e) Marketable Securities
 
Marketable securities with original maturities longer than
three
months but that mature in less than
one
year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of
January
31,
2017
and
April
30,
2016,
all of the Company’s investments were classified as held-to-maturity.
 
(f) Restricted Cash and Credit Facility
 
A portion of the Company’s cash is restricted under the terms of
two
security agreements.
 
One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD,
one
of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility carries a fee of
1%
per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of
January
31,
2017,
there was
€0.3
million
($0.3
million) in letters of credit outstanding under this agreement.
 
The
second
agreement was between the Company and the New Jersey Board of Public Utilities (“NJBPU”). The Company received a
$0.5
million recoverable grant award from the NJBPU, repayable over a
five
-year period beginning in
November
2011.
The agreement also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of
January
31,
2017,
the grant was fully repaid and therefore there was no certificate of deposit. See Note
(6)
“Debt” for additional information. Restricted cash includes the following:
 
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
NJBPU agreement
  $
-
    $
50
 
Barclay's Bank Agreement
   
299
     
250
 
    $
299
    $
300
 
 
(g) Foreign Exchange Gains and Losses
 
The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions
may
result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in foreign exchange gain in the accompanying consolidated statements of operations.
 
(h) Property and Equipment
 
Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives
(three
to
seven
years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset
may
not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.
 
(i) Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.
 
The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least
10%
of the Company's consolidated revenues for at least
one
of the periods indicated:
 
 
 
Three months ended January 31,
 
 
Nine months ended January 31,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Mitsui Engineering & Shipbuilding
   
56
%    
-
     
83
%    
-
 
U.S. Department of Defense Office of
                               
Naval Research
   
44
%    
-
     
17
%    
-
 
US Department of Energy
   
-
     
100
%    
-
     
33
%
European Union (WavePort project)
   
-
     
-
     
-
     
67
%
     
100
%    
100
%    
100
%    
100
%
 
The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.
 
(j) Warrant Liabilities
 
The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “(loss) gain on fair value of warrant liabilities”. The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “additional paid-in capital”, a component of “stockholders' equity” on the consolidated balance sheets.
 
(k) Net Loss per Common Share
 
Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.
 
In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling
680,429
for the
three
and
nine
months ended
January
31,
2017
and
154,537
for the
three
and
nine
months ended
January
31,
2016,
were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.
 
 
(l) Recently Issued Accounting Standards
 
In
May
2014,
the Financial Accounting Standards Board (“FASB”) issued ASU No.
2014
-
09,
“Revenue from Contracts with Customers”. This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Qualitative and quantitative information is required about:
 
 
Contracts with customers—including revenue and impairments recognized, disaggregation of revenue and information about contract balances and performance obligations (including the transaction price allocated to the remaining performance obligations).
 
Significant judgments and changes in judgments—determining the timing of satisfaction of performance obligations (over time or at a point in time), and determining the transaction price and amounts allocated to performance obligations.
 
Certain assets—assets recognized from the costs to obtain or fulfill a contract.
 
In
August
2015,
the FASB issued updated guidance deferring the effective date of the revenue recognition standard. In
March
and
April
2016,
the FASB issued additional updated guidance, which clarifies certain aspects of the ASU and the related implementation guidance issued by the FASB-IASB Joint Transition Resource Group for Revenue Recognition. This guidance is effective for the Company for annual reporting periods beginning after
December
15,
2017.
The Company is currently evaluating the impact that this guidance will have on its results of operations, financial position and cash flows.
 
In
August
2014,
the FASB issued ASU
2014
-
15,
“Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the
first
annual period ending after
December
15,
2016,
and interim periods thereafter. Early application is permitted. The Company is evaluating the effect ASU
2014
-
15
will have on its consolidated financial statements and disclosures and have not yet determined the effect of the standard on its ongoing financial reporting at this time. See Note
(1)
 “Background, Basis of Presentation and Liquidity” for discussion on the Company’s ability to continue as a going concern.
 
In
January
2016,
the FASB issued ASU No.
2016
-
01,
“Recognition and Measurement of Financial Assets and Financial Liabilities”, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after
December
15,
2017,
including interim periods within those fiscal years. The Company will evaluate the effect of ASU
2016
-
01
for future periods as applicable. 
 
In
February
2016,
the FASB issued ASU No.
2016
-
02,
“Leases (Topic
842)”.
The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than
12
months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU
2016
-
02
is effective for annual periods beginning after
December
15,
2018,
including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU
2016
-
02
will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.
 
In
March
2016,
the FASB issued ASU No.
2016
-
09,
“Compensation - Stock Compensation (Topic
718)”,
or ASU No.
2016
-
09.
The amendments of ASU No.
2016
-
09
were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity
may
be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No.
2016
-
09
is effective for fiscal years beginning after
December
15,
2016,
and interim periods within those annual periods. Early adoption is permitted. The Company will evaluate the effect of ASU
2016
-
09
for future periods as applicable.
 
In
June
2016,
the FASB issued ASU
2016
-
13,
“Financial Instruments - Credit Losses (Topic
326):
Measurement of Credit Losses on Financial Instruments”. The standard provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets held. The ASU is effective for public companies for annual periods, and interim periods within those annual periods, beginning after
December
15,
2019.
The Company is evaluating the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and believes the standard will have no impact on its ongoing financial reporting at this time.
 
In
August
2016,
the FASB issued ASU
2016
-
15,
“Statement of Cash Flows (Topic
230):
Classification of Certain Cash Receipts and Cash Payments”, providing additional guidance on
eight
specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for
fiscal years beginning after
December
15,
2017,
and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.
 
In
November
2016,
the FASB issued ASU
2016
-
18,
“Statement of Cash Flows (Topic
230):
Restricted Cash”, providing additional guidance on specific restricted cash flow classification on the cash flow statement. Cash flow should include restricted cash in total cash, and an entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for
fiscal years beginning after
December
15,
2017,
and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU
2016
-
18
will have on its consolidated financial statements and disclosures and believes the effect of the standard on its ongoing financial reporting will not have a material impact.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
(3)
 Marketable Securities
 
Marketable securities with initial maturities greater than
three
months but that mature within
one
year from the balance sheet date are classified as current assets and are summarized as follows:
 
 
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Certificate of Deposit
  $
25
    $
75
 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Balance Sheet Detail
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]
(4)
 Balance Sheet Detail
 
Accrued expenses
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Project costs (a)
  $
1,239
    $
818
 
Contract loss reserve
   
199
     
199
 
Employee incentive payments
   
463
     
688
 
Accrued salary and benefits
   
593
     
456
 
Legal and accounting fees
   
329
     
240
 
Other
   
298
     
274
 
    $
3,121
    $
2,675
 
 
 
(a)
Project costs at
January
31,
2017
include accruals of
$0.8
million and
$0.5
million for the disposition of the legacy Reedsport project anchors and site remediation for the legacy
PB40
projects, respectively. The Reedsport project is anticipated to be completed by the end of the
first
quarter of fiscal
2018.
The
PB40
project is weather dependant and therefore it is not possible to predict a specific end date.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Related Party Transactions
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
(5)
 Related Party Transactions
 
In
April
2014,
the Company entered into an Executive Transition Agreement with George W. Taylor, who was formerly employed by the Company as Executive Vice Chairman and served on the Company’s Board of Directors prior to that date. Under this agreement, Dr. Taylor received
fifteen
months of consulting fees at a monthly rate of
$20
thousand (this period terminated on
July
18,
2015).
During the
nine
months ended
January
31,
2016
the Company recorded
$53
thousand in expense relating to this agreement, which was recorded in selling, general and administrative expense in the unaudited consolidated statements of operations.  There were
no
such amounts recorded during the
three
and
nine
months ended
January
31,
2017.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Debt
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Debt Disclosure [Text Block]
(6)
 Debt
 
The Company was awarded a recoverable grant totaling
$0.5
million between
April
2009
and
June
2010
from the NJBPU under the Renewable Energy Business Venture Assistance Program. Under the terms of this agreement, the amount to be repaid is a fixed monthly amount of principal only, repayable over a
five
-year period beginning in
November
2011.
The terms also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of
April
30,
2016
the Company had
$50
thousand outstanding and the respective
$50
thousand certificate of deposit was recorded within “Other current assets” on the balance sheet. As of
January
31,
2017,
the grant was fully repaid, and therefore, there is
no
balance outstanding and
no
respective certificate of deposit assigned to restricted cash. See Note
2(f).
“Summary of Significant Accounting Policies - Restricted Cash and Credit Facility” for more information regarding the certificate of deposit.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Deferred Credits Payable
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Customer Advances and Deposits Disclosure [Text Block]
(7)
 Deferred Credits Payable
 
During the year ended
April
 
30,
2001,
in connection with the sale of common stock to an investor, the Company received
$0.6
million from the investor in exchange for an option to purchase up to
500,000
metric tons of carbon emissions credits generated by the Company during the years
2008
through
2012,
at a
30%
discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to
30%
of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).  Under the terms of the agreement, if the Company did not become entitled under applicable laws to the full amount of emission credits covered by the option by
December
 
31,
2012,
the Company was obligated to return the option fee of
$0.6
million, less the aggregate discount on any emission credits sold to the investor prior to such date. In
December
2012,
the Company and the investor agreed to extend the period for the sale of emission credits until
December
31,
2017.
As of
January
31,
2017,
the Company has not generated any emissions credits eligible for purchase under the agreement. The
$0.6
million is reflected on the balance sheet within “Deferred credits payable current” and “Deferred credits payable non-current” as of
January
31,
2017
and
April
30,
2016,
respectively.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Warrants
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Warrant Disclosure [Text Block]
(8)
Warrants
 
On
June
2,
2016,
the Company entered into a securities purchase agreement, which was amended on
June
7,
2016
(as amended, the
“June
Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The warrants have an exercise price of
$6.08
per share, became exercisable on
December
3,
2016
(“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
 
On
July
22,
2016,
the Company entered into a Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain institutional purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(5th)
anniversary of the initial date of issuance.
  
The warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC
480.
As such, the warrants with a value of
$0.7
million at
January
31,
2017
are reflected within “warrant liabilities” in the unaudited consolidated balance sheets. There were
no
such amounts at
April
30,
2016.
 
An unrealized loss and unrealized gain of
$0.1
million and
$1.2
million, respectively, were included within “(Loss) gain on fair value of warrant liabilities” in the consolidated statements of operations for the
three
and
nine
months ended
January
31,
2017,
respectively. There were
no
unrealized gains or losses during the
three
and
nine
months ended
January
31,
2016.
The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:
 
 
 
January 31, 2017
 
Dividend rate  
 
0.0%
 
 
Risk-free rate  
 
1.9%
 
 
Expected life (years)
 
4.5
-
4.9
 
Expected volatility
 
129.0%
-
138.2%
 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Share-based Compensation
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(9)
 Stock-Based Compensation
 
The aggregate stock-based compensation expense related to all stock-based transactions recorded in the consolidated statements of operations was approximately
$1.0
million and
$0.3
million during the
nine
months ended
January
31,
2017
and
2016,
respectively.
 
(a) Stock Options
 
Valuation Assumptions for Options Granted during the
nine
months ended
January
31,
2017
and
2016
 
The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the
nine
months ended
January
31,
2017,
was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the "simplified" method as permitted by the SEC's Staff Accounting Bulletin No. 
110,
Share-Based Payment.
Expected volatility was based on the Company’s historical volatility during the
nine
months ended
January
31,
2017.
The below assumptions were used to determine the weighted average per share fair value of
$1.89
and
$4.05
for stock options granted during the
nine
months ended
January
31,
2017
and
2016,
respectively.
 
 
 
Nine months ended January 31,
 
 
 
2017
 
 
2016
 
Risk-free interest rate
   
1.3
%    
1.6
%
Expected dividend yield
   
0.0
%    
0.0
%
Expected life (in years)
   
5.50
     
5.5
 
Expected volatility
   
96.2
%    
85.7
%
 
A summary of stock options under our stock incentive plans is detailed in the following table. 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
 
Remaining
 
 
 
Shares
 
 
Average
 
 
Contractual
 
 
 
Underlying
 
 
Exercise
 
 
Term
 
 
 
Options
 
 
Price
 
 
(In Years)
 
Outstanding as of April 30, 2016
   
89,303
    $
42.90
     
3.6
 
Forfeited
   
(987
)   $
46.45
     
 
 
Exercised
   
-
    $
-
     
 
 
Granted
   
171,749
    $
2.12
     
 
 
Outstanding as of January 31, 2017
   
260,065
    $
15.96
     
7.2
 
Exercisable as of January 31, 2017
   
157,066
    $
24.44
     
5.6
 
 
As of
January
31,
2017,
the total intrinsic value of outstanding and exercisable options was approximately
$107
thousand and
$95
thousand, respectively. As of
January
31,
2017,
approximately
101,392
additional options are expected to vest in the future with an intrinsic value of approximately
$10
thousand and a weighted average remaining contractual term of
9.6
years. There was approximately
$0.2
million and
$0.1
million of total recognized compensation cost related to stock options during the
nine
months ended
January
31,
2017
and
2016,
respectively. As of
January
31,
2017,
there was approximately
$0.2
million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of
0.8
years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.
 
(b) Restricted Stock
 
Compensation expense for non-restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the
nine
months ended
January
31,
2017,
the Company granted
223,662
shares subject to service-based vesting requirements and
no
shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company’s total shareholder return (“TSR”) relative to the total shareholder return of
three
alternative energy Exchange Traded Funds as measured over a specific performance period. No vesting of the relevant shares will occur in instances where the Company’s TSR for the relevant period is below
80%
of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period
may
occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.
 
In
January
2016,
the Board of Directors authorized a modification to certain outstanding restricted stock grants, which converted certain grants with performance-based grants to service-based grants. The modification of the restricted stock grants did not have a material impact on the Company’s statement of operations during the
nine
months ended
January
31,
2017.
Restricted stock issued and unvested as of
January
31,
2017
included
4,000
shares of unvested restricted stock subjected to performance-based vesting requirements.
 
A summary of non-vested restricted stock under our stock incentive plans is as follows:
 
 
 
 
 
 
 
Weighted
 
 
 
Number
 
 
Average Price per
 
 
 
of Shares
 
 
Share
 
                 
Issued and unvested at April 30, 2016
   
40,008
    $
6.70
 
Granted
   
223,662
    $
3.94
 
Forfeited
   
(28,266
)   $
3.98
 
Vested
   
(139,492
)   $
4.70
 
Issued and unvested at January 31, 2017
   
95,912
    $
3.99
 
 
There was approximately
$0.8
million and
$0.2
million of total recognized compensation cost related to restricted stock for the
nine
months ended
January
31,
2017
and
2016,
respectively. As of
January
31,
2017,
there was approximately
$0.2
million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of
0.4
 years.
 
(c)Treasury Stock
 
During the
nine
months ended
January
31,
2017
and
2016,
39,882
and
1,839
shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Fair Value Measurements
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
(10)
Fair Value Measurements
 
The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a
three
-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument’s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the
three
hierarchy levels.
 
Level
1
Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
 
 
Level
2
Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.
 
 
Level
3
   
Unobservable inputs are not corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.
 
Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were no transfers between any levels during the
three
and
nine
months ended
January
 
31,
2017
and
2016.
 
The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.
 
Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.
 
Warrant Liabilities
 
The fair value of the Company's warrant liabilities (refer to Note 
8)
recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level 
3
measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.  
 
The following table presents financial assets and liabilities measured at fair value on a recurring basis as of
January
 
31,
2017.
 
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
As of January 31, 2017:
 
(in thousands)
 
Warrant liabilities
  $
653
    $
-
    $
-
    $
653
 
 
The changes in the value of the warrant liabilities during the
nine
months ended
January
31,
2017
were as follows.
 
Fair value – April 30, 2016
  $
-
 
Issuance
   
1,814
 
Transfers
   
-
 
Change in fair value
   
(1,161
)
Fair value – January 31, 2017
  $
653
 
 
There were
no
re-measured assets or liabilities at fair value on a non-recurring basis during the
nine
months ended
January
31,
2017
and
2016,
respectively.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Commitments and Contingencies
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
 
(11)
 Commitments and Contingencies
 
(a) Litigation
 
Shareholder Litigation and Demands 
 
The Company and its former Chief Executive Officer Charles Dunleavy were named as defendants in consolidated securities class action lawsuits that were pending in the United States District Court for the District of New Jersey captioned In Re: Ocean Power Technologies, Inc. Securities Litigation, Civil Action No.
14
-
3799
(FLW) (LHG).
 
On
May
5,
2016,
the parties entered into a Stipulation and Agreement of Class Settlement (“Stipulation”) in which they agreed to a settlement of the consolidated securities class action lawsuits, subject to Court approval. The Stipulation provides, among other things, for a settlement payment by or on behalf of the Company of
$3.0
million in cash, of which the Company would pay
$0.5
million and the Company’s insurer would pay
$2.5
million, and the issuance by the Company of
380,000
shares (valued at
$0.6
million on the date the Stipulation was signed by the parties) of its Common Stock to the class members. In connection with the settlement, the parties have agreed to execute mutually agreeable releases. The amounts agreed in the Stipulation, including the amount to be contributed by our insurance carrier, were reflected in the Company’s Consolidated Financial Statements as of
April
30,
2016.
In
July
2016,
the Company paid the
$0.5
million portion of the settlement and the remaining balance of
$2.5
million was paid by the Company’s insurer in
August
2016.
On
November
14,
2016,
the Court held its previously scheduled Settlement Hearing to consider whether to grant final approval of the settlement, and on
November
15,
2016,
the Court issued its Final Judgment approving the settlement and dismissing the proceeding with prejudice.
The
380,000
shares of common stock were issued on
November
22,
2016.
The time to file an appeal from the Final Judgment has expired without any appeal being filed.  
 
The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on
March
18,
2015
in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No.
3:15
-cv-
01980
-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.
 
On
July
10,
2015,
a
second
derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No.
3:15
-cv-
05469,
was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief.
 
On
April
21,
2016,
a
third
derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No.
3:16
-cv-
02249,
was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief.
 
On
June
9,
2016,
a
fourth
derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief.
 
On
October
25,
2016,
the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the
four
derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for
November
14,
2016
in the securities class action and further order of the Court. Defendants have not responded to the consolidated derivative actions because the actions remain stayed pending further order from the Court.
 
The Company and certain of its current directors are defendants in a lawsuit filed by an alleged shareholder in the Superior Court of New Jersey, Mercer County Chancery Division on
January
25,
2016,
captioned Stern v. Ocean Power Technologies, Inc., et al., Civil Action No. C-
5
-
16.
The complaint alleges that certain provisions of the Company’s Certificate of Incorporation and By-laws providing that the Company’s directors
may
be removed only for cause and only by an affirmative vote of at least
75%
of the votes which all the stockholders would be entitled to cast in any annual election of directors are invalid under Section
141(k)
of the Delaware General Corporation Law. The Complaint asserts a breach of fiduciary claim against the director defendants and a declaratory judgment claim against all defendants seeking, among other things, to invalidate the current provisions and declare that the Company’s directors
may
be removed and replaced without cause and by a simple majority vote. The Complaint seeks declaratory and injunctive relief as well as unspecified costs and attorneys’ fees. By Unanimous Written Consent dated
June
17,
2016,
the Company’s Board of Directors amended the Company’s By-laws to delete the “only for cause” requirement, thereby allowing for removal of directors with or without cause by the Company’s stockholders. In addition, the Board proposed, subject to approval by the Company’s stockholders at the next annual general meeting of stockholders, a similar amendment to the director removal provision in the Company’s Certificate of Incorporation. On
June
22,
2016,
the parties to the lawsuit submitted a Stipulation and Proposed Order Staying Proceedings that
(1)
stays the case pending the stockholder vote on the proposed amendment to the Company’s Certificate of Incorporation;
(2)
provides for dismissal of the action with prejudice if the stockholders approve the amendment, subject to plaintiff’s right to make a fee application to the court and defendants’ right to oppose any such application; and
(3)
provides for the stay to be lifted and the action to resume, without waiver of any parties’ rights, if the stockholders do not approve the amendment. The Court approved the Stipulation on
June
30,
2016.
On
September
2,
2016,
the Company filed a definitive proxy statement with the SEC which includes this proposal. At the annual shareholder meeting on
October
21,
2016,
the proposal was not approved because an insufficient number of votes were cast to satisfy the requirement that the proposal be approved by the holders of at least
75%
of the outstanding shares of common stock entitled to vote at the meeting.  However, stockholders approved an amendment to the Company’s Certificate of Incorporation to add a provision which requires that any provision of the Certificate of Incorporation that is contrary to a requirement of the Delaware General Corporate Law shall be read in conformity with the applicable requirement of the Delaware General Corporate Law
. The parties have agreed that the case shall remain stayed until further steps, if any, can be agreed to and taken as needed.
 
Employment Litigation 
 
On
June
10,
2014,
the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective
June
9,
2014,
and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On
June
17,
2014,
Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On
July
28,
2014,
Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.
 
Except for the Stipulation noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.
 
(b) Regulatory Matters
 
SEC Investigation
 
On
February
4,
2015,
the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on
July
12,
2016,
the SEC issued a
second
subpoena requesting information related to the Company’s
April
4,
2014
public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.
 
Spain IVA (sales tax)
 
In
June
2012,
the Company received notice that the Spanish tax authorities are inquiring into its
2010
IVA (value-added tax) filing for which the Company benefitted from the offset of approximately
$0.3
million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued
two
letters of credit totaling
€0.3
million
($0.3
million) at the request of the Spanish tax authorities. Separately, as of
January
31,
2017
the Company has received
$0.2
million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during
February
2017,
the Spanish tax authorities approved of the release of the
two
outstanding letters of credit.
 
Spain Income Tax Audit
 
We are currently undergoing an income tax audit in Spain for the period from
2008
to
2014,
when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. We have not established any provision for losses related to this matter.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
(12)
 Income Taxes
 
During the
three
and
nine
months ended
January
31,
2017,
the Company recorded an income tax benefit of
$0.7
million, representing the proceeds from the sale of
$7.8
million of New Jersey net operating loss carryforwards and research and development tax credits. During the
three
and
nine
months ended
January
31,
2016,
the Company recorded an income tax benefit of
$1.7
million representing the proceeds from the sale of
$19.7
million of New Jersey net operating loss carryforwards and research and development tax credits.
 
Other than as a result of the sale of New Jersey net operating loss carryforwards, the Company did
not
recognize any consolidated income tax benefit (expense) during the
three
and
nine
month periods ended
January
31,
2017
and
2016.
 
During the
three
and
nine
months ended
January
31,
2017,
the Company had
no
material changes in uncertain tax positions.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Operating Segments and Geographic Information
9 Months Ended
Jan. 31, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
(13)
 Operating Segments and Geographic Information
 
The Company's business consists of
one
segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with
one
operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the
three
and
nine
months ended
January
31,
2017
and
2016,
the Company’s primary business operations were in North America.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant Accounting Policies (Policies)
9 Months Ended
Jan. 31, 2017
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
b)
Basis of Presentation
 
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form
10
-Q and Article 
10
of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form
10
-K for the year ended
April
30,
2016
filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form
10
-Q.
Liquidity, Policy [Policy Text Block]
c)
Liquidity/Going Concern
 
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of
$184.8
million as of
January
31,
2017.
As of
January
31,
2017,
the Company had approximately
$11.1
million in cash on hand. The Company generated revenues of
$0.6
million during each of the
nine
months ended
January
31,
2017
and
2016.
Based on the Company’s cash and cash equivalents and marketable securities as of
January
31,
2017,
the Company believes that it will be able to finance its capital requirements and operations into the quarter ending
January
31,
2018.
The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
 
Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies
may
include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.
 
In fiscal
2017
and
2016,
the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed
three
equity financing arrangements during the
nine
months ended
January
31,
2017.
 The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company
may
be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and
may
cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.
 
On
June
2,
2016,
the Company entered into a securities purchase agreement, which was amended on
June
7,
2016
(as amended, the “Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The net proceeds to the Company from the offering were approximately
$1.7
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of
$6.08
per share, became exercisable on
December
3,
2016
(“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
 
On
July
22,
2016,
the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The net proceeds to the Company from the offering were approximately
$3.6
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(5th)
anniversary of the initial date of issuance.
 
On
October
19,
2016,
the Company sold
2,760,000
shares of common stock at a price of
$2.75
per share, which includes the sale of
360,000
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$6.9
million, after deducting placement agent fees and offering expenses payable by the Company.
 
The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing
may
not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it
may
be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it
may
be forced to cease operations.
Consolidation, Policy [Policy Text Block]
(a) Consolidation
 
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Participation of stockholders other than the Company in the net assets and in the earnings or losses of a consolidated subsidiary is reflected as a non-controlling interest in the Company's Consolidated Balance Sheets and Statements of Operations, which adjusts the Company's consolidated results of operations to reflect only the Company's share of the earnings or losses of the consolidated subsidiary. As of
January
31,
2017,
there were no non-controlling interests.
 
In
September
2015,
the Company re-purchased the non-controlling interest (consisting of
11.8%)
of OPTA for nominal consideration and now has
100%
ownership of OPTA. The Company also periodically evaluates its relationships with other entities to identify whether they are variable interest entities, and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is included in the consolidated financial statements. As of
January
31,
2017,
there were no such entities.
Use of Estimates, Policy [Policy Text Block]
(b) Use of Estimates
 
The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]
(c) Revenue Recognition
 
The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.
 
The Company has
two
types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of
zero.
The Company’s share of the costs is recorded as product development expense.
 
Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria
may
be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.
 
In addition, recognition of revenue (and the related costs)
may
be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management
may
make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects
may
have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.
 
Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within
one
year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.
 
A portion of the Company’s projects have been under cost-sharing contracts.
Cash and Cash Equivalents, Policy [Policy Text Block]
(d) Cash and Cash Equivalents
 
The Company considers all highly liquid investments with a maturity of
three
months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least
100%
of the bank’s total obligations under the agreement.
 
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Checking and savings accounts
  $
8,587
    $
4,535
 
Overnight repurchase account
   
2,523
     
2,195
 
    $
11,110
    $
6,730
 
Marketable Securities, Policy [Policy Text Block]
(e) Marketable Securities
 
Marketable securities with original maturities longer than
three
months but that mature in less than
one
year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of
January
31,
2017
and
April
30,
2016,
all of the Company’s investments were classified as held-to-maturity.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
(f) Restricted Cash and Credit Facility
 
A portion of the Company’s cash is restricted under the terms of
two
security agreements.
 
One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD,
one
of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility carries a fee of
1%
per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of
January
31,
2017,
there was
€0.3
million
($0.3
million) in letters of credit outstanding under this agreement.
 
The
second
agreement was between the Company and the New Jersey Board of Public Utilities (“NJBPU”). The Company received a
$0.5
million recoverable grant award from the NJBPU, repayable over a
five
-year period beginning in
November
2011.
The agreement also required the Company to annually assign to the NJBPU a certificate of deposit in an amount equal to the outstanding grant balance. As of
January
31,
2017,
the grant was fully repaid and therefore there was no certificate of deposit. See Note
(6)
“Debt” for additional information. Restricted cash includes the following:
 
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
NJBPU agreement
  $
-
    $
50
 
Barclay's Bank Agreement
   
299
     
250
 
    $
299
    $
300
 
Foreign Currency Transactions and Translations Policy [Policy Text Block]
(g) Foreign Exchange Gains and Losses
 
The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions
may
result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in foreign exchange gain in the accompanying consolidated statements of operations.
Property, Plant and Equipment, Policy [Policy Text Block]
(h) Property and Equipment
 
Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives
(three
to
seven
years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset
may
not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
(i) Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.
 
The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least
10%
of the Company's consolidated revenues for at least
one
of the periods indicated:
 
 
 
Three months ended January 31,
 
 
Nine months ended January 31,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Mitsui Engineering & Shipbuilding
   
56
%    
-
     
83
%    
-
 
U.S. Department of Defense Office of
                               
Naval Research
   
44
%    
-
     
17
%    
-
 
US Department of Energy
   
-
     
100
%    
-
     
33
%
European Union (WavePort project)
   
-
     
-
     
-
     
67
%
     
100
%    
100
%    
100
%    
100
%
 
The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.
Warrant Liability, Policy [Policy Text Block]
(j) Warrant Liabilities
 
The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “(loss) gain on fair value of warrant liabilities”. The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “additional paid-in capital”, a component of “stockholders' equity” on the consolidated balance sheets.
Earnings Per Share, Policy [Policy Text Block]
(k) Net Loss per Common Share
 
Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.
 
In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling
680,429
for the
three
and
nine
months ended
January
31,
2017
and
154,537
for the
three
and
nine
months ended
January
31,
2016,
were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.
 
New Accounting Pronouncements, Policy [Policy Text Block]
(l) Recently Issued Accounting Standards
 
In
May
2014,
the Financial Accounting Standards Board (“FASB”) issued ASU No.
2014
-
09,
“Revenue from Contracts with Customers”. This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires an entity to disclose sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Qualitative and quantitative information is required about:
 
 
Contracts with customers—including revenue and impairments recognized, disaggregation of revenue and information about contract balances and performance obligations (including the transaction price allocated to the remaining performance obligations).
 
Significant judgments and changes in judgments—determining the timing of satisfaction of performance obligations (over time or at a point in time), and determining the transaction price and amounts allocated to performance obligations.
 
Certain assets—assets recognized from the costs to obtain or fulfill a contract.
 
In
August
2015,
the FASB issued updated guidance deferring the effective date of the revenue recognition standard. In
March
and
April
2016,
the FASB issued additional updated guidance, which clarifies certain aspects of the ASU and the related implementation guidance issued by the FASB-IASB Joint Transition Resource Group for Revenue Recognition. This guidance is effective for the Company for annual reporting periods beginning after
December
15,
2017.
The Company is currently evaluating the impact that this guidance will have on its results of operations, financial position and cash flows.
 
In
August
2014,
the FASB issued ASU
2014
-
15,
“Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the
first
annual period ending after
December
15,
2016,
and interim periods thereafter. Early application is permitted. The Company is evaluating the effect ASU
2014
-
15
will have on its consolidated financial statements and disclosures and have not yet determined the effect of the standard on its ongoing financial reporting at this time. See Note
(1)
 “Background, Basis of Presentation and Liquidity” for discussion on the Company’s ability to continue as a going concern.
 
In
January
2016,
the FASB issued ASU No.
2016
-
01,
“Recognition and Measurement of Financial Assets and Financial Liabilities”, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after
December
15,
2017,
including interim periods within those fiscal years. The Company will evaluate the effect of ASU
2016
-
01
for future periods as applicable. 
 
In
February
2016,
the FASB issued ASU No.
2016
-
02,
“Leases (Topic
842)”.
The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than
12
months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU
2016
-
02
is effective for annual periods beginning after
December
15,
2018,
including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU
2016
-
02
will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.
 
In
March
2016,
the FASB issued ASU No.
2016
-
09,
“Compensation - Stock Compensation (Topic
718)”,
or ASU No.
2016
-
09.
The amendments of ASU No.
2016
-
09
were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity
may
be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No.
2016
-
09
is effective for fiscal years beginning after
December
15,
2016,
and interim periods within those annual periods. Early adoption is permitted. The Company will evaluate the effect of ASU
2016
-
09
for future periods as applicable.
 
In
June
2016,
the FASB issued ASU
2016
-
13,
“Financial Instruments - Credit Losses (Topic
326):
Measurement of Credit Losses on Financial Instruments”. The standard provides for a new impairment model which requires measurement and recognition of expected credit losses for most financial assets held. The ASU is effective for public companies for annual periods, and interim periods within those annual periods, beginning after
December
15,
2019.
The Company is evaluating the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and believes the standard will have no impact on its ongoing financial reporting at this time.
 
In
August
2016,
the FASB issued ASU
2016
-
15,
“Statement of Cash Flows (Topic
230):
Classification of Certain Cash Receipts and Cash Payments”, providing additional guidance on
eight
specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for
fiscal years beginning after
December
15,
2017,
and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.
 
In
November
2016,
the FASB issued ASU
2016
-
18,
“Statement of Cash Flows (Topic
230):
Restricted Cash”, providing additional guidance on specific restricted cash flow classification on the cash flow statement. Cash flow should include restricted cash in total cash, and an entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for
fiscal years beginning after
December
15,
2017,
and interim periods within those fiscal years and early adoption is permitted. The Company is evaluating the effect ASU
2016
-
18
will have on its consolidated financial statements and disclosures and believes the effect of the standard on its ongoing financial reporting will not have a material impact.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jan. 31, 2017
Notes Tables  
Schedule of Cash and Cash Equivalents [Table Text Block]
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Checking and savings accounts
  $
8,587
    $
4,535
 
Overnight repurchase account
   
2,523
     
2,195
 
    $
11,110
    $
6,730
 
Schedule of Restricted Cash and Cash Equivalents [Table Text Block]
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
NJBPU agreement
  $
-
    $
50
 
Barclay's Bank Agreement
   
299
     
250
 
    $
299
    $
300
 
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
 
 
Three months ended January 31,
 
 
Nine months ended January 31,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Mitsui Engineering & Shipbuilding
   
56
%    
-
     
83
%    
-
 
U.S. Department of Defense Office of
                               
Naval Research
   
44
%    
-
     
17
%    
-
 
US Department of Energy
   
-
     
100
%    
-
     
33
%
European Union (WavePort project)
   
-
     
-
     
-
     
67
%
     
100
%    
100
%    
100
%    
100
%
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities (Tables)
9 Months Ended
Jan. 31, 2017
Current [Member]  
Notes Tables  
Marketable Securities [Table Text Block]
 
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Certificate of Deposit
  $
25
    $
75
 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Balance Sheet Detail (Tables)
9 Months Ended
Jan. 31, 2017
Notes Tables  
Schedule of Other Assets and Other Liabilities [Table Text Block]
Accrued expenses
 
January 31, 2017
 
 
April 30, 2016
 
   
(in thousands)
 
Project costs (a)
  $
1,239
    $
818
 
Contract loss reserve
   
199
     
199
 
Employee incentive payments
   
463
     
688
 
Accrued salary and benefits
   
593
     
456
 
Legal and accounting fees
   
329
     
240
 
Other
   
298
     
274
 
    $
3,121
    $
2,675
 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Warrants (Tables)
9 Months Ended
Jan. 31, 2017
Notes Tables  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
 
 
January 31, 2017
 
Dividend rate  
 
0.0%
 
 
Risk-free rate  
 
1.9%
 
 
Expected life (years)
 
4.5
-
4.9
 
Expected volatility
 
129.0%
-
138.2%
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Share-based Compensation (Tables)
9 Months Ended
Jan. 31, 2017
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
 
Nine months ended January 31,
 
 
 
2017
 
 
2016
 
Risk-free interest rate
   
1.3
%    
1.6
%
Expected dividend yield
   
0.0
%    
0.0
%
Expected life (in years)
   
5.50
     
5.5
 
Expected volatility
   
96.2
%    
85.7
%
Schedule of Share-based Compensation, Activity [Table Text Block]
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
 
Remaining
 
 
 
Shares
 
 
Average
 
 
Contractual
 
 
 
Underlying
 
 
Exercise
 
 
Term
 
 
 
Options
 
 
Price
 
 
(In Years)
 
Outstanding as of April 30, 2016
   
89,303
    $
42.90
     
3.6
 
Forfeited
   
(987
)   $
46.45
     
 
 
Exercised
   
-
    $
-
     
 
 
Granted
   
171,749
    $
2.12
     
 
 
Outstanding as of January 31, 2017
   
260,065
    $
15.96
     
7.2
 
Exercisable as of January 31, 2017
   
157,066
    $
24.44
     
5.6
 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
 
 
 
 
 
 
Weighted
 
 
 
Number
 
 
Average Price per
 
 
 
of Shares
 
 
Share
 
                 
Issued and unvested at April 30, 2016
   
40,008
    $
6.70
 
Granted
   
223,662
    $
3.94
 
Forfeited
   
(28,266
)   $
3.98
 
Vested
   
(139,492
)   $
4.70
 
Issued and unvested at January 31, 2017
   
95,912
    $
3.99
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Fair Value Measurements (Tables)
9 Months Ended
Jan. 31, 2017
Notes Tables  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
As of January 31, 2017:
 
(in thousands)
 
Warrant liabilities
  $
653
    $
-
    $
-
    $
653
 
Changes on Value of Warrant Liability [Table Text Block]
Fair value – April 30, 2016
  $
-
 
Issuance
   
1,814
 
Transfers
   
-
 
Change in fair value
   
(1,161
)
Fair value – January 31, 2017
  $
653
 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Background, Basis of Presentation and Liquidity (Details Textual)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 19, 2016
USD ($)
$ / shares
shares
Jul. 22, 2016
USD ($)
$ / shares
shares
Jun. 02, 2016
USD ($)
$ / shares
shares
Jan. 31, 2017
USD ($)
Jan. 31, 2016
USD ($)
Jan. 31, 2017
USD ($)
Jan. 31, 2016
USD ($)
Apr. 30, 2016
USD ($)
Apr. 30, 2015
USD ($)
Retained Earnings (Accumulated Deficit) | $       $ (184,794)   $ (184,794)   $ (177,884)  
Cash and Cash Equivalents, at Carrying Value | $       11,110 $ 9,413 11,110 $ 9,413 $ 6,730 $ 17,336
Revenues | $       $ 221 $ 5 $ 593 605    
Number of Financing Agreements Closed           3      
Stock Issued During Period, Shares, New Issues | shares 2,760,000                
Proceeds from Issuance or Sale of Equity | $ $ 6,900         $ 12,150    
Share Price | $ / shares $ 2.75                
Purchase Agreement [Member]                  
Stock Issued During Period, Shares, New Issues | shares   595,000 417,000            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares   178,500 145,952            
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares   0.3 0.35            
Price Per Common Stock and Warrant | $ / shares   $ 6.75 $ 4.60            
Proceeds from Issuance or Sale of Equity | $   $ 3,600 $ 1,700            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares   $ 9.36 $ 6.08            
Class of Warrant or Right, Expiration Period     5 years            
Over-Allotment Option [Member]                  
Stock Issued During Period, Shares, New Issues | shares 360,000                
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
$ in Thousands, € in Millions
3 Months Ended 6 Months Ended 9 Months Ended
Jan. 31, 2017
USD ($)
shares
Jan. 31, 2016
shares
Oct. 31, 2016
Jan. 31, 2017
USD ($)
shares
Jan. 31, 2016
shares
Jan. 31, 2017
EUR (€)
Sep. 30, 2015
Nov. 30, 2011
USD ($)
Stockholders' Equity Attributable to Noncontrolling Interest $ 0     $ 0        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 680,429 154,537   680,429 154,537      
Minimum [Member]                
Property, Plant and Equipment, Useful Life       3 years        
Maximum [Member]                
Property, Plant and Equipment, Useful Life       7 years        
Barclays Bank [Member]                
Line of Credit Facility, Commitment Fee Percentage     1.00%          
Long-term Line of Credit $ 300     $ 300   € 0.3    
New Jersey Board of Public Utilities 1 [Member]                
Restricted Cash and Cash Equivalents               $ 500
OPTA [Member]                
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners             11.80%  
Ownership Percentage             100.00%  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
Jan. 31, 2016
Apr. 30, 2015
Cash and cash equivalents $ 11,110 $ 6,730 $ 9,413 $ 17,336
Checking and Savings Accounts [Member]        
Cash and cash equivalents 8,587 4,535    
Overnight Repurchase Account [Member]        
Cash and cash equivalents $ 2,523 $ 2,195    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
Restricted cash, current $ 299 $ 300
NJBPU Agreement [Member]    
Restricted cash, current 50
Barclays Bank Agreement [Member]    
Restricted cash, current $ 299 $ 250
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) - Customer Concentration Risk [Member] - Sales Revenue, Net [Member]
3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Revenues, percentage 100.00% 100.00% 100.00% 100.00%
Mitsui Engineering and Ship Building [Member]        
Revenues, percentage 56.00% 83.00%
U.S. Department of Defense Office of Naval Research [Member]        
Revenues, percentage 44.00% 17.00%
US Department of Energy [Member]        
Revenues, percentage 100.00% 33.00%
European Union Waver Port Project [Member]        
Revenues, percentage 67.00%
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
Marketable securities $ 25 $ 75
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Balance Sheet Detail (Details Textual)
$ in Millions
Jan. 31, 2017
USD ($)
Reedsport Project [Member]  
Environmental Exit Costs, Costs Accrued to Date $ 0.8
PB40 Projects [Member]  
Environmental Exit Costs, Costs Accrued to Date $ 0.5
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Balance Sheet Detail - Balance Sheet Details (Details) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
Project costs (a) [1] $ 1,239 $ 818
Contract loss reserve 199 199
Employee incentive payments 463 688
Accrued salary and benefits 593 456
Legal and accounting fees 329 240
Other 298 274
Accrued expenses total $ 3,121 $ 2,675
[1] Project costs at January 31, 2017 include accruals of $0.8 milliion and $0.5 million for the disposition of the legacy Reedsport project anchors and site remediation for the legacy PB40 projects, respectively. Both efforts are anticipated to be completed in the first quarter of fiscal 2018.
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Related Party Transactions (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2014
Jan. 31, 2017
Jan. 31, 2017
Jan. 31, 2016
Related Party Transaction Term of Agreement 1 year 90 days      
Related Party Transaction Monthly Consulting Fee $ 20      
Related Party Transaction, Expenses from Transactions with Related Party   $ 0 $ 0 $ 53
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Debt (Details Textual) - USD ($)
$ in Thousands
1 Months Ended
Nov. 30, 2011
Jan. 31, 2017
Apr. 30, 2016
Jun. 30, 2010
Other Assets, Current   $ 337 $ 117  
New Jersey Board of Public Utilities 1 [Member]        
Long-term Debt   0 50  
Long-term Debt Payment Terms 5 years      
New Jersey Board of Public Utilities 1 [Member] | Certificates of Deposit [Member]        
Other Assets, Current   $ 0 $ 50  
Corporation [Member]        
Long-term Debt       $ 500
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Deferred Credits Payable (Details Textual)
$ in Millions
Jan. 31, 2017
USD ($)
Apr. 30, 2016
USD ($)
Apr. 30, 2001
USD ($)
T
Rate
Customer Advances or Deposits, Noncurrent | $ $ 0.6 $ 0.6
Deferred Credits Payable Option Details | T     500,000
Deferred Credits Payable Market Discount Rate | Rate     30.00%
Deferred Credits Payable Market Liquidated Damages Rate | Rate     30.00%
Customer Advances and Deposits, Current | $ $ 0.6  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Warrants (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 19, 2016
Jul. 22, 2016
Jun. 02, 2016
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Apr. 30, 2016
Stock Issued During Period, Shares, New Issues 2,760,000              
Fair Value Adjustment of Warrants       $ 100 $ 0 $ (1,161) $ 0  
Warrant [Member]                
Derivative Liability, Current       $ 700   $ 700   $ 0
Purchase Agreement [Member]                
Stock Issued During Period, Shares, New Issues   595,000 417,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   178,500 145,952          
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right   0.3 0.35          
Price Per Common Stock and Warrant   $ 6.75 $ 4.60          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 9.36 $ 6.08          
Class of Warrant or Right, Expiration Period     5 years          
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Warrants - Fair Value Assumptions for Warrants (Details) - Warrant [Member]
9 Months Ended
Jan. 31, 2017
Dividend rate 0.00%
Risk-free rate 1.90%
Expected volatility
Minimum [Member]  
Expected life (years) (Year) 4 years 182 days
Expected volatility 129.00%
Maximum [Member]  
Expected life (years) (Year) 4 years 328 days
Expected volatility 138.20%
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Share-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Allocated Share-based Compensation Expense $ 1,000 $ 300
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 1.89 $ 4.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 107  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 95  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 101,392  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 10  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term 9 years 219 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 95,912  
Treasury Stock, Shares, Acquired 39,882 1,839
Employee Stock Option [Member]    
Allocated Share-based Compensation Expense $ 200 $ 100
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options $ 200  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 292 days  
Restricted Stock [Member]    
Allocated Share-based Compensation Expense $ 800 $ 200
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 146 days  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options $ 200  
Restricted Stock [Member] | Service-based Vesting [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 223,662  
Restricted Stock [Member] | Performance based vesting [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 4,000  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Share-based Compensation - Fair Value Assumptions for Options (Details) - Employee Stock Option [Member]
9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Risk-free interest rate 1.30% 1.60%
Expected dividend yield 0.00% 0.00%
Expected life (in years) (Year) 5 years 182 days 5 years 182 days
Expected volatility 96.20% 85.70%
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Share-based Compensation - Stock Options Under the Plans (Details) - $ / shares
9 Months Ended 12 Months Ended
Jan. 31, 2017
Apr. 30, 2016
Beginning Balance, shares underlying options (in shares) 89,303  
Beginning Balance, weighted average exercise price (in dollars per share) $ 42.90  
Balance, weighted average remaining contractual term (Year) 7 years 73 days 3 years 219 days
Forfeited (in shares) (987)  
Forfeited. (in dollars per share) $ 46.45  
Exercised (in shares)  
Exercised. (in dollars per share)  
Granted (in shares) 171,749  
Granted. (in dollars per share) $ 2.12  
Ending Balance, shares underlying options (in shares) 260,065 89,303
Ending Balance, weighted average exercise price (in dollars per share) $ 15.96 $ 42.90
Exercisable, shares underlying options (in shares) 157,066  
Exercisable, weighted average exercise price (in dollars per share) $ 24.44  
Exercisable, weighted average remaining contractual term (Year) 5 years 219 days  
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Stock-based Compensation - Non-vested Restricted Stock Under the Plans (Details)
9 Months Ended
Jan. 31, 2017
$ / shares
shares
Ending Balance, issued and unvested (in shares) | shares 95,912
Ending Balance, issued and unvested (in dollars per share) | $ / shares $ 3.99
Non-vested Restricted Stock [Member]  
Beginning Balance, issued and unvested (in shares) | shares 40,008
Beginning Balance, issued and unvested (in dollars per share) | $ / shares $ 6.70
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 223,662
Granted (in dollars per share) | $ / shares $ 3.94
Forfeited (in shares) | shares (28,266)
Forfeited (in dollars per share) | $ / shares $ 3.98
Vested (in shares) | shares (139,492)
Vested (in dollars per share) | $ / shares $ 4.70
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Fair Value Measurements (Details Textual) - Fair Value, Measurements, Nonrecurring [Member] - USD ($)
$ in Thousands
9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Assets, Fair Value Adjustment $ 0 $ 0
Liabilities, Fair Value Adjustment $ 0 $ 0
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jan. 31, 2017
Apr. 30, 2016
Warrant liabilities $ 653
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Reported Value Measurement [Member]    
Warrant liabilities 653  
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]    
Warrant liabilities  
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]    
Warrant liabilities  
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]    
Warrant liabilities $ 653  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Fair value – April 30, 2016      
Issuance     1,814  
Transfers      
Fair Value Adjustment of Warrants $ 100 $ 0 (1,161) $ 0
Fair value – January 31, 2017 $ 653   $ 653  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Commitments and Contingencies (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Nov. 14, 2016
Dec. 15, 2016
Aug. 31, 2016
Jul. 31, 2016
Jun. 30, 2012
Jan. 31, 2017
Jan. 31, 2016
Jan. 25, 2016
Payments for Legal Settlements           $ 500  
Tax Authority, Spain [Member]                
Input Tax         $ 300      
Letters of Credit Outstanding, Amount         $ 300      
Foreign Tax Examination Refund           $ (200)    
Stipulation [Member]                
Litigation Settlement, Amount $ 3,000              
Payments for Legal Settlements       $ 500        
Litigation Settlement, Amount Paid by Insurer     $ 2,500          
Stock Issued During Period, Shares, Litigation Settlement   380,000            
Stock Issued During Period, Value, Litigation Settlement   $ 600            
Stern Lawsuit [Member]                
Affirmative Vote Percentage By Stockholders               75.00%
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2017
Jan. 31, 2016
Unrecognized Tax Benefits, Period Increase (Decrease) $ 0   $ 0  
Income Tax Expense (Benefit) (698) $ (1,674) (698) $ (1,674)
New Jersey Division of Taxation [Member]        
Unrecognized Tax Benefits, Period Increase (Decrease) 700 1,700 700 1,700
Proceed from Sale of Loss Carryforwards and Tax Credits 7,800 19,700 7,800 19,700
Income Tax Expense (Benefit) $ 0 $ 0 $ 0 $ 0
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Operating Segments and Geographic Information (Details Textual)
9 Months Ended
Jan. 31, 2017
Number of Operating Segments 1
EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 111 230 1 true 45 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement--consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-consolidated-statements-of-comprehensive-loss-unaudited Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-1-background-basis-of-presentation-and-liquidity Note 1 - Background, Basis of Presentation and Liquidity Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Document - Note 3 - Marketable Securities Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-3-marketable-securities Note 3 - Marketable Securities Uncategorized 10 false false R11.htm 010 - Disclosure - Note 4 - Balance Sheet Detail Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-4-balance-sheet-detail Note 4 - Balance Sheet Detail Uncategorized 11 false false R12.htm 011 - Disclosure - Note 5 - Related Party Transactions Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-5-related-party-transactions Note 5 - Related Party Transactions Uncategorized 12 false false R13.htm 012 - Disclosure - Note 6 - Debt Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-6-debt Note 6 - Debt Uncategorized 13 false false R14.htm 013 - Disclosure - Note 7 - Deferred Credits Payable Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-7-deferred-credits-payable Note 7 - Deferred Credits Payable Uncategorized 14 false false R15.htm 014 - Disclosure - Note 8 - Warrants Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-8-warrants Note 8 - Warrants Uncategorized 15 false false R16.htm 015 - Disclosure - Note 9 - Share-based Compensation Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-sharebased-compensation Note 9 - Share-based Compensation Uncategorized 16 false false R17.htm 016 - Disclosure - Note 10 - Fair Value Measurements Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-10-fair-value-measurements Note 10 - Fair Value Measurements Uncategorized 17 false false R18.htm 017 - Disclosure - Note 11 - Commitments and Contingencies Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-11-commitments-and-contingencies Note 11 - Commitments and Contingencies Uncategorized 18 false false R19.htm 018 - Disclosure - Note 12 - Income Taxes Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-12-income-taxes Note 12 - Income Taxes Uncategorized 19 false false R20.htm 019 - Disclosure - Note 13 - Operating Segments and Geographic Information Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-13-operating-segments-and-geographic-information Note 13 - Operating Segments and Geographic Information Uncategorized 20 false false R21.htm 020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 3 - Marketable Securities (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-3-marketable-securities-tables Note 3 - Marketable Securities (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 4 - Balance Sheet Detail (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-4-balance-sheet-detail-tables Note 4 - Balance Sheet Detail (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 8 - Warrants (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-8-warrants-tables Note 8 - Warrants (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 9 - Share-based Compensation (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-sharebased-compensation-tables Note 9 - Share-based Compensation (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 10 - Fair Value Measurements (Tables) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-10-fair-value-measurements-tables Note 10 - Fair Value Measurements (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-1-background-basis-of-presentation-and-liquidity-details-textual Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies-cash-and-cash-equivalents-details Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies-cash-restricted-under-security-agreements-details Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-2-summary-of-significant-accounting-policies-revenues-by-major-customers-details Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-3-marketable-securities-marketable-securities-that-mature-within-one-year-details Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 4 - Balance Sheet Detail (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-4-balance-sheet-detail-details-textual Note 4 - Balance Sheet Detail (Details Textual) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 4 - Balance Sheet Detail - Balance Sheet Details (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-4-balance-sheet-detail-balance-sheet-details-details Note 4 - Balance Sheet Detail - Balance Sheet Details (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 5 - Related Party Transactions (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-5-related-party-transactions-details-textual Note 5 - Related Party Transactions (Details Textual) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 6 - Debt (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-6-debt-details-textual Note 6 - Debt (Details Textual) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 7 - Deferred Credits Payable (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-7-deferred-credits-payable-details-textual Note 7 - Deferred Credits Payable (Details Textual) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 8 - Warrants (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-8-warrants-details-textual Note 8 - Warrants (Details Textual) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 8 - Warrants - Fair Value Assumptions for Warrants (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-8-warrants-fair-value-assumptions-for-warrants-details Note 8 - Warrants - Fair Value Assumptions for Warrants (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 9 - Share-based Compensation (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-sharebased-compensation-details-textual Note 9 - Share-based Compensation (Details Textual) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 9 - Share-based Compensation - Fair Value Assumptions for Options (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-sharebased-compensation-fair-value-assumptions-for-options-details Note 9 - Share-based Compensation - Fair Value Assumptions for Options (Details) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 9 - Share-based Compensation - Stock Options Under the Plans (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-sharebased-compensation-stock-options-under-the-plans-details Note 9 - Share-based Compensation - Stock Options Under the Plans (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 9 - Stock-based Compensation - Non-vested Restricted Stock Under the Plans (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-9-stockbased-compensation-nonvested-restricted-stock-under-the-plans-details Note 9 - Stock-based Compensation - Non-vested Restricted Stock Under the Plans (Details) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 10 - Fair Value Measurements (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-10-fair-value-measurements-details-textual Note 10 - Fair Value Measurements (Details Textual) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 10 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-10-fair-value-measurements-financial-assets-and-liabilities-measured-at-fair-value-on-a-recurring-basis-details Note 10 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 10 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-10-fair-value-measurements-changes-on-value-of-warrant-liability-details Note 10 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-11-commitments-and-contingencies-details-textual Note 11 - Commitments and Contingencies (Details Textual) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 12 - Income Taxes (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-12-income-taxes-details-textual Note 12 - Income Taxes (Details Textual) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 13 - Operating Segments and Geographic Information (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170131/role/statement-note-13-operating-segments-and-geographic-information-details-textual Note 13 - Operating Segments and Geographic Information (Details Textual) Uncategorized 50 false false All Reports Book All Reports optt-20170131.xml optt-20170131.xsd optt-20170131_cal.xml optt-20170131_def.xml optt-20170131_lab.xml optt-20170131_pre.xml true true ZIP 68 0001437749-17-003944-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-17-003944-xbrl.zip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

.YW@\ &+ 1 M " 1#O !O<'1T+3(P,3